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Checklists and Illustrative Financial Statements for Life and Health Insurance Entities 1
FSP Section 20,000
Checklists and Illustrative Financial 
Statements for Life and Health 
Insurance Entities
.01 The checklists and illustrative financial statements in this section have been developed by the staff 
of the Accounting and Auditing Publications Team of the AICPA as nonauthoritative technical practice aids. 
Readers should be aware of the following:
• The checklists and illustrative financial statements do not include all disclosures and presentation 
items promulgated; as a result, pronouncements deemed unlikely to be encountered in financial 
statements of life insurance companies are not included.
• The checklists and illustrative financial statements are "tools" and in no way represent official 
positions or pronouncements of the AICPA.
The financial statements and notes checklist have been updated to include relevant disclosure 
guidance in accounting pronouncements issued through November 30, 2001. Those 
pronouncements include:
• FASB Statement of Financial Accounting Standards (SFAS) No. 144, Accounting for the 
Impairment or Disposal of Long-Lived Assets
• FASB Interpretation (FASBI) No. 44, Accounting for Certain Transactions Involving 
Stock Compensation—an Interpretation of APB Opinion No. 25
FASB Technical Bulletin (FTB) No. 01-1, Effective Date for Certain Financial Institutions of 
Certain Provisions of Statement 140 Related to the Isolation of Transferred Financial Assets
• FASB Emerging Issues Task Force (EITF) consensuses adopted through the September 
2001.
• AICPA Statement on Auditing Standards (SAS) No. 94, The Effect of Information 
Technology on the Auditor's Consideration of Internal Control in a Financial Statement Audit
• AICPA Statement of Position (SOP) 01-4, Reporting Pursuant to the Association for 
Investment Management and Research Performance Presentation Standards
• AICPA Practice Bulletin (PB) No. 15, Accounting by the Issuer of Surplus Notes
• AICPA Statement on Standards for Accounting and Review Services (SSARS) 8, 
Amendment to Statement on Standards for Accounting and Review Services 1, Compilation 
and Review of Financial Statements
• AICPA Statement on Standards for Attestation Engagements (SSAE) No. 10, Attestation 
Standards: Revisions and Recodifications
• AICPA Audit and Accounting Guide Life and Health Insurance Entities (with conforming 
changes as of May 1, 2001)
FSP §20,000.01
2 Life and Health Insurance Entities
.02 A description of the insurance industry and a description of common accounting and reporting 
features of stock life insurance companies are presented in the AICPA Audit and Accounting Guide Life and 
Health Insurance Entities.
.03 The checklists and illustrative financial statements should be used by, or under the supervision of, 
persons having adequate technical training and proficiency in the application of generally accepted account­
ing principles, generally accepted auditing standards, and statements on standards for accounting and 
review services.
.04 Users of the checklists and illustrative financial statements are urged to refer directly to applicable 
authoritative pronouncements when appropriate. If you have further questions, call the AICPA Technical 
Hotline at 1-888-777-7077.
Note: This publication was extracted from sections 20,000 through 20,600 of the AICPA Financial Statement 
Preparation Manual (FSP).
FSP §20,000.02
Introduction 3
FSP Section 20,100
Introduction
.01 The function of insurance is to pool the risks of many persons who are exposed to similar risks. For 
a payment known as a premium, insurance companies undertake to relieve the policyholder of all or part of 
a risk and to spread the total cost of similar risks among large groups of policyholders. One of the primary 
purposes of life insurance is to provide financial assistance to named beneficiaries at the time of the death of 
the insured. The long-term nature of the coverage involving the risk of death—a risk that increases with 
age—is the distinguishing characteristic that sets life insurance apart from other forms of insurance. 
Traditionally, life insurance entities provided life and health products to protect against the loss of financial 
stability resulting from premature death or illness, and provided annuity products to protect against the risk 
of outliving one's financial resources. The primary emphasis was on meeting the customer's insurance needs. 
The provisions of the AICPA Audit and Accounting Guide Life and Health Insurance Entities, apply to all life 
and health insurance entities including stock, mutual, fraternal and assessment entities.
.02 In 1999, the National Association of Insurance Commissioners (NAIC) completed a process to codify 
statutory accounting practices for certain insurance enterprises, resulting in a revised Accounting Practices 
and Procedures Manual, effective January 1, 2001 (the revised Manual). The insurance laws and regulations of 
most states require insurance companies domiciled in those states to comply with the guidance provided in 
the NAIC Accounting Practices and Procedures Manual except as prescribed or permitted by state law.
.03 The AICPA is reviewing its guidance on reporting on statutory accounting practices (SAP) and will 
modify existing guidance as deemed necessary. AcSEC anticipates issuing a final SOP in December 2001 that 
will modify those SOPs that are affected by the codification.
FSP §20,100.03
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FSP Section 20,200
Checklists—General
.01 AICPA disclosure checklists have been designed as practice aids to assist accountants in the 
preparation of financial statements and to assist auditors in their evaluation of the adequacy of disclosures 
in the financial statements they audit. Authoritative literature does not require the use of checklists, nor does 
it prescribe their format or content.
.02 This checklist consists of a number of questions or statements that are accompanied by references to 
the established sources of GAAP in which the disclosure requirements are found. These sources include 
Statements of Financial Accounting Standards, FASB Interpretations, Accounting Principles Board Opinions, 
Accounting Research Bulletins, AICPA Audit and Accounting Guides, AICPA Statements of Position, and 
EITF consensuses. Checklists are designed to serve as convenient memory aids but should not be used as a 
substitute for direct reference to authoritative literature.
.03 These checklists consist of a number of questions or statements that are accompanied by references 
to applicable authoritative pronouncements. The checklists provide spaces for checking off or initialing each 
question or point to indicate that it has been considered. Users should check or initial:
• Yes—If the disclosure is required and has been made appropriately.
• No—If the disclosure is required but is not made.
• N/A (Not applicable)—If the disclosure is not required to be made.
Users may find it helpful to include references to the place where each disclosure for which a "Yes" is 
indicated can be found in the financial statements. It may also be helpful to include either on the checklist or 
elsewhere the reasons that items marked "N/ A" do not apply in the circumstances of the particular report.
.04 It is important that the effect of any "No" response be considered on the auditor's report. A "No" 
response that is material to the financial statements may warrant the issuance of a qualified or adverse report 
on the financial statements. (See paragraphs 35-60 of SAS No. 58, Reports on Audited Financial Statements, as 
amended [AICPA, Professional Standards, vol. 1, AU sec. 508.35-.60]. If a "No" response is indicated, the 
authors recommend that a notation be made in the margin to explain why the disclosure was not made (for 
example, because the item was not considered to be material to the financial statements) or to indicate the 
effect that the response will have on the auditor's report.
.05 At the beginning of certain sections, a □ appears in the "N/A" column. If the entire section is 
deemed to be non-applicable, place a check mark in the □ and proceed to the next section.
.06 As you use this checklist, please remember that:
• The exercise of sound professional judgment is of paramount importance in applying the checklist 
provisions.
• The checklist may require modification based on the engagement circumstances.
• The checklist may not be all-inclusive.
• Users need to modify the checklist for any pronouncements issued subsequent to those mentioned 
in the checklist.
FSP §20,200.06
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.07 These checklists and illustrative materials have been prepared by the AICPA staff. They have not 
been reviewed, approved, disapproved, or otherwise acted on by any senior technical committee of the 
AICPA and do not represent official positions or pronouncements of the AICPA.
FSP §20,200.07
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FSP Section 20,300
Financial Statements and Notes Checklist
.01 This checklist has been developed by the Accounting and Auditing Publications Team of the AICPA 
as a nonauthoritative practice aid for use by preparers and auditors of financial statements.
This checklist includes disclosures commonly encountered in the financial statements of stock life insurance 
companies and reporting issues likely to be encountered by accountants who audit, compile, and review 
those types of financial statements. They do not include all disclosures required by GAAP or address all 
reporting situations that may arise in performing engagements in accordance with GAAS and SSARS.
.02 Explanation of References:
SFAS = FASB Statement of Financial Accounting Standards
FASBI = FASB Financial Accounting Standards Board Interpretation
AC = Reference to section number in FASB Accounting Standards—Current Text
APB = Accounting Principles Board Opinion
ARB = Accounting Research Bulletin
FTB = Technical Bulletin issued by the staff of the FASB
AAG = AICPA Audit and Accounting Guide Life and Health Insurance Entities
SOP = AICPA Statement of Position
EITF = Emerging Issues Task Force Consensus
PB = AICPA Practice Bulletin
SAS = AICPA Statement on Auditing Standards
AU = Reference to section number in AICPA Professional Standards (vol. 1)
.03 Checklist Questionnaire:
This checklist is organized into the sections listed below. Carefully review the topics listed and consider 
whether they represent potential disclosure items for the life insurance company.
Place  by 
Applicable Sections
• Balance Sheet
A. General
B. Cash
C. Investment Securities
D. Investments Accounted for by the Equity Method
E. Impairment of a Loan
F. Accounts and Notes Receivable and Agents' Balances
G. Reinsurance Receivables
H. Lease Finance Receivables
I. Deferred Acquisition Costs
J. Property and Equipment
K. Lessee Leases
FSP §20,300.03
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Place   by 
Applicable Sections
L. Other Assets
M. Intangible Assets and Goodwill [Only applicable if the provisions 
of SFAS 142 are effective]
Ml. Transitional Disclosures for Goodwill and Other Intangible Assets 
[Only applicable if the provisions of SFAS 142 are effective]
N. Separate Account Assets
O. Deposit Accounting
P. Policy Liabilities
Q. Income Taxes
R. Current Liabilities, Notes Payable, and Long-Term Debt
S. Other Liabilities
T. Shareholders' Equity
• Income Statement
A. Premium Revenue
B. Investment Income
C. Other Income
D. Benefits and Expenses
E. Income Taxes
F. Discontinued Operations [Not applicable if SFAS 144 is effective]
G. Extraordinary Items, Unusual Items, Infrequent Items
H. Earnings Per Share
I. Comprehensive Income
J. Other
• Statement of Changes in Shareholders' Equity
• Statement of Cash Flows
• General
A. Titles and References
B. Disclosure of Accounting Policies
C. Comparative Financial Statements
D. Accounting Changes
E. Risks and Uncertainties
F. Contingencies and Commitments
G. Environmental Remediation Liabilities
H. Related-Party Transactions and Economic Dependency
I. Employee Stock Ownership Plans
J. Pensions and Other Postretirement Benefits
K. Consolidations
L. Financial Instruments
M. Foreign Currency
N. Impairment of Long-Lived Assets [Not applicable if the provisions 
of SFAS 144 are effective]
N1. Impairment of Long-Lived Assets to Be Held and Used [Only 
applicable if the provisions of SFAS 144 are effective]
O. Long-Lived Assets and Disposal Groups to Be Disposed of [Only 
applicable if SFAS 144 is effective]
P. Transfers and Servicing of Financial Assets and Securitizations
Q. Nonmonetary Transactions
R. Subsequent Events
FSP §20,300.03
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Place   by 
Applicable Sections
S. Costs to Exit an Activity _________
T./T 1. Business Combinations _________
U. Segment Information _________
V. Postemployment Benefits _________
W. Stock Compensation Plans _________
X. Asset Retirement Obligations _________
Y. Demutualizations and Formations of Mutual Insurance Holding
Companies _________
• Auditors' Reports Checklist _________
• Supplemental Information for Life Insurance Companies That Are
Securities and Exchange Commission Registrants _________
Yes No N/A
Note: Reminder—A "no" answer is indicative of a potential GAAP de­
parture. The reason for the "no" answer and the resolution of the matter 
should be documented in the working papers.
Balance Sheet
A. General
1. For classified balance sheets, are assets and liabilities segregated into 
current and noncurrent classifications, with totals presented for cur­
rent assets and current liabilities?
[ARB 43, Ch. 3A, pars. 2-8; SFAS 78, pars. 5 and 13 (AC B05.102- 
.109B); SFAS 6, par. 15 (AC B05.118); FASBI8, par. 3 (AC B05.117); TB 
79-3, par. 2 (AC B05.501-.503)]
2. Are assets not expected to be realized during the current operating 
cycle classified as noncurrent?
[ARB 43, Ch. 3A, pars. 5 and 6 (AC B05.106 and .107)1
3. Are valuation allowances for assets shown as deductions from their 
related assets with appropriate disclosure?
[APB 12, par. 3 (AC ¥18.102)1
B. Cash
1. Is restricted cash appropriately segregated from cash available for 
current operations?
[ARB 43, Ch. 3A, par. 6 (AC B05.107)]
2. Are restrictions on cash appropriately disclosed?
[SFAS 5, pars. 18 and 19 (AC C59.120)]
3. Is the policy for determining cash equivalents disclosed?
[SFAS 95, par. 10 (AC C25.108)]
4. If the company has material bank overdrafts or material balance of 
undelivered checks as of the balance-sheet date, are:
a. Bank overdrafts presented as a separate caption within current 
liabilities?
b. Undelivered checks classified as accounts payable?
[Generally accepted]
FSP §20,300.03
10 Life and Health Insurance Entities
Yes No N/A
Practice Tip
Be sure that the amount of cash and cash equivalents displayed on the balance sheet equals the amount of 
cash and cash equivalents displayed on the statement of cash flows.
C. Investment Securities
1. Are there separate captions for each of the following investment 
categories:
a. Fixed-maturity securities?
b. Mortgage loans on real estate?
c. Investment real estate?
d. Policy loans?
e. Other long-term investments?
[AAG, App. B]
2. Are the carrying amounts of investment securities on deposit with 
regulatory authorities disclosed?
[AAG, App. C, par. 1]
3. Are debt and equity securities classified as (a) held-to-maturity, (b) 
available-for-sale, or (c) trading?
[SFAS 115, par. 6 (AC I80.103)]
4. If an enterprise presents a classified statement of financial position, 
are all individual held-to-maturity securities, individual available- 
for-sale securities, and individual trading securities reported as either 
current or noncurrent, as appropriate, under the provisions of ARB 
No. 43, Chapter 3A, “Working Capital—Current Assets and Current 
Liabilities"?
[SFAS 115, par. 17 (AC I80.116), as amended by SFAS 135]
Practice Tip
Presentation of individual amounts for trading securities, held-to-maturity securities, and available-for-sale 
securities on the face of the balance sheet is not required as long as the information is provided in the notes 
to the financial statements.
FSP §20,300.03
5. For securities classified as available-for-sale, has the reporting entity 
made the following disclosures by major-security type as of each date 
for which a statement of financial position is presented:
a. Aggregate fair value?
b. Total gains for securities with net gains in accumulated other 
comprehensive income?
c. Total losses for securities with net losses in accumulated other 
comprehensive income?
[SFAS 115, par. 19 (AC I80.118)]
6. For securities classified as held-to-maturity, has the reporting entity 
made the following disclosures by major-security type as of each date 
for which a statement of financial position is presented:
a. Aggregate fair value?
b. Gross unrecognized holding gains or losses?
Financial Statements and Notes Checklist 11
Yes No N/A
c. Net carrying amount?
d. Gross gains and losses in accumulated other comprehensive in­
come for any derivatives that hedged the forecasted acquisition of 
the held-to-maturity securities?
[SFAS 115, par. 19 (AC I80.118)]
7. For investments in debt securities classified as available-for-sale or 
held-to-maturity:
a. Is disclosure made about their contractual maturities as of the date 
of the latest balance sheet presented (maturity information may be 
combined in appropriate groupings)?
b. If securities not due at a single date (such as mortgage-backed 
securities) are allocated over several maturity groupings, is the 
basis for allocation disclosed?
[SFAS 115, par. 20 (AC I80.119)]
8. For each period for which an income statement is presented, are the 
following disclosed:
a. The proceeds from sales of available-for-sale securities and gross 
realized gains and losses that have been included in earnings as a 
result of those sales?
b. The basis on which the cost of a security sold or the amount 
reclassified out of accumulated other comprehensive income into 
earnings was determined (i.e., specified identification, average 
cost, or other method used)?
c. The gross gains and losses included in earnings from transfers 
of securities from the available-for-sale category to the trading 
category?
d. The amount of the net unrealized holding gain or loss on available- 
for-sale securities for the period that has been included in accumu­
lated other comprehensive income and the amount of gains and 
losses reclassified out of accumulated other comprehensive in­
come into earnings for the period?
e. The portion of trading gains and losses for the period that relates 
to trading securities still held at the reporting date?
[SFAS 115, par. 21 (AC I80.120)]
9. For any sales of or transfers from securities classified as held-to- 
maturity, are the following disclosed for each period for which an 
earnings statement is presented:
a. Net carrying amount of the sold or transferred security?
b. The net gain or loss in accumulated other comprehensive income 
for any derivative that hedged the forecasted acquisition of the 
held-to-maturity security?
c. Related realized or unrealized gain or loss?
d. The circumstances leading to the decision to sell or transfer the 
security?
[SFAS 115, par. 22 (AC I80.121)]
FSP §20,300.03
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Yes
10. Are mortgage loans that are purchased at a discount or premium 
reported at amortized cost with an allowance for uncollectible
amounts, if any? ____
[SFAS 60, par. 47 (AC In6.153)]
11. Are changes in the allowance for uncollectible amounts relating to
mortgage loans reported in income as prescribed in SFAS 114, Ac­
counting by Creditors for Impairment of a Loan ? ____
[SFAS 60, par. 47, as amended by SFAS 114, par. 23 (AC In6.153)]
Note: SFAS 144, Accounting for the Impairment or Disposal of Long-Lived 
Assets, supercedes SFAS 121, Accounting for the Impairment of Long-Lived 
Assets and for Long-Lived Assets to be Disposed Of. SFAS 144 is effective for 
fiscal years beginning after December 15, 2001. The disclosure require­
ments in Steps 12 and 13 below remained the same since the amendments 
made by SFAS 121 have been carried forward in SFAS 144 with minor 
changes.
[SFAS 144, App. C28]
12. Are real estate investments (except those held for sale) reported at cost 
less accumulated depreciation and less an allowance for any impaired
value that would be recorded under SFAS 121? ____
[SFAS 60, par. 48, as amended by SFAS 121, par. 28a (AC In6.154);
AAG, par. 11.74]
13. Are reductions in the carrying amounts of real estate investments 
resulting from the application of SFAS 121, Accounting for the Impair­
ment of Long-Lived Assets and for Long-Lived Assets to Be Disposed Of,
included in realized gains and losses? ____
[SFAS 60, par. 48, as amended by SFAS 121, par. 28b (AC In6.154)]
14. For those entities that enter into options with no intrinsic value at 
acquisition in order to purchase securities accounted for under SFAS 
115, is disclosure made of the accounting policy for the premium paid 
(time value) to acquire the option that is classified as held-to-maturity
or available-for-sale disclosed? ____
[EITF 96-11]
15. Are mortgage loans that are acquired at par value reported at out­
standing principal balances? ____
[SFAS 60, par. 47 (AC In6.153)]
16. Are adjustments to deferred acquisition costs (DAC) and other assets 
and liabilities as a result of including unrealized gains or losses as part
of shareholders equity in accordance with SFAS 115 disclosed? ____
[AAG, App. C, par. 3]
D. Investments Accounted for by the Equity Method
1. Are investments in common stock shown in the balance sheet of the 
investor as a single amount, and is the investor's share of earnings or 
losses of the investee shown in the income statement as a single
amount (except for extraordinary items or prior period adjustments)? ____
[APB 18, par. 19 (AC I82.109c)]
2. Are the following disclosures made for investments in common stock 
accounted for by the equity method:
a. The name of each investee and their percentage of ownership of
common stock? ____
FSP §20,300.03
No N/A
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Yes No N/A
b. The accounting policies of the investor with respect to investments
in common stock? ____  ____  _____
c. The difference between the amount at which an investment is
carried and the amount of underlying equity in net assets? ____  ____  _____
d. The accounting treatment of the difference described in c.? ____  ____  _____
e. For investments in common stock for which a quoted market price 
is available, the aggregate value of each identified investment
based on the quoted market price? ____ ____  _____
(This is not required for investments in common stock of subsidiaries.)
f. For investments in common stock, corporate joint ventures, or 
other investments which are in the aggregate material in relation 
to the financial position or results of operations of an investor, 
summarized information as to assets, liabilities, and results of
operation of the investees as appropriate? ____  ____  ____
g. Material effects of conversions of outstanding convertible securi­
ties, exercises, or contingent issuances? ____  ____  _____
[APB 18, par. 20 (AC I82.110)]
3. If the reporting entity holds 20 percent or more of the voting stock of 
a significant investee corporation but does not account for the invest­
ment using the equity method, are the following disclosed:
a. The name of such investee? ____  ____  _____
b. The reasons why the equity method is not considered appropriate? ____  ____  _____
[APB 18, par. 20, fn. 13 (AC I82.110, fn. 14)]
4. If the reporting entity holds less than 20 percent of the voting stock of 
a significant investee corporation and accounts for the investment 
using the equity method, are the following disclosed:
a. The name of such investee? ____  ____  _____
b. The reasons why the equity method is considered appropriate? ____  ____  _____
[APB 18, par. 20, fn. 13 (AC I82.110, fn. 14)]
5. Does the life insurance entity disclose any contingent obligations or 
commitments for additional funding or guarantees of obligations of
the investee? ____  ____  _____
[AAG, par. 11.80]
Practice Tip
The significance of an investment to the investor's financial position and results of operations should be 
considered in evaluating the extent of disclosures relating to the financial position and results of operations 
of an investee.
E. Impairment of a Loan
1. Is the allowance deducted from the related assets?
[APB 12, par. 3 (AC V18.102)]
2. Is the following information disclosed, either in the body of the 
financial statements or in the accompanying notes for impaired 
loans:1
1 In certain circumstances, information about an impaired loan that has been restructured in a troubled debt restructuring involving 
a modification of terms need not be included in the disclosures in Steps 2.a. and 2.b. (1)-(3).
FSP §20,300.03
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Yes
a. As of the date of each balance sheet presented:
(1) Total recorded investment in the impaired loans at the end of 
each period and the amount of the recorded investment for 
which there is a related allowance for loan losses?
(2) The amount of the allowance?
(3) The amount of the recorded investment for which no allow­
ance for loan losses was recorded?
(4) The company's policy for recognizing interest on impaired 
loans, including how cash receipts are recorded?
b. For each period for which a statement of income is presented:
(1) Average recorded investments?
(2) Related amount of interest income recognized using the cash 
basis method of accounting during the time within the period 
the loans were impaired?
(3) If practicable, the amount of interest income recognized using 
cash basis method of accounting during the time within the 
period the loans were impaired?
(4) The activity in the allowance for loan losses related to im­
paired loans including the following:
(i) Opening balance?
(ii) Additions charged to operations?
(iii) Direct write-down charged against the allowance?
(iv) Recovery of amounts previously charged off?
(v) Ending balance?
[SFAS 114, par. 20, as amended by SFAS 118, par. 6 (AC 
I08.118 and 118A)]
3. When a loan is restructured in a troubled debt restructuring (as 
defined in SFAS 15) into two (or more) loan agreements, are the 
restructured loans considered separately when assessing the applica­
bility of the disclosures described in Step 2 above?
[EITF 96-22]
F. Accounts and Notes Receivable and Agents' Balances
1. Are premiums due reported as assets?
[AAG, Table 3.1]
2. Are deferred premiums offset against liabilities for future policy 
benefits?
[AAG, Table 3.1 and par. 7.18]
3. Are hypothecation or other pledging of receivables disclosed?
[SFAS 5, pars. 18 and 19 (AC C59.120)]
4. Are accounts and notes receivable from officers, employees, and 
affiliated entities shown separately with appropriate disclosures? 
[ARB 43, Ch. 1A, par. 5 (AC R36.105)]
FSP §20,300.03
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Yes No N/A
5. If a note is noninterest bearing or has an inappropriate stated interest 
rate:
a. Is the discount or premium presented as a deduction from or 
addition to the face amount of the note?
b. Does the disclosure include the effective interest rate and face 
amount of the note?
c. Is amortization of discount or premium reported as interest in the 
income statement?
[APB 21, par. 16 (AC I69.109)]
6. Is the unamortized balance of loan origination, commitment, and 
other fees and costs and purchase premiums and discounts that is 
being recognized as an adjustment of yield reported as part of the loan 
balance to which it relates?
[SFAS 91, par. 21 (AC I20.120)]
G. Reinsurance Receivables
1. Are fronting arrangements treated as reinsurance arrangements for 
purposes of disclosures required by SFAS 60 and SFAS 113?
[SFAS 113, par. 6 (AC In6.169)]
2. Are the following disclosed in relation to ceded insurance transactions:
a. Nature of the transaction(s)?
b. Purpose of the transaction(s)?
c. Effect of the transaction(s)?
d. The fact that the insurer is not relieved of its primary obligation to 
the policyholder in a reinsurance transaction?
[SFAS 113, par. 27a (AC In6.191a)]
3. Are the following disclosed for short-duration reinsurance contracts 
on both a written and an earned basis:
a. Premiums from direct business?
b. Reinsurance assumed?
c. Reinsurance ceded?
[SFAS 113, par. 27b (AC In6.191b)]
4. Are the following disclosed for long-duration reinsurance contracts:
a. Premiums and amounts assessed against policyholders from di­
rect business?
b. Reinsurance assumed?
c. Reinsurance ceded?
d. Premiums and amounts earned?
[SFAS 113, par. 27b (AC In6.191b)]
5. Are the methods used for income recognition on reinsurance contracts 
disclosed?
[SFAS 113, par. 27c (AC In6.191c)]
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6. Are concentrations of credit risk associated with reinsurance receiv­
ables and prepaid reinsurance premiums disclosed for a ceding enter­
prise under the provisions of paragraph 15A of SFAS 107, Disclosures 
about Fair Value of Financial Instruments, as amended by SFAS 133,
Accounting for Derivative Instruments and Hedging Activities? ____
[SFAS 113, par. 28 (AC In6.192); SFAS 133, par. 533]
7. Are the following items reported separately as assets for those com­
panies participating in ceding transactions:
a. Estimated reinsurance receivables arising from ceding transactions? ____
b. Amounts paid to the reinsurer relating to the unexpired portion
of reinsured contracts (prepaid reinsurance premiums)? ____
[SFAS 113, par. 14 (AC In6.178)]
8. Are amounts receivable and payable between the ceding company 
and an individual reinsurer offset only when a right of offset exists as
defined in FASB Interpretation 39? ____
[SFAS 113, par. 15 (AC In6.179)]
9. Are the amounts of earned premiums ceded and recoveries recog­
nized under reinsurance contracts reported in the statements of earn­
ings as separate line items or disclosed in the notes? ____
[SFAS 113, par. 16 (AC In6.180); AAG, par. 12.30]
H. Lease Finance Receivables
1. Do disclosures include:
a. Appropriate components of the net investment in the leases as of 
the date of each balance sheet presented?
b. Future minimum lease payments to be received for each of the five 
succeeding fiscal years as of the date of the latest balance sheet 
presented?
c. Total contingent rentals included in income for each period for 
which a statement of income is presented?
[SFAS 13, par. 23a, as amended by SFAS 91, par. 25d (AC 
L10.119a)]
2. Are leasing arrangements described?
[SFAS 13, pars. 23 and 29 (AC L10.119 and .125); SFAS 91, par. 25 (AC 
L10.119a(l)-(3)); SFAS 98, pars. 17-19 (AC L10.130k-m)]
3. Are leveraged leases appropriately accounted for and reported?
[SFAS 13, pars. 41-47 (AC L10.143-.149)]
I. Deferred Acquisition Costs
1. Are unamortized acquisition costs classified in the balance sheet as 
assets?
[AAG, par. 10.22]
2. Are the following disclosed relating to deferred acquisition costs:
a. The nature of costs capitalized?
b. The method of amortizing these costs?
c. The amount of these costs amortized for the period?
[AAG, App. C, par. 5; SFAS 60, par. 60c (AC In6.166c)]
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3. Is the fact that the company considers anticipated investment income 
in determining if a premium deficiency relating to short-duration
contracts exists disclosed? ____ ___
[SFAS 60, par. 60e (AC In6.166e)]
4. If a public company acquires a life insurance entity accounted for as 
a purchase and the acquirer recognizes an asset for the present value 
of future profits (PVP) is the following disclosed:
a. A description of the company's accounting policy? ____ ___
b. An analysis of the PVP asset account for each year for which an 
income statement is presented, including the PVP balance at the 
beginning of the year, the amount of PVP additions during the 
year arising from acquisitions of insurance entities, the amount of 
interest accrued on the unamortized PVP balance during the year, 
the interest accrual rate, the amount of amortization during the 
year, the amount of any write-offs during the year attributable to 
impairment and how those write-offs were determined, and the
PVP balance at the end of the year? ____ ____
c. The estimated amount or percentage of the end of the year PVP
balance to be amortized during each of the next five years? ____ ____
[AAG, App. C, par. 6]
J. Property and Equipment
1. Is the carrying basis of property and equipment disclosed? ____ ____
[AAG, App. B; APB 12, par. 5 (AC D40.105)]
2. For depreciable assets, does disclosure include:
a. Depreciation expense for each period for which an income state­
ment is presented? ____ ____
b. Balances of major classes of depreciable assets, by nature or func­
tion, at the balance-sheet date? ____ ____
c. Accumulated depreciation, either by major classes of depreciable
assets or in total, at the balance-sheet date? ____ ____
d. A general description of the method or methods used in comput­
ing depreciation for major classes of depreciable assets? ____ ____
[APB 12, par. 5 (AC D40.105)]
3. Are pledged assets and material commitments for property expendi­
tures disclosed? ____ ____
[SFAS 5, pars. 18 and 19 (AC C59.120)]
4. For any accounting period in which interest costs are capitalized, is 
the total amount of interest cost incurred during the period, and the
amount thereof that is capitalized, disclosed? ____ ____
[SFAS 34, par. 21b (AC I67.118)]
5. Is the amount of interest cost incurred and charged to expense during 
the period disclosed for an accounting period in which no interest cost
is capitalized? ____ ____
[SFAS 34, par. 21a (AC I67.118)]
6. For an existing property with an asbestos problem, are the costs 
incurred to treat the problem, if charged to expense, not classified as
an extraordinary item? ____ ____
[EITF 89-13]
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K. Lessee Leases
1. Is the following information disclosed with respect to capital leases:
a. The gross amount of assets recorded under capital leases as of the
date of each balance sheet presented by major classes according to 
nature or function (this information may be combined with the 
comparable information for owned assets)? ____
b. Future minimum lease payments as of the date of the latest balance 
sheet presented, in the aggregate and for each of the next five fiscal 
years, with separate deductions from the total for executory costs, 
including any profit thereon that is included in the minimum lease 
payments and for the amount of the imputed interest necessary to
reduce the net minimum lease payments to present value? ____
c. The total of minimum sublease rentals to be received in the future 
under noncancelable subleases as of the date of the latest balance
sheet presented? ____
d. Total contingent rentals actually incurred for each period for
which an income statement is presented? ____
[SFAS 13, par. 16 (AC L10.112)]
e. Separate identification of:
(1) Assets recorded under capital leases? ____
(2) Accumulated amortization of capital leases? ____
(3) Obligations under capital leases? ____
(4) Amount of amortization of capital lease assets or the fact that
the amortization of capital lease assets is included in depre­
ciation expense? ____
[SFAS 13, par. 13 (AC L10.112)]
2. Are the following disclosed for operating leases that have initial or 
remaining noncancelable lease terms in excess of one year:
a. Future minimum rental payments required, as of the date of the 
latest balance sheet presented, in the aggregate, and for each of the
five succeeding fiscal years? ____
b. The total of minimum rentals to be received in the future under 
noncancelable subleases as of the date of the latest balance sheet
presented? ____
[SFAS 13, par. 16 (AC L10.112)]
3. For all operating leases, do disclosures include rental expense for each 
period for which an income statement is presented, with separate 
amounts for minimum rentals, contingent rentals, and sublease rent­
als (rental payments under leases with terms of a month or less that
are not renewed need not be included)? ____
4. Do disclosures include a general description of the lessee's leasing 
arrangements including, but not limited to, the following:
a. The basis on which contingent rental payments are determined? ____
b. The existence and terms of renewal or purchase options and
escalation clauses? ____
c. Restrictions imposed by lease agreements, such as those concern­
ing dividends, additional debt, and further leasing? ____
[SFAS 13, par. 16 (AC L10.112)]
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5. Is the nature and extent of leasing transactions with related parties
disclosed? ____  ___
[SFAS 13, par. 29 (AC L10.125)]
6. If the conditions of EITF 90-15 are met, does the lessee consolidate 
special-purpose entities established for both the construction and 
subsequent lease of an asset and does consolidation occur at the
inception of the lease rather than at the beginning of the lease term? ____ ___
[EITF 90-15]
L. Other Assets
Note: If SFAS 142, Goodwill and Other Intangible Assets, has not been 
adopted, the following questions do apply. See section M for the disclo­
sures required after the effective date of SFAS 142. SFAS 142, is effective 
starting with fiscal years beginning after December 15, 2001. SFAS 142 is 
required to be applied at the beginning of an entity's fiscal year and to be 
applied to all goodwill and other intangible assets recognized in its 
financial statements at that date.
1. Do disclosures include the method and period of amortization of 
intangible assets?
[APB 22, par. 13 (AC A10.106)]
2. For an unidentified intangible asset arising as a result of the fair value 
of liabilities assumed in a purchase method business combination 
exceeding fair value of tangible and identified intangible assets ac­
quired in a combination initiated after September 30, 1982, is the 
method and period of amortization disclosed?
[APB 17, par. 30 (AC I60.111)]
M. Intangible Assets and Goodwill (Only applicable if the provisions of
SFAS 142 are being applied to the financial statements)
Note: SFAS 142 is not applicable to goodwill and other intangible assets 
arising from combinations between mutual enterprises until the Financial 
Accounting Standards Board completes its deliberation with respect to 
application of the purchase method by those entities. Goodwill and intan­
gible assets acquired in a combination between two or more mutual 
enterprises for which the acquisition date is after June 30, 2001, shall 
continue to be accounted for in accordance with APB Opinion 17.
1. At a minimum, are all intangible assets aggregated and presented as 
a separate line item in the statement of financial position? (This 
requirement does not preclude presentation of individual intangible 
assets or classes of intangible assets as separate line items.)
[SFAS 142, par. 42]
2. Are amortization expense and impairment losses for intangible assets 
presented in income statement line items within continuing opera­
tions as deemed appropriate for each entity?
[SFAS 142, par. 42]
3. Is the aggregate amount of goodwill presented as a separate line item 
in the statement of financial position?
[SFAS 142, par. 43]
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4. Is the aggregate amount of goodwill impairment losses presented as 
a separate line item in the income statement before the subtotal income 
form continuing operations (or similar caption) unless a goodwill im­
pairment loss is associated with a discontinued operation?
[SFAS 142, par. 43]
5. Is a goodwill impairment loss associated with a discontinued opera­
tion included (on a net-of-tax basis) within the results of discontinued 
operations?
[SFAS 142, par. 43]
6. For intangible assets acquired either individually or with a group of 
assets, is the following information disclosed in the notes to the 
financial statements in the period of acquisition:
a. For intangible assets subject to amortization:
(1) The total amount assigned and the amount assigned to any 
major intangible asset class?
(2) The amount of any significant residual value, in total and by 
major intangible asset class?
(3) The weighted-average amortization period, in total and by 
major intangible asset class?
b. For intangible assets not subject to amortization, the total amount 
assigned and the amount assigned to any major intangible asset 
class?
c. The amount of research and development assets acquired and 
written off in the period and the line item in the income statement 
in which the amounts written off are aggregated?
[SFAS 142, par. 44]
7. Has the following information been disclosed in the financial state­
ments or the notes to the financial statements for each period for which 
a statement of financial position is presented:
a. For intangible assets subject to amortization:
(1) The gross carrying amount and accumulated amortization, in 
total and by major intangible asset class?
(2) The aggregate amortization expense for the period?
(3) The estimated aggregate amortization expense for each of the 
five succeeding fiscal years?
b. For intangible assets not subject to amortization, the total carrying 
amount and the carrying amount for each major intangible asset 
class?
c. The changes in the carrying amount of goodwill during the period 
including:
(1) The aggregate amount of goodwill acquired?
(2) The aggregate amount of impairment losses recognized?
(3) The amount of goodwill included in the gain or loss on 
disposal of all or a portion of a reporting unit?
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8. If the entity reports segment information in accordance with SFAS
131, is the above information about goodwill provided in total and for 
each reportable segment and are any significant changes in the allo­
cation of goodwill by reportable segment disclosed? ____
[SFAS 142, par. 451
9. If any portion of goodwill has not yet been allocated to a reporting 
unit at the date the financial statements are issued, is that unallocated
amount and the reasons for not allocating that amount disclosed? ____
[SFAS 142, par. 45]
10. For each impairment loss recognized related to an intangible asset, is 
the following information disclosed in the notes to the financial 
statements that include the period in which the impairment loss is 
recognized:
a. A description of the impaired intangible asset and the facts and
circumstances leading to the impairment? ____
b. The amount of the impairment loss and the method for determin­
ing fair value? ____
c. The caption in the income statement in which the impairment loss
is aggregated? ____
d. If applicable, the segment in which the impaired intangible asset
is reported under SFAS 131? ____
[SFAS 142, par. 46]
11. For each goodwill impairment loss recognized, is the following infor­
mation disclosed in the notes to the financial statement that include 
the period in which the impairment loss is recognized:
a. A description of the facts and circumstances leading to the impairment? ____
b. The amount of the impairment loss and the method of determining 
the fair value of the associated reporting unit (whether based on 
quoted market prices, prices of comparable businesses, a present
value or other valuation technique, or a combination thereof)? ____
c. If a recognized impairment loss is an estimate that has not yet been
finalized (refer to SFAS 142, par. 22), that fact and the reasons 
therefor and, in subsequent periods, the nature and amount of any 
significant adjustments made to the initial estimate of the impair­
ment loss? ____
[SFAS 142, par. 47]
Ml. Transitional Disclosures for Goodwill and Other Intangible Assets
Note: Readers should refer to paragraphs 48-61 of SFAS 142 for effective 
date and transition guidance related to SFAS 142.
1. Upon completion of the first step of the transitional goodwill impair­
ment test, is the reportable segment or segments in which an impair­
ment loss might have to be recognized and the period in which that 
potential loss will be measured disclosed in any interim financial 
information?
[SFAS 142, par. 60]
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2. In the period of initial application and thereafter until goodwill and 
all other intangible assets have been accounted for in accordance with 
SFAS 142 in all periods presented, is the following information dis­
played either on the face of the income statement or in the notes to the 
financial statements:
a. Income before extraordinary items and net income for all periods 
presented adjusted to exclude amortization expense (including 
any related tax effects) recognized in these periods related to 
goodwill?
b. Intangible assets that are no longer being amortized?
c. Any deferred credit related to an excess over cost (amortized in 
accordance with APB 16)?
d. Equity method goodwill?
[SFAS 142, par. 61]
3. Does the adjusted income before extraordinary items and net income 
also reflect any adjustments for changes in amortization periods for 
intangible assets that will continue to be amortized as a result of 
initially applying SFAS 142 (including any related tax effects?
[SFAS 142, par. 61]
4. Is a reconciliation of reported net income to the adjusted net income 
disclosed?
[SFAS 142, par. 61]
5. Are adjusted earnings per share amounts for all periods presented in 
either the face of the income statement or in the notes?
[SFAS 142, par. 61]
N. Separate Account Assets
1. Are separate account assets reported as summary totals in the finan­
cial statements?
[SFAS 60, par. 54 (AC In6.160)]
O. Deposit Accounting
1. Has a description of the contracts accounted for as deposits and the 
separate amounts of total deposit assets and total deposit liabilities 
reported in the statement of financial position been disclosed?
[SOP 98-7, par. 18]
2. Has the following information regarding the changes in the recorded 
amount of the deposit arising from an insurance or reinsurance con­
tract that transfers only significant underwriting risk been disclosed?
a. The present values of initial expected recoveries that will be reim­
bursed under the insurance or reinsurance contracts that have 
been recorded as an adjustment to incurred losses?
b. Any adjustment of amounts initially recognized for expected re­
coveries? (The individual components of the adjustment (mean­
ing, interest accrual, the present value of additional expected 
recoveries, and the present value of reductions in expected recov­
eries) should be disclosed separately.)
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c. The amortization expense attributable to the expiration of cover­
age provided under the contract? ____ ___
[SOP 98-7, par. 19; AAG, App. C, par. 22]
P. Policy Liabilities
1. Is the basis for estimating the liabilities for unpaid claims and claim
adjustment expenses disclosed? ____ ___
[SFAS 60, par. 60a (AC In6.166a); AAG, App. C, par. 7a]
2. Are the methods and assumptions used in estimating the liability for 
future policy benefits and the average rate of assumed investment
yields in effect for the current year disclosed? ____ ___
[SFAS 60, par. 60b (AC In6.166b); AAG, App. C, par. 10]
3. Is the carrying amount of liabilities for unpaid claims and claim 
adjustment expenses relating to short-duration contracts that are 
presented at present value in the financial statements and the range
of interest rates used to discount those liabilities disclosed? ____ ___
[SFAS 60, par. 60d (AC In6.166d); AAG, App. C, par. 7b]
4. For each fiscal year for which an income statement is presented is the 
following information about the liability for unpaid claims and claim 
adjustment expenses disclosed:
a. The balance in the liability for unpaid claims and claim adjustment 
expenses at the beginning and end of the period presented with, 
if net balances are presented, separate disclosure of the related
amount of reinsurance recoverable? ____ ___
b. Incurred claims and claim adjustment expenses with separate 
disclosure of the provision of insured events of the current period 
and for increases or decreases in the provision for insured events
of prior fiscal years? ____ ___
c. Payments of claims and claim adjustment expenses with separate 
disclosure of payments of claims and claim adjustment expenses 
attributable to insured events of the current fiscal year and to
insured events of the prior period? ____ ____
[SOP 94-5, par. 10; AAG, App. C, par. 8]
5. If changes in the provision for incurred claims and claim adjustment 
expenses are attributable to insured events of prior periods are the 
following disclosed in the financial statements:
a. The reasons for the change? ____ ____
b. Whether additional premiums or return premiums have been
accrued as a result of the prior-period effects? ____ ____
[SOP 94-5, par. 10; AAG, App. C, par. 19]
6. Is the fact that the company considers anticipated investment income 
in determining if a premium deficiency relating to short-duration
contracts exists disclosed? ____ ____
[SFAS 60, par. 60e (AC In6.166e); AAG, App. C, par. 7c]
7. For participating insurance, does disclosure include:
a. The relative percentage? ____ ____
b. The method of accounting for policyholders' dividends? ____ ____
N/A
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c. The amount of dividends?
d. The amount of any additional income allocated to participating 
policyholders?
[SFAS 60, par. 60g (AC In6.166g); AAG, App. C, par. 16]
Note: SOP 95-1, Accounting for Certain Insurance Activities of Mutual Life 
Insurance Enterprises applies to life insurance contracts that have both of 
the following characteristics:2
2 SFAS 120, Accounting and Reporting by Mutual Life Insurance Enterprises and by Insurance Enterprises for Certain Long-Duration 
Participating Contracts, permits stock life insurance enterprises with participating life insurance contracts that meet the conditions listed 
above to account for those contracts in accordance with SOP 95-1.
[SFAS 120, par. 6]
• They are long-duration participating contracts that are expected to 
pay dividends to policyholders based on actual experience of the insur­
ance enterprise.
• Annual policyholder dividends are paid in a manner that identifies 
divisible surplus and distributes that surplus in approximately the 
same proportion as the contracts are considered to have contributed 
to divisible surplus (commonly referred to in actuarial literature as 
the contribution principle).
8. Are premiums from participating insurance contracts reported as 
revenue in the statement of income when due from policy holders? 
[SOP 95-1, par. 12]
9. Are death and surrender benefits incurred reported as expense in the 
statement of income?
[SOP 95-1, par. 13]
10. Are annual policyholder dividends:
a. Reported separately as an expense in the statement of income? 
[SOP 95-1, par. 14]
11. Are the following disclosed in the financial statements with respect to 
participating contracts:
a. The methods and assumptions used in estimating the liability for 
future policy benefits?
b. The average rate of assumed investment yields used in estimating 
expected gross margins?
c. The nature of acquisition costs capitalized, the method of amortiz­
ing those costs, and the amount of those costs amortized for the 
period?
[SOP 95-1, par. 24]
Q. Income Taxes
1. Are deferred tax assets and liabilities determined for each tax-paying 
component (an individual company or group of companies that is 
consolidated for tax purposes) in each tax jurisdiction presented 
separately?
[SFAS 109, par. 17 (AC I27.116)]
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2. Are the components of the net deferred tax liability or asset recog­
nized in the balance sheet disclosed as follows:
a. The total of all deferred tax liabilities?
b. The total of all deferred tax assets?
c. The total valuation allowance for deferred tax assets?
[SFAS109, par. 43 (AC I27.142)]
3. Is the net change during the year in the total valuation allowance 
disclosed?
[SFAS 109, par. 43 (AC I27.142)]
4. Is the following information disclosed whenever a deferred tax liabil­
ity is not recognized because of the exceptions to comprehensive 
recognition of deferred taxes for any of the areas addressed by APB 
23, Accounting for Income Taxes—Special Areas (as amended by SFAS 
109, Accounting for Income Taxes):
a. A description of the types of temporary differences for which a 
deferred tax liability is not recognized and the types of events that 
would cause those temporary differences to become taxable?
b. The cumulative amount of each type of temporary differences?
c. The amount of the unrecognized deferred tax liability for tempo­
rary differences related to investments in foreign subsidiaries and 
foreign corporate joint ventures that are essentially permanent in 
duration if determination of that liability is practicable, or a state­
ment that determination is not practicable?
d. The amount of the deferred tax liability for temporary differences 
other than those in c. above (i.e., undistributed domestic earnings, 
the bad debt reserve for tax purposes of a U.S. savings and loan 
association or other qualified thrift lender, the policyholders' sur­
plus of a life insurance enterprise, and the statutory reserve funds 
of a U.S. steamship enterprise) that is not recognized in accordance 
with the provisions of paragraphs 31 and 32 of SFAS 109 (AC 
I27.130 and .131)?
[SFAS 109, par. 44 (AC I27.143)]
5. In a classified balance sheet:
a. Are deferred tax assets and deferred tax liabilities classified as 
current or noncurrent based on the classification of the related 
asset or liability for financial reporting?
[SFAS 109, par. 41 (AC I27.140)]
b. Are deferred tax assets or liabilities not related to an asset or 
liability for financial reporting (including those related to carry­
forwards) classified according to the expected reversal date of the 
temporary difference?
[SFAS 109, pars. 41 and .288p (AC I27.140)]
c. Is the valuation allowance for a particular tax jurisdiction allocated 
between current and noncurrent deferred tax assets for that tax 
jurisdiction on a pro rata basis?
[SFAS 109, par. 41 (AC I27.140)]
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d. Are the following items offset and presented as a single amount 
for a particular taxpaying component and within a particular 
taxpaying jurisdiction:
(1) All current deferred tax liabilities and assets?
(2) All noncurrent deferred tax liabilities and assets?
[SFAS 109, par. 42 (AC I27.141)]
6. Do the financial statements include disclosure of the following:
a. Disclosures relating to "Policyholders' Surplus" as defined in the 
Internal Revenue Code and as prescribed by APB 23?
b. The portion of retained earnings in excess of statutory unassigned 
surplus upon which no income tax provisions have been made and 
the reasons therefor?
[AAG, App. C, par. 11]
R. Current Liabilities, Notes Payable, and Long-Term Debt
1. For classified balance sheets, do current liabilities include:
a. Obligations for items that entered the operating cycle?
b. Collections received in advance of the performance of services?
c. Debts that arise from operations directly related to the operating 
cycle?
d. Other liabilities whose regular and ordinary liquidation is likely 
to occur within a relatively short time period?
e. Obligations that, by their terms, are due on demand or will be due 
within one year (or operating cycle, if longer) from the balance- 
sheet date, even though liquidation may not be expected within 
that period?
[ARB 43, Ch. 3A, pars. 7 and 8 (AC B05.108 and .109); SFAS 78, par. 
5 (AC B05.109a)]
2. Do current liabilities exclude short-term obligations that the provider 
intends to refinance on a long-term basis, provided the provider has 
demonstrated the ability to consummate the long-term financing? 
[SFAS 6, pars. 8-14 (AC B05.113-.116); FASBI 8, pars. 2-4 (AC B05.117, 
.138 and .139)]
3. Is there adequate disclosure of interest rates, maturities, and other 
terms and conditions provided in loan agreements and bond inden­
tures (such as assets pledged as collateral, and covenants to reduce 
debt, and maintain working capital)?
[FASCON 5, par. 11; SFAS 5, par. 18 (AC C59.120)]
4. Are the following disclosed for each of the five years following the 
date of the latest balance sheet presented:
a. The aggregate amount of payments for unconditional purchase 
obligations that meet the criteria of SFAS 47, Disclosure of Long- 
Term Obligations, and that are recognized on the purchaser's bal­
ance sheet?
b. The combined aggregate amount of maturities and sinking fund 
requirements for all long-term borrowings?
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c. The amount of redemption requirements for all issues of capital 
stock that are redeemable at fixed or determinable prices on fixed
or determinable dates, separately by issue or combined? ____ ___
[SFAS 47, par. 10 (AC C32.105)]
5. Are conversion features appropriately accounted for and disclosed? ____ ___
[APB 14, par. 12 (AC D10.103); APB 15, par. 19 (AC E09.110)]
6. If a note is noninterest bearing or has an inappropriate stated interest 
rate:
a. Is the discount or premium presented as a deduction from or
addition to the face amount of the note? ____ ___
b. Does the disclosure include the effective interest rate and face
amount of the note? ____ ___
c. Is amortization of the discount or premium reported as interest
expense? ____ ___
d. Are issue costs reported in the balance sheet as deferred charges? ____ ___
[APB 21, par. 16 (AC I69.109)]
7. If a short-term obligation is to be excluded from current liabilities in 
a classified balance sheet, do disclosures include:
a. A general description of the financing agreement? ____ ___
b. The terms of any new obligation incurred or expected to be in­
curred, or equity securities issued or expected to be issued as a
result of the refinancing? ____ ___
[SFAS 6, par. 15 (AC B05.118)]
8. For a troubled debt restructuring occurring during the current period, 
do disclosures include:
a. Description of the principal changes in terms, the major features
of settlement, or both? ____ ___
b. Aggregate gain on restructuring of payables and the related in­
come tax effect? ____ ___
c. Aggregate net gain or loss on transfers of assets recognized during
the period? ____ ___
d. Per-share amount of the aggregate gain on restructuring of pay­
ables, net of related income tax effect? ____ ____
[SFAS 15, par. 25 (AC D22.121)]
9. For periods after a troubled debt restructuring, do disclosures include:
a. Extent to which amounts contingently payable are included in the
carrying amount of restructured payables? ____ ____
b. Total amounts that are contingently payable, if applicable, and 
conditions under which those amounts would become payable or
forgiven? ____ ____
[SFAS 15, par. 26 (AC D22.122)]
10. If there is an extinguishment of debt, is the difference between reac­
quisition price and carrying amount identified as a separate or ex­
traordinary item? ____ ____
[SFAS 4, par. 8, as amended by SFAS 64, par. 4 (AC D14.105)]
N/A
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11. If there is an early extinguishment of debt, is the difference between 
reacquisition price and carrying amount identified as income in the 
period of extinguishment as gain or loss?
[APB 26, pars. 20 and 21 (AC D14.103 and .104)]
12. Do disclosures for extinguishments of debt classified as extraordinary 
items include:
a. Description of the extinguishment transactions, including the 
source of any funds used to extinguish debt if it is practicable to 
identify the sources?
b. Income tax effect in the period of extinguishment?
c. The per-share amount of the aggregate gain or loss net of related 
income tax effect?
[SFAS 4, par. 9 (AC D14.107)]
13. Is the following disclosed if debt was considered to be extinguished 
by in-substance defeasance under the provisions of SFAS 76, Extin­
guishment of Debt, prior to the effective date of SFAS 125:
a. A general description of the transaction?
b. The amount of debt that is considered extinguished at the end of 
the period so long as that debt remains outstanding?
[SFAS 140, par. 17(b) (AC L35.109a)]
14. If assets are set aside after January 1, 1997 solely for satisfying sched­
uled payments of a specific obligation, is disclosure made describing 
the nature of restrictions placed on those assets?
[SFAS 140, par. 17(c) (AC L35.109b)]
15. Are long-term obligations that are or will be callable by the creditor, 
either because the debtor's violation of the debt agreement at the 
balance-sheet date makes the obligation callable, or because the vio­
lation (if not cured within a specified grace period) will make the 
obligation callable, classified as current unless one of the following 
conditions is met:
a. The creditor waives or subsequently loses the right to demand 
repayment for more than one year (or operating cycle, if longer) 
from the balance-sheet date?
b. The obligation contains a grace period within which the debtor 
may cure the violation and it is probable that the violation will be 
cured within that period, thus preventing the obligation from 
becoming callable?
[SFAS 78, par. 5 (AC B05.109A)]
16. If a covenant on a long-term loan agreement is not met, and thus, the 
lender has the right to call the debt, and the lender waives that right 
for a period of greater than one year but retains the future covenant 
requirements, is the debt classified as noncurrent unless both of the 
following are met:
a. The covenant violation occurred at the balance-sheet date or 
would have occurred absent a loan modification?
b. It is probable the company will not be able to comply with the 
covenant at a measurement date within the next 12 months? 
[EITF 86-30]
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17. If the company issued debt securities convertible into a fixed number
of common shares, and upon conversion the company either is re­
quested or has the option to satisfy all or part of the obligation in cash, 
is the conversion features and debt obligation presented on the bal­
ance sheet as one amount? ____ ___
[EITF 90-19]
18. Are borrowings outstanding under a revolving credit agreement that
includes both a subjective acceleration clause and a requirement to 
maintain a lock-box arrangement, whereby remittances from the 
borrower's customers reduce the debt outstanding, classified as short­
term obligations? ____ ___
[EITF 95-22]
19. In accordance with AICPA Practice Bulletin No. 15, Accounting by the
Issuer of Surplus Notes, are surplus notes classified as debt in the 
financial statements of the issuer, and are existing disclosure require­
ments for debt instruments complied with? ____ ___
[AAG, par. 14.13, App. C, par. 12]
20. In accordance with Practice Bulletin No. 15, is the Insurance Commis­
sioner's role and ability to approve or disapprove any interest or
principal payments disclosed? ____ ___
[AAG, par. 14.13, App. C, par. 13]
21. If the reclassification to earnings of the amount in accumulated com­
prehensive income resulting from a cash flow hedge of debt is re­
quired under SFAS 133 when the debt is extinguished, is the
reclassified amount not classified as extraordinary? ____ ___
[EITF 00-9]
22. Is the component of gain or loss resulting from a prior period adjust­
ment of the debt's carrying amount for a fair value hedge classified in 
accordance with the requirements of SFAS 4 when that debt is extin­
guished? ____ ___
[EITF 00-9]
S. Other Liabilities
1. Are liabilities appropriately accrued and reported for employees'
compensation for future absences? ____ ___
[SFAS 43, par. 6 (AC C44.104)]
2. For insurance-related assessments:
a. If amounts relating to insurance-related assessments have been 
discounted pursuant to the provisions of SOP 97-3, Accounting by 
Insurance and Other Enterprises for Insurance-Related Assessments has 
the entity disclosed in the financial statements the undiscounted 
amounts of the liability and any related asset for premium tax
offsets or policy surcharges as well as the discount rate used? ____ ____
b. If amounts have not been discounted, has the entity disclosed in 
the financial statements the amounts of the liability, any related 
asset for premium tax offsets or policy surcharges, the periods 
over which the assessments are expected to be paid, and the period 
over which the recorded premium tax offsets or policy surcharges
are expected to be realized? ____ ____
[SOP 97-3, par. 27; AAG, App. C, par. 25]
N/A
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T. Shareholders' Equity
1. For each class of stock, do disclosures include the number of shares 
authorized, issued, and outstanding, and par or stated value per 
share?
[Generally Accepted]
2. Are classes of capital stock presented in order of priority in liquida­
tion?
[Generally Accepted]
3. Do the financial statements include a description, in summary form, 
sufficient to explain the pertinent rights and privileges of the various 
securities outstanding (e.g., dividend and liquidation preferences, 
participation rights, call prices and dates, conversion or exercise 
prices or rates and pertinent dates, sinking fund requirements, un­
usual voting rights, and significant terms of contracts to issue addi­
tional shares)?
[SFAS 129, par. 4 (AC C24.102)]
4. Do disclosures include the number of shares issued upon conversion, 
exercise, or satisfaction of required conditions during at least the 
most recent annual fiscal period and any subsequent interim period 
presented?
[SFAS 129, par. 5 (AC C24.103)]
5. For preferred stock that has a preference in involuntary liquidation 
considerably in excess of par or stated value of the shares, is the 
liquidation preference disclosed in the equity section of the balance 
sheet in the aggregate, either parenthetically or "in short," rather than 
on a per share basis or in the notes to the financial statements?
[SFAS 129, par. 6 (AC C24.104)]
6. Are the following disclosed on the face of the balance sheet or in the 
notes:
a. The aggregate or per-share amounts at which preferred stock may 
be called or are subject to redemption through sinking-fund op­
erations or otherwise?
b. The aggregate and per-share amounts of arrearages in cumulative 
preferred dividends?
[SFAS 129, par. 7 (AC C24.105)]
7. For redeemable stock, do disclosures include the amount of redemp­
tion requirements, separately by issue or combined, for all issues of 
capital stock that are redeemable at fixed or determinable prices on 
fixed or redeemable dates in each of the five years following the date 
of the latest balance sheet?
[SFAS 129, par. 8 (AC C24.106)]
8. Are appropriations of retained earnings for loss contingencies clearly 
identified and included in shareholders' equity?
[SFAS 5, par. 15 (AC R70.103)]
9. Are restrictions on payment of dividends disclosed?
[SFAS 5, pars. 18 and 19 (AC C59.120)]
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10. After completion of a quasi-reorganization, is a new retained earnings
account established and dated with the date being disclosed in sub­
sequent financial statements until it is no longer deemed significant?3 ____  ___
3 As stated in paragraph 8(a)3 of SFAS 111, the dating would rarely, if ever, be of significance after a period of ten years.
[ARB 43, Ch. 7A, par. 10 (AC Q15.111); ARB 46 (AC Q15.111); SFAS
111, par. 8(a)3]
11. Are the carrying basis, cost and number of shares of any treasury stock
held by the reporting entity disclosed? ____  ___
[Generally Accepted]
12. If treasury stock is purchased for purposes other than retirement or if 
ultimate disposition has not yet been decided is its cost:
a. Shown separately as a deduction from the total of capital stock,
additional paid-in capital, and retained earnings? ____  ___
or
b. Accorded the accounting treatment appropriate for retired stock? ____  ___
13. If state laws relating to acquisition of stock restrict the availability of
retained earnings for payment of dividends or other significant ef­
fects, is appropriate disclosure made? ____  ____
[APB 6, par. 13 (AC C23.104)]
14. If an additional liability required to be recognized pursuant to SFAS 
87, paragraph 36 (AC P16.130), exceeds unrecognized prior-service 
cost, is the excess (which would represent a net loss not yet recognized 
as net periodic pension cost) reported in other comprehensive income, 
net of any tax benefits that result from considering such losses as 
temporary differences, for purposes of applying the provisions of
SFAS 87, paragraph 37 (AC I27) and SFAS 109, paragraph 287? ____  ____
[SFAS 87, par. 37 (AC Pl 6.131)]
15. For treasury shares purchased at a stated price significantly in excess 
of current market price, is the allocation of amounts paid and the
accounting treatment for such amounts disclosed? ____  ____
[FTB 85-6, pars. 1-3 (AC C23.501-.503)]
16. Is the following information relating to stockholders' equity, statutory 
capital and surplus, and the effects of statutory accounting practices 
on the ability to pay dividends to stockholders disclosed:
a. The amount of statutory capital and surplus? ____  ____
b. The amount of statutory capital and surplus necessary to satisfy
regulatory requirements (based on current operations) if signifi­
cant in relation to the statutory capital and surplus? ____  ____
c. The nature of statutory restrictions on the payment of dividends 
and the amount of retained earnings that is not available for the
payment of dividends to stockholders? ____  ____
[SFAS 60, par. 60h (AC In6.166h); AAG, App. C, par. 14]
17. If the company receives a note rather than cash as a contribution to its 
equity, is the note classified as a reduction of stockholders' equity 
unless (in the very limited circumstance) there is substantial evidence
of ability and intent to pay within a reasonably short period of time? ____  ____
[EITF 85-1]
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Income Statement
A. Premium Revenue
1. Are premiums from universal life contracts no longer included in 
revenue but recorded in the balance sheet policyholder accounts? 
[SFAS 97, par. 59 (AC In6.116A)]
B. Investment Income
1. Are amounts of interest income, loan origination, commitment, am­
ortization amounts, and other fees and costs recognized as an adjust­
ment of yield reported as part of interest income?
[SFAS 91, par. 22 (AC L20.121); AAG, par. 11.551
2. Is investment income presented net of investment expenses?
[SFAS 97, par. 23 (AC In6.137B)]
3. Are realized gains and losses on all investments (except investments 
that are classified as trading securities and those that are accounted 
for as either hedges of net investments in foreign operations or cash 
flow hedges as described in SFAS 133) reported in the statement of 
income as a component of other income, on a pretax basis?
[SFAS 97, par. 28 (AC In6.156)]
4. For all three categories of investments under SFAS 115, is interest and 
dividend income, including amortization of premium and discount, 
included in earnings?
[AAG, par. 11.12]
C. Other Income
1. Is amortization of other fees, such as commitment fees that are being 
amortized on a straight-line basis over the commitment period or 
included in income when the commitment expires, reported as service 
fee income?
[SFAS 91, par. 22 (AC L20.121)]
D. Benefits and Expenses
1. Do disclosures for advertising costs include:
a. The accounting policy selected from the two alternatives in para­
graph 26 of SOP 93-7, Reporting on Advertising Costs, for reporting 
advertising, indicating whether such costs are expensed as in­
curred or the first time the advertising takes place?
b. A description of the direct-response advertising reported as assets 
(if any), the accounting policy, and the amortization period?
c. The total amount charged to advertising expense for each income 
statement presented, with separate disclosure of amounts, if any, 
representing a write-down to net realizable value and the reasons 
for such a write-down?
d. The total amount of advertising reported as assets in each balance 
sheet?
[SOP 93-7, par. 49]
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2. Are payments to policyholders that represent a return of policyholder
balances not reported as expenses in the statement of earnings? _____ ___
[AAG, par. 9.19; SFAS 97, par. 21 ]
3. Do amounts reported as expenses include benefit claims in excess of
the related policyholder balances, expenses of contract administra­
tion, interest accrued to policyholders, and amortization of capital­
ized acquisition costs? _____ ___
[AAG, par. 9.19]
4. Are depreciation and other related charges or credits related to real 
estate investments recorded as investment expense or operating ex­
pense depending on the balance-sheet classification of the underlying
assets? _____ ___
[AAG, par. 11.74; SFAS 60, par. 48 (AC In6.154)]
E. Income Taxes
1. Are the types of significant temporary differences and carryforwards
disclosed? _____
[SFAS 109, par. 43 (AC I27.142)]
2. Are the following significant components of income tax expense 
attributable to continuing operations for each year presented dis­
closed in the financial statements or notes thereto:
a. Current tax expense or benefit? _____
b. Deferred tax expense or benefit (exclusive of the effects of other
components listed below)? _____
c. Investment tax credits? _____
d. The benefits of operating loss carryforwards? _____
e. Tax expense that results from allocating certain benefits, either
directly to contributed capital or to reduce goodwill or other 
noncurrent intangible assets, of an acquired company? _____
f. Adjustments of a deferred tax liability or asset for enacted changes
in tax laws or rates or a change in the tax status of the enterprise? _____
g. Adjustments of the beginning-of-the-year balance of a valuation 
allowance because of a change in circumstances that causes a 
change in judgment about the realizability of the related deferred
tax asset in future years? _____
[SFAS 109, par. 45a-h (AC I27.144A-H)]
h. The amounts and expiration dates of operating loss and tax credit
carryforwards for tax purposes? _____
i. Any portion of the valuation allowance for deferred tax assets for
which subsequently recognized tax benefits will be allocated to 
reduce goodwill or other noncurrent intangible assets of an ac­
quired entity or directly to contributed capital? _____
[SFAS 109, pars. 45 and 48 (AC I27.144 and .147)]
3. Is the amount of income tax expense or benefit allocated to continuing 
operations and the amounts separately allocated to other items (in 
accordance with the provisions of paragraphs 35-39 of SFAS 109 
(ACI27.134-.138)) disclosed for each year for which those items are
presented? _____
[SFAS 109, par. 46 (AC I27.145)]
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4. If the company is a public enterprise, do the financial statements 
disclose a reconciliation using percentages or dollar amounts of (i) the 
reported amount of income tax expense attributable to continuing 
operations for the year to (ii) the amount of income tax expense that 
would result from applying domestic federal statutory tax rates to 
pretax income from continuing operations?
5. If the company is a public enterprise, is the estimated amount and the 
nature of each significant reconciling item disclosed?
6. If the company is a non-public enterprise, is the nature of signifi­
cant reconciling items disclosed (a numerical reconciliation may be 
omitted)?
[SFAS 109, par. 47 (AC I27.146)]
7. If the company is a member of a group that files a consolidated tax 
return, are the following items disclosed in its separately issued 
financial statements:
a. The aggregate amount of current and deferred tax expense for 
each statement of income presented and the amount of any tax-re­
lated balances due to or from affiliates as of the date of each 
statement of financial position presented?
b. The principal provisions of the method by which the consolidated 
amount of current and deferred tax expense is allocated to mem­
bers of the group and the nature and effect of any changes in that 
method (and in determining related balances to or from affiliates) 
during the years for which the disclosures in Step a. above are 
presented?
[SFAS 109, par. 49a and b (AC I27.148A and B)]
F. Discontinued Operations
Note: This section is not applicable if the provisions of SFAS 144 are 
effective. The provisions of SFAS 144 are effective for financial statements 
issued for fiscal years beginning after December 15, 2001, and interim 
periods within those fiscal years.
1. Are operations of any segments that have been or will be discontinued 
reported separately from income from continuing operations and as 
a component of income before extraordinary items and the cumula­
tive effect of accounting changes (if any)?
[APB 30, par. 8 (AC I13.105)]
2. Is any gain or loss from disposal of any discontinued segments 
reported in conjunction with results of discontinued operations as a 
component of income before extraordinary items?
[APB 30, par. 8 (AC I13.105)]
3. Are amounts of income taxes applicable to the results of discontinued 
operations and the gains or losses from disposals disclosed on the face 
of the income statement or in the notes to the financial statements? 
[APB 30, par. 8 (AC I13.105)]
4. Are revenues applicable to discontinued operations separately dis­
closed in the notes to the financial statements?
[APB 30, par. 8 (AC I13.105)]
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5. For the period encompassing the measurement date, do notes to the 
financial statements disclose:
a. Identity of the segment discontinued?
b. Expected disposal date, if known?
c. Expected manner of disposal?
d. Description of the remaining assets and liabilities of the discontin­
ued segment at the balance-sheet date?
e. Income or loss from operations and any proceeds from disposal 
of the discontinued segment during the period from the measure­
ment date to the balance-sheet date?
f. A statement that the loss on disposal cannot be estimated within 
reasonable limits?
[APB 30, par. 18 (AC I13.108 and .109)]
6. For periods after the measurement date and including the period of 
disposal, do notes to the financial statements disclose the information 
required by Steps 3.a.-d. above and the information required by Step
3.e.  above compared with prior estimates?
[APB 30, par. 18 (AC I13.108 and .109)]
7. For discontinued operations or sale of a portion of a line of business 
that is not a segment of a business, is the gain or loss from disposal 
reported as a separate component of income from continuing opera­
tions, and is it not reduced for income taxes (information similar to 
that in Steps 3a.-f. above should be disclosed, and disclosures for 
revenues and related costs and expenses included in the income 
statement that relate to the disposed portion of the line of business for 
the period prior to the measurement date is encouraged)?
[AIN-APB 30, par. 1 (AC I22.502)]
8. If any losses on disposals of business segments that were reported in 
prior periods are adjusted during the current period, are the adjust­
ments separately disclosed as to year of origin, nature, and amount 
and classified separately on the current period as a gain or loss on 
disposal of a segment?
[APB 30, par. 25 (AC I13.104)]
9. If the company decides to dispose of a segment of a business ac­
counted for in accordance with APB 30 and the measurement date 
occurs after the balance-sheet date but before the financial statements 
for the prior period have been issued and a loss is expected, are the 
segment's operating results presented as discontinued operations in 
the income statement of the not yet released financial statements 
(assuming that the loss does not result from a discrete and identifiable 
event that occurs unexpectedly after the balance-sheet date?
[EITF 95-18]
10. If the company has accounted for the discontinuance of a segment in 
accordance with APB 30 and subsequently decides to retain the seg­
ment, is any impairment of the individual assets classified in continu­
ing operations?
[EITF 90-16]
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G. Extraordinary Items, Unusual Items, Infrequent Items
1. Do extraordinary items meet both criteria of (1) unusual nature and
(2) infrequency of occurrence?
[APB 30, par. 20 (AC I17.107)]
2. Are extraordinary items segregated and shown (including applicable 
income taxes) following income before extraordinary items and be­
fore net income?
[APB 30, par. 11 (AC I17.102)]
3. Are descriptive captions and amounts (including applicable income 
taxes) presented for individual extraordinary events or transactions, 
preferably on the face of the income statement?
[APB 30, par. 11 (AC I17.102)]
4. Do disclosures include descriptions of an extraordinary event or 
transaction and the principal items entering into determination of 
extraordinary gain or loss?
[APB 30, par. 11 (AC I17.102)]
5. Are the income taxes applicable to extraordinary events disclosed on 
the face of the statement of operations or in related notes?
[APB 30, par. 11 (AC I17.102)]
6. Is each adjustment in the current period of an element of an extraor­
dinary item that was reported in a prior period separately disclosed 
as to year of origin, nature, and amount and classified separately in 
the current period as an extraordinary item?
[SFAS 16, par. 16c (AC I17.119)]
7. Are material events or transactions that are either unusual in nature 
or of infrequent occurrence, but not both (and therefore not meeting 
criteria for extraordinary items):
a. Reported as a separate component of income from continuing 
operations?
b. Accompanied by disclosure of the nature and financial effects of 
each event?
[APB 30, par. 26 (AC I22.101)]
8. If the losses and costs incurred as a result of the September 11, 2001 
attacks meet the criteria for disclosure of unusual or infrequently 
occurring items, are they reported as a separate component of income 
from continuing operations, either on the face of the statement of 
operations or in the notes to the financial statements?
[EITF 01-10]
9. For gains or losses from extinguishment of debt classified as extraor­
dinary items, do disclosures include:
a. Description of the extinguishment transactions, including the 
sources of any funds used to extinguish the debt if it is practicable 
to identify the sources?
b. Income tax effect in the period of extinguishment?
c. The per share amount of the aggregate gain or loss net of related 
income tax effect?
[SFAS 4, par. 9 (AC I17.104)]
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H. Earnings Per Share
Note: SFAS 128, Earnings per Share, applies only to entities with publicly 
held common stock or potential common stock.
1. If the reporting entity has a simple capital structure (only common 
stock outstanding), are basic per-share amounts for income from 
continuing operations and for net income presented on the face of the 
income statement for all periods for which an income statement or
summary of earnings is presented? ____
[SFAS 128, pars. 36 and 38 (AC E11.131 and .133)]
2. If the reporting entity has other than a simple capital structure, are 
basic and diluted per-share amounts for income from continuing 
operations and for net income presented on the face of the income 
statement with equal prominence for all periods for which an income
statement or summary of earnings is presented? ____
(Note: If diluted EPS data are reported for at least one period, they
should be reported for all periods presented, even if they are the same 
amounts as basic EPS.)
[SFAS 128, pars. 36 and 38 (AC E11.131 and .133)]
3. If discontinued operations, extraordinary items, or the cumulative 
effect of accounting changes are reported in the period, are the basic 
and diluted per share amounts for those line items presented on the
face of the income statement or in the notes? ____
[SFAS 128, par. 37 (AC E11.132)]
4. If per share amounts not required to be presented by SFAS 128 are 
disclosed, are they disclosed only in the notes and do the disclosures
indicate whether the per share amounts are pretax or net of tax? ____
[SFAS 128, par. 37 (AC E11.132)]
5. Are the following disclosed for each period for which an income 
statement is presented:
a. A reconciliation of the numerators and denominators of the basic
and diluted per share computations for income from continuing 
operations? ____
b. The effect that has been given to preferred dividends in arriving 
at income available to common shareholders' in computing basic
EPS? ____
c. Securities (including those issuable pursuant to contingent stock 
agreements) that could potentially dilute basic EPS in the future 
that were not included in the computation of diluted EPS because
to do so would have been antidilutive for the period(s) presented? ____
[SFAS 128, par. 40 (AC E11.135)]
6. For the latest period for which an income statement is presented, do 
disclosures include a description of any transaction that occurs after 
the end of the most recent period but before issuance of the financial 
statements that would have changed materially the number of com­
mon shares or potential common shares outstanding at the end of the
period if the transaction had occurred before the end of the period? ____
[SFAS 128, par. 41 (AC E11.136)]
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I. Comprehensive Income
1. Are all components of comprehensive income reported in the finan­
cial statements in the period in which they are recognized?
[SFAS 130, par. 14 (AC C49.108)]
2. Is a total amount for comprehensive income displayed in the financial 
statement where the components of other comprehensive income are 
reported?
[SFAS 130, par. 14 (AC C49.108)]
3. Is an amount for net income displayed and included as a component 
of comprehensive income?
[SFAS 130, pars. 15 and 22 (AC C49.109 and .116)1
4. Are items included in other comprehensive income classified sepa­
rately into foreign currency items, minimum pension liability adjust­
ments, and unrealized gains and losses on certain investments in debt 
and equity securities?
[SFAS 130, par. 17 (AC C49.111)]
5. Are reclassification adjustments made to avoid double counting in 
comprehensive income of items that are displayed as part of net 
income for a period that also had been displayed as part of other 
comprehensive income in that period or other periods presented on 
the face of the financial statement in which comprehensive income is 
reported or disclosed in the notes?
[SFAS 130, par. 20 (AC C49.114)]
6. Are comprehensive income and its components displayed in a finan­
cial statement that is displayed with the same prominence as the other 
financial statements?
(Note: SFAS 130 encourages but does not require that the compo­
nents of other comprehensive income and total comprehensive in­
come be displayed below the total for net income in a statement that 
reports results of operations or in a separate statement of comprehen­
sive income that begins with net income.)
[SFAS 130, pars. 22 and 23 (AC C49.116 and .117)]
7. Are the components of other comprehensive income displayed either 
net of related tax effects, or before related tax effects with one amount 
shown for the aggregate tax effect related to the total of other compre­
hensive income items?
[SFAS 130, par. 24 (AC C49.118)]
8. Is the amount of income tax expense or benefit allocated to each 
component of other comprehensive income (including reclassifica­
tion adjustments) displayed on the face of the statement in which 
those components are displayed or disclosed in the notes to the 
financial statements?
[SFAS 130, par. 25 (AC C49.119)]
9. Is the total of other comprehensive income for a period transferred to 
a component of equity that is displayed separately from retained 
earnings and additional paid-in-capital in the balance sheet with a 
descriptive title such as accumulated other comprehensive income?
[SFAS 130, par. 26 (AC C49.120)]
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10. Are accumulated balances for each classification within accumulated 
other comprehensive income disclosed on the face of the balance sheet,
in the statement of changes in shareholders' equity, or in the notes? ____ ___
[SFAS 130, par. 26 (AC C49.120)]
11. Has the enterprise reported a total for comprehensive income in
condensed financial statements of interim periods? ____ ___
[SFAS 130, par. 27 (AC C49.121)]
12. Has the entity displayed as a separate classification within other 
comprehensive income the net gain or loss on derivative instruments 
designated and qualifying as cash flow hedging instruments that are 
reported in comprehensive income pursuant to paragraphs 30 and 41
of SFAS 133? ____ ___
[SFAS 133, par. 46 (AC D50)]
13. As part of the disclosures of accumulated other comprehensive in­
come, pursuant to paragraph 26 of SFAS 130, Reporting Comprehensive 
Income, has the entity separately disclosed the beginning and ending 
accumulated derivative gain or loss, the related net change associated 
with current period hedging transactions, and the net amount of any
reclassification into earnings? ____ ___
[SFAS 133, par. 47 (AC D50)]
J. Other
1. Are the following excluded from determination of net income or 
results of operations under all circumstances:
a. Adjustments or charges or credits resulting from transactions in
the company's own capital stock? ____ ___
b. Transfers to and from accounts properly designated as appropri­
ated retained earnings? ____ ___
c. Adjustments made pursuant to a quasi reorganization? ____ ___
[APB 9, par. 28 (AC C08.101)]
2. For a sales incentive offered voluntarily by a vendor and without 
charge to customers that can be used in, or that becomes exercisable 
by a customer as a result of, a single exchange transaction:
a. Is the reduction in or refund of the selling price of the product or 
service resulting from any cash sales incentive classified as a
reduction of revenue? ____ ___
b. If the sales incentive is a free product or service delivered at the 
time of sale (for example, a gift certificate or free airline ticket that 
will be honored by another, unrelated entity), is the cost of the free
product or service classified as an expense? ____ ____
[EITF 00-14]
3. Is the amount of revenue and expense recognized from advertising barter
transactions disclosed for each income statement period presented? ____ ____
[EITF 99-17]
4. If the entity engages in advertising barter transactions for which the 
fair value is not determinable within the limits of EITF Issue 99-17, is 
information regarding the volume and type of advertising surren­
dered and received (such as the number of equivalent pages, the 
number of minutes, or the overall percentage of advertising volume)
disclosed for each income statement period presented? ____ ____
[EITF 99-17]
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5. At a minimum, is a description of the nature and amounts of losses 
and costs recognized as a result of the September 11 events and the 
amount of related insurance recoveries (if any) recognized disclosed 
in the notes to the financial statements in all periods affected by the 
September 11, 2001 attacks?
[EITF 01-10]
6. Are losses and costs incurred as a result of the September 11, 2001 
attacks classified as part of income from continuing operations? 
[EITF 01-10]
Statement of Changes in Shareholders' Equity
1. Are changes in the separate accounts of shareholders' equity disclosed? ____
[APB 12, par. 10 (AC C08.102)]
2. Are changes in the number of shares of equity securities disclosed? ____
[APB 12, par. 10 (AC C08.102)]
3. If prior-period adjustments have been recorded during the current 
year, are their resulting effects (both gross and net of applicable 
income taxes and including the amounts of income tax applicable to 
the prior period adjustments) appropriately disclosed:
a. For single-period statements, does the disclosure indicate the
effects of such restatement on the balance of retained earnings at 
the beginning of the period and on the net income of the immedi­
ately preceding period? ____
b. If financial statements of more than one period are presented, does 
disclosure include the effects for each of the periods presented in
the statements? ____
[APB 9, par. 26 (AC A35.107)]
Practice Tip
Disclosure of restatements in annual reports issued subsequent to the first such post-revision disclosure 
would ordinarily not be required.
4. If the reporting entity is a publicly traded company and if interim 
financial data and disclosures are not separately reported for the 
fourth quarter, are accounting changes made during the fourth quar­
ter, disposals of segments of a business (components of an entity, if 
SFAS 144 is effective), extraordinary, unusual, or infrequently occur­
ring items recognized in the fourth quarter, and the aggregate effect 
of year end adjustments that are material to the results of that quarter 
disclosed in a note to the financial statements?
[APB 28, par. 31 (AC I73.147); SFAS 3, par. 14]
5. If the reporting entity is a publicly traded company, is disclosure 
about the effect of accounting changes on interim periods that are 
required by paragraphs 23-26 of APB 28 or by paragraphs 9-13 of 
SFAS 3 included in a note to the financial statements for the fiscal year 
in which the change is made?
[SFAS 3, par. 14 (AC I73.147)]
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6. For a correction of an error, is the nature of the error disclosed in the 
period in which the error was discovered and corrected:
a. Nature of the error in previously issued financial statements? ____ ___
b. Effect of its correction on income before extraordinary items, net
income, and related per-share amounts, if applicable? ____ ___
[APB 20, par. 37 (AC A35.105)]
Statement of Cash Flows
1. Is a statement of cash flows presented as a basic financial statement
(for each period for which a statement of income is presented) if 
financial statements present both financial position and results of
operations? ____ ___
[SFAS 95, par. 3 (AC C25.101)]
2. Are cash receipts and cash payments from operating activities shown
separately on the statement of cash flows? ____ ___
[SFAS 95, pars. 27 and 28 (AC C25.125 and .126)]
a. Are cash receipts and cash payments from purchases and sales of
securities and other assets acquired for resale and carried at mar­
ket value in a trading account classified as operating cash flows? ____ ___
[SFAS 102, par. 8, as amended by SFAS 115 (AC C25.122A)]
b. Are cash receipts and cash payments resulting from purchases, 
acquisitions and sales of loans, if those loans are acquired specifi­
cally for resale and are carried at market value or the lower of cost
or market, classified as operating cash flows? ____ ___
[SFAS 102, par. 9 (AC C25.122B)]
3. Are cash receipts and cash payments for the following transactions 
classified as cash flows from operating activities:
a. Cash receipts from sales of goods or services? ____ ___
b. Cash receipts from interest and dividends? ____ ___
c. All other cash receipts that do not stem from transactions defined
as investing or financing activities? ____ ___
d. Cash payments to suppliers and employees, such as benefits paid
to policyholders, surrender benefits, and dividends paid to poli­
cyholders? ____ ___
e. Cash payments to governments for taxes, duties, fines, and other
fees or penalties? ____ ___
f. Cash payments to lenders and other creditors for interest? ____ ___
g. Payments to settle lawsuits? ____ ___
h. Contributions to charities? ____ ___
i. Cash flows from purchases, sales, and maturities of trading
securities? ____ ___
j. All other cash payments that do not stem from transactions de­
fined as investing or financing activities? ____ ___
[SFAS 95, pars. 22 and 23 (AC C25.120 and .121)]
4. Are cash receipts and cash payments from investing activities shown
separately on statement of cash flows? ____ ___
[SFAS 95, par. 31 (AC C25.129)]
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5. Are cash receipts and cash payments for the following transactions 
classified as cash flows from investing activities:
a. Receipts from collections or sales of loans? ____ ____  ____
b. Purchases of and proceeds from sales of available-for-sale securities? ____ ____ ____
c. Proceeds from maturities of available-for-sale and held-to-maturity
securities? ____  ____  ____
d. Purchases of held-to-maturity securities? ____  ____  ____
e. Net purchases of property and equipment? ____  ____  ____
[SFAS 95, pars. 16 and 17, as amended by SFAS 102, as amended
by SFAS 115 (AC C25.114 and .115)]
6. Are cash receipts and cash payments from financing activities shown
separately on the statement of cash flows? ____  ____  ____
[SFAS 95, par. 31 (AC C25.129)]
7. Are cash receipts and cash payments for the following transactions 
classified as cash flows from financing activities:
a. Proceeds from issuing equity instruments? ____  ____  ____
b. Proceeds from issuing bonds, mortgages, and notes, and from
other short- or long-term borrowing? ____  ____  ____
c. Repayment of amounts borrowed? ____  ____ ____
d. Dividend payments to stockholders? ____  ____ ____
e. Acquisition of treasury stock? ____  ____  ____
f. Other principal payments to creditors who have extended long­
term credit? ____  ____  ____
g. Debt issue costs? ____  ____  ____
[SFAS 95, pars. 19 and 20 (AC C25.117 and .118); EITF 95-13]
8. If applicable, is the effect of exchange rate changes on cash balances
held in foreign currencies shown separately on statement of cash flows? ____  ____  ____
[SFAS 95, par. 25 (AC C25.123)]
9. Is the change in cash and cash equivalents shown? ____  ____  ____
[SFAS 95, pars. 7 and 26 (AC C25.105 and .124)]
10. Is the policy for defining cash equivalent disclosed? ____  ____  ____
[SFAS 95, par. 10 (AC C25.108)]
Practice Tip
Any change in policy for determining which items are treated as cash equivalents is a change in accounting 
principle.
11. Are noncash investing and financing activities, such as converting 
debt to equity, summarized in a separate schedule?
[SFAS 95, par. 32 (AC C25.134)]
12. If the direct method is used, is a separate schedule provided to 
reconcile net income to net cash flow from operating activities? 
[SFAS 95, par. 29 (AC C25.128)]
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13. If the indirect method is used:
a. Is the same amount for net cash flow from operating activities 
reported indirectly, by adjusting net income to reconcile it to net
cash flow from operating activities? ____ ___
b. Is the reconciliation of net income to net cash flows from operating 
activities reported, either within the statement of cash flows or 
provided in a separate schedule (the reconciliation should sepa­
rately report all major reconciling items pertaining to operating
activities)? ____ ___
[SFAS 95, pars. 29 and 30 (AC C25.128)]
14. If the indirect method is used, are the amounts of interest paid (net of 
amounts capitalized) and income taxes paid during the period(s)
disclosed? ____ ___
[SFAS 95, par. 29 (AC C25.127)]
15. Are the following classes of operating cash receipts and payments for 
life insurance companies using the direct method, at a minimum, 
separately disclosed:
a. Cash collected from customers, including lessees, licensees, and
the like? ____ ___
b. Interest and dividends received? ____ ___
c. Other operating cash receipts, if any? ____ ___
d. Cash paid to employees and other suppliers of goods or services,
including suppliers of insurance, advertising, and the like? ____ ___
e. Interest paid? ____ ___
f. Income taxes paid? ____ ___
g. Other operating cash payments, if any? ____ ___
[SFAS 95, par. 27 (AC C25.125)]
16. If the indirect method is used, is the reduction of income taxes paid 
as a result of a deduction triggered by employee exercise of stock
options classified as an operating cash flow? ____ ___
[EITF 00-151
17. If a material income tax benefit realized as a result of the deduction 
triggered by employee exercise of stock options is not presented as a 
separate line item in the statement of cash flows or in the statement 
of changes in stockholders' equity, is disclosure made of the material
income tax benefit realized? ____ ___
[EITF 00-151
General
A. Titles and References
1. For a full presentation in conformity with generally accepted accounting 
principles (GAAP), are the following financial statements presented:
a. Balance sheet? ____
b. Statement of income (operations)? ____
c. Statement of retained earnings or changes in shareholders' equity? ____
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d. Statement of cash flows?
e. Description of accounting policies?
f. Notes to the financial statements?
[Generally Accepted]
2. Are the financial statements suitably titled?
[Generally Accepted]
3. Does each statement include a general reference indicating that the 
notes are an integral part of the financial statement presentation? 
[Generally Accepted]
B. Disclosure of Accounting Policies
1. Is a description of all significant accounting policies of the reporting 
company presented as an integral part of the financial statements? 
[APB 22, par. 8 (AC A10.102)]
2. Do the summary or notes identify and describe all significant account­
ing principles followed by the reporting entity and the methods of 
applying those principles that materially affect the determination of 
financial position, cash flows, and results of operations?
[APB 22, par. 12 (AC A10.105)]
3. Do those principles and methods identified in Step 2 include all 
instances in which there:
a. Is a selection from existing acceptable alternatives?
b. Are principles and methods peculiar to the industry in which the 
reporting entity operates, even if such principles and methods are 
predominantly followed in that industry?
c. Are unusual or innovative applications of GAAP?
[APB 22, par. 12 (AC A10.105)]
4. Does disclosure of significant accounting policies include appropriate 
reference to details presented elsewhere (in the statements and notes 
thereto) so duplication of details is avoided?
[APB 22, par. 14 (AC A10.107)]
5. Do mutual life insurance companies disclose the principles and meth­
ods used to account for marketable securities and insurance activities? 
[FASBI40, par. 5 (AC A10.102A)]
6. When the permitted practices differ from the prescribed statutory 
accounting practices, is the following information about permitted 
statutory accounting practices that individually or in the aggregate 
affect statutory surplus or risk-based capital, including GAAP prac­
tices, disclosed:
a. A description of the permitted statutory accounting practices?
b. A statement that the permitted statutory accounting practice dif­
fers from prescribed statutory accounting practices?
c. The monetary effect on statutory surplus?
[SOP 94-5, par. 8]
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7. When prescribed statutory accounting practices do not address the 
accounting for the transaction, is the following information about 
permitted statutory accounting practices, excluding GAAP practices 
used, disclosed:
a. A description of the transaction and of the permitted statutory 
accounting practice used?
b. A statement that prescribed statutory accounting practices do not 
address the accounting for the transaction?
[SOP 94-5, par. 8]
8. If consolidated statements are presented; is the consolidation policy 
disclosed?
[ARB 51, par. 5 (AC C51.108); APB 22, par. 13 (AC A10.106)]
C. Comparative Financial Statements
1. Are comparative statements considered?
[ARB 43, Ch. 2A, pars. 1 and 2 (AC F43.101 and .102)]
2. Are the notes and other disclosures included in the financial state­
ments of the preceding year(s) presented, repeated, or at least referred 
to, to the extent that they continue to be of significance?
[ARB 43, Ch. 2A, par. 2 (AC F43.102)]
3. If changes occurred in the manner of or basis for presenting corre­
sponding items for two or more periods, are appropriate explanations 
of the changes disclosed?
[ARB 43, Ch. 2A, par. 3, as amended by APB 20 (AC F43.103)]
4. In connection with prospectively applying the consensuses in EITF 
Issue 00-14, Accounting for Certain Sales Incentives, if it is impracticable 
to reclassify prior-period financial statements to comply with the 
income statement display requirements under Issue 3 of EITF Issue 
00-14, is disclosure made of the reasons why reclassification was not 
made and the effects of the reclassification on the current period? 
[EITF 00-14]
5. In connection with applying the consensuses in EITF Issue 99-19, 
Reporting Revenue Gross as a Principal versus Net as an Agent, if it is 
impracticable to reclassify prior-period financial statements, is disclo­
sure made of both the reasons why reclassification was not made and 
the effect of the reclassification on the current period?
[EITF 99-19]
D. Accounting Changes
1. For all changes in accounting principles, are the following disclosures 
made in the year of change:
a. Nature of the change?
b. Justification for the change?
c. Effect on income before extraordinary items and on net income?
d. Effect on related per-share amounts?
[APB 20, pars. 17 and 19 (AC A06.113 and .115)]
N/A
□
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2. For all changes in accounting principles, except those concerning a 
change in entity and those recognized in paragraphs 27-30 of APB 20:
a. Are financial statements for prior periods, included for compara­
tive purposes, presented as previously reported? ____
b. Is the effect of adopting the new accounting principle on income
before extraordinary items and on net income and the related 
per-share amounts disclosed in the period of the change? ____
c. Are income before extraordinary items and net income computed 
on a pro forma basis shown on the face of the income statements 
for all periods presented as if the newly adopted accounting
principle had been applied during all periods affected? ____
[APB 20, pars. 19-21 and 25 (AC A06.115-.117 and .121)]
3. If appropriate, is the cumulative effect of a change in accounting 
principle shown separately between the captions "extraordinary
items" and "net income"? ____
[APB 20, pars. 19b, 20, and 21 (AC A06.114-.122 and E09.104)]
4. Is the reason for not reporting the cumulative effect of the change and 
not disclosing the pro forma amounts for prior years disclosed if it is
impossible to determine such effects? ____
[APB 20, pars. 25 and 26 (AC A06.121 and .122)]
5. For changes in accounting principle that are required to be accounted 
for by applying retroactively the new method in restatements of prior 
periods, is the effect of the change on income before extraordinary
items, net income, and related per share amounts disclosed? ____
[APB 20, par. 28 (AC A10.124)]
6. For a change in accounting estimate affecting several future periods, 
are the following disclosures made in the year of change:
a. Effect on income before extraordinary items and on net income? ____
b. Effect on related per-share amounts? ____
[APB 20, par. 33 (AC A06.132)]
7. For correction of an error, is the nature of the error disclosed in the 
period in which the error was discovered and corrected:
a. Nature of the error in previously issued financial statements? ____
b. Effect of its correction on income before extraordinary items, net
income, and related per-share amounts, if applicable? ____
[APB 20, par. 37 (AC A35.105)]
8. If any accounting change has no material effect in the period of change 
but is reasonably certain to materially affect later periods, is the 
change disclosed in the financial statements of the period of the
change? ____
[APB 20, par. 38 (AC A06.133)]
9. For an accounting change that is in effect a change in reporting entity, 
are the financial statements of all prior periods restated in order to 
show financial information for the new reporting entity for all periods 
and are the following disclosures made for all periods presented:
a. The nature of the change? ____
b. The reason for the change? ____
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c. The effect of the change on income before extraordinary items, net
income, and related per share amounts? ____ ____ ____
[APB 20, pars. 34 and 35 (AC A35.112-. 113)]
10. If interim financial reports contain an adjustment related to prior 
interim periods of the current fiscal year, do disclosures include:
a. The effect on income from continuing operations, net income, and 
related per share amounts for each prior interim period of the
current fiscal year? ____ ____ ____
b. Income from continuing operations, net income, and related per
share amounts for each prior interim period restated? ____ ____ ____
[SFAS 16, par. 15 (AC A35.111)]
11. If the accounting practice for internal replacements, other than re­
placements by a universal life-type contract, is changed and the effect 
is material, does the life insurance entity reflect the accounting change 
as well as disclose the change in their financial statements as a change 
in accounting principle, as described in paragraphs 18 through 26 of
APB Opinion 20? ____ ____ ____
[AAG, par. 10.52]
E. Risks and Uncertainties
1. Is a description of the major products and services the entity sells or 
provides and the principal markets, including the location of those
markets, disclosed? ____
[SOP 94-6, par. 10]
2. If the company operates in more than one business, are the relative 
importance of its operations in each business and the basis for the
determination (for example, assets, revenues, or earnings) disclosed? ____
[SOP 94-6, par. 10]
3. Is an explanation that the preparation of financial statements in 
conformity with GAAP requires the use of management's estimates
included in the financial statements? ____
[SOP 94-6, par. 11]
4. Is the disclosure regarding an estimate made when known informa­
tion available prior to the issuance of the financial statements indi­
cates that both of the following criteria have been met:
a. It is at least reasonably possible that the estimate of the effect on
the financial statements of a condition, situation, or set of circum­
stances that existed at the date of the financial statements will 
change in the near term due to one or more future confirming 
events? ____
b. The effect of the change will be material? ____
[SOP 94-6, par. 13]
5. Does the disclosure in Step 4 above, indicate the nature of the uncer­
tainty and include an indication that it is reasonably possible that a
change in estimate will occur in the near term?4 ____
4 If risk reduction techniques are used to mitigate losses or the uncertainty that may result from certain events, these disclosures are 
encouraged but not required.
[SOP 94-6, par. 14]
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6. If the estimate in Step 4 above involves a loss contingency covered by 
SFAS 5, do disclosures include an estimate of the possible loss or range 
of loss, or state that such an estimate cannot be made?5
[SOP 94-6, pars. 13 and 14]
7. Is disclosure of the concentrations described in paragraph 22 of SOP 
94-6 made if, based on information known to management before the 
financial statements are issued, the criteria in paragraph 21 of SOP 
94-6 are met?
[SOP 94-6, pars. 21 and 22]
8. For those concentrations of labor subject to collective bargaining 
agreements and concentrations of operations located outside of the 
company's home country that meet the criteria of paragraph 21 of SOP 
94-6, are the following disclosed:
a. The percentage of labor force covered by a collective agreement 
and the percentage of the labor force covered by a collective 
bargaining agreement that will expire in one year?
b. The carrying amounts of net assets and the geographic areas in 
which they are located for operations located outside the com­
pany's home country?
[SOP 94-6, par. 24]
9. Have the optional disclosures in paragraphs 14 and 15 of SOP 94-6 
been considered?
[SOP 94-6, pars. 14 and 15]
10. Are applicable disclosures related to the attacks of September 11 made 
in the notes to the financial statements in all periods affected by the 
September 11, 2001 attacks, pursuant to SOP 94-6?
[EITF 01-01]
F. Contingencies and Commitments
1. Is the nature and amount of significant accrued loss contingencies not 
related to life insurance disclosed as necessary to keep the financial 
statements from being misleading?
[SFAS 5, par. 9 (AC C59.108)]
2. For loss contingencies not accrued, do disclosures indicate:
a. Nature of the contingency?
b. Estimate of possible loss or range of loss, or a statement that such 
estimate cannot be made?
[SFAS 5, par. 10 (AC C59.109)]
3. Is the nature and amount of guarantees disclosed (e.g., obligations 
under standby letters of credit, guarantees to repurchase loans that 
are sold)?
[SFAS 5, par. 12 (AC C59.113); FASBI 34, pars. 2 and 3 (AC C59.114)]
4. Are gain contingencies adequately disclosed with care to avoid any 
misleading implications about likelihood of realization?
[SFAS 5, par. 17 (AC C59.118)]
5 See footnote 4.
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5. Is there adequate disclosure of commitments, such as those for capital 
expenditures, for purchase or sale of securities under financial futures
contracts, and for funding of loans and unused letters of credit? ____ ___
[SFAS 5, pars. 18 and 19 (AC C59.120); FASB 80 (AC F80)]
6. If the company as guarantor "lends" its creditworthiness to another 
party (borrower) for a fee, is the guarantee disclosed in a note, if
material? ____ ___
[EITF 85-20]
7. If exposure to loss exists in excess of the amount accrued for a loss 
contingency, do disclosures include the excess amount or state that
no estimate is possible? ____ ___
[SFAS 5, par. 10 (AC C59.109)]
8. When, after considering management's plans, the auditor concludes 
there is substantial doubt about the entity's ability to continue as a 
going concern for a reasonable period of time, is adequate disclosure
of the situation made in the financial statements? ____ ___
[SAS 59, par. 10 (AU 341.10); AAG, par. 5.89]
9. Is a description of contingencies resulting from the September 11 
events that have not yet been recognized in the financial statements 
but that are reasonably expected to impact the entity's financial 
statements in the near term disclosed in the notes to the financial
statements in all periods affected by the September 11, 2001 attacks? ____ ___
[EITF 01-10]
G. Environmental Remediation Liabilities
Note: SOP 96-1, Environmental Remediation Liabilities, does not provide 
guidance on recognizing liabilities of insurance companies for unpaid 
claims.
1. Is there disclosure of the following accounting policies:
a. Whether accruals for environmental remediation liabilities are
measured on a discounted basis? ____
b. The policy concerning the timing of recognition of recoveries?
(Encouraged, but not required.) ____
[SOP 96-1 (Ch. 7, pars. 11 and 12)]
2. Do the financial statements disclose the event, situation, or set of 
circumstances that triggered recognition of loss contingencies that 
arose out of the reporting entity's environmental remediation-related
obligations? (Encouraged, but not required.) ____
[SOP 96-1 (Ch. 7, par. 12)]
Recognized Losses and Recoveries of Losses, and Reasonably Possible 
Loss Exposures
3. With respect to recorded accruals for environmental remediation loss 
contingencies and assets for third-party recoveries related to environ­
mental remediation obligations, are the following disclosed:
a. The nature of the accruals, if such disclosure is necessary for the 
financial statements not to be misleading, and, in situations where 
disclosure of the nature of the accruals is necessary, the total 
amount accrued for the remediation obligation, if such disclosure 
is also necessary for the financial statements not to be misleading? ____
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b. If any portion of the accrued obligation is discounted, the undis­
counted amount of the obligation and the discount rate used in the 
present-value determinations? ____
c. If the criteria of SOP 94-6 (it is at least reasonably possible that an 
estimate of the effect on the financial statements of a matter that 
existed at the balance-sheet date will change in the near term and 
the effect of the change would be material to financial statements) 
are met with respect to the accrued obligation or to any recognized 
asset for third-party recoveries, an indication that it is at least 
reasonably possible that a change in the estimate of the obligation
or of the asset will occur in the near term? ____
[SOP 96-1 (Ch. 7, par. 20)]
4. With respect to reasonably possible loss contingencies, including 
reasonably possible loss exposures in excess of the amount accrued, 
are the following disclosed:
a. The nature of the reasonably possible loss contingency, that is, a
description of the reasonably possible remediation obligation, and 
an estimate of the possible loss exposure or the fact that such an 
estimate cannot be made? ____
b. If the criteria of SOP 94-6 are met with respect to estimated loss (or
gain) contingencies, an indication that it is at least reasonably 
possible that a change in the estimate will occur in the near term? ____
c. The estimated time frame of disbursements for recorded amounts
if expenditures are expected to continue over the long term? 
(Encouraged, but not required.) ____
d. The estimated time frame for realization of recognized probable
recoveries, if realization is not expected in the near term? (Encour­
aged, but not required.) ____
e. If the criteria of SOP 94-6 are met with respect to the accrued
obligation, to any recognized asset for third-party recoveries, or to 
reasonably possible loss exposures or disclosed gain contingen­
cies, the factors that cause the estimate to be sensitive to change? 
(Encouraged, but not required.) ____
f. If an estimate of the probable or reasonably possible loss or range
of loss cannot be made, the reasons why it cannot be made? 
(Encouraged, but not required.) ____
g. If information about the reasonably possible loss or the recognized 
and additional reasonably possible loss for an environmental 
remediation obligation related to an individual site is relevant to 
an understanding of the financial position, cash flows, or results 
of operations of the entity, the following with respect to the site: 
(Encouraged, but not required.)
(1) The total amount accrued for the site? ____
(2) The nature of any reasonably possible loss contingency or 
additional loss, and an estimate of the possible loss or the fact 
that an estimate cannot be made and the reasons why it
cannot be made? ____
(3) Whether other potentially responsible parties are involved
and the entity's estimated share of the obligation? ____
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(4) The status of regulatory proceedings? ____
(5) The estimated time frame for resolution of the contingency? ____
[SOP 96-1 (Ch. 7, pars. 21 and 22)1
Probable But Not Reasonably Estimable Losses
5. If the reporting entity's probable but not reasonably estimable envi­
ronmental remediation obligations may be material, are the nature of 
the probable contingency (that is, a description of the remediation 
obligation) and the fact that a reasonable estimate cannot currently be
made disclosed? ____
[SOP 96-1 (Ch. 7, par. 25)]
6. Is the estimated time frame for resolution of the uncertainty as to the
amount of the loss disclosed? (Encouraged, but not required.) ____
[SOP 96-1 (Ch. 7, par. 25)]
Environmental Remediation Costs Recognized Currently
7. Is the amount of environmental remediation costs recognized in the 
income statement disclosed in the following detail: (Encouraged, but 
not required.)
a. The amount recognized for environmental remediation loss con­
tingencies in each period? ____
b. The amount of any recovery from third parties that is credited to
environmental remediation costs in each period? ____
c. The income statement caption in which environmental remedia­
tion costs and credits are included? ____
[SOP 96-1 (Ch. 7, par. 29)]
Other Matters
8. Do the financial statements include a contingency conclusion that ad­
dresses the estimated total unrecognized exposure to environmental
remediation and other loss contingencies? (Optional.) ____
[SOP 96-1 (Ch. 7, par. 30)]
9. Is there a description of the general applicability and impact of
environmental laws and regulations upon their business and how the 
existence of such laws and regulations may give rise to loss contin­
gencies for future environmental remediation? (Optional.) ____
[SOP 96-1 (Ch. 7, par. 31)]
10. Are applicable disclosures about environmental obligations (and re­
coveries) related to the attacks of September 11 disclosed in the notes 
to the financial statements in all periods affected by the September 11,
2001 attacks, pursuant to SOP 96-1? ____
[EITF 01-01]
H. Related-Party Transactions and Economic Dependency
1. For related-party transactions, do disclosures include:
a. The nature of the relationship(s) involved (e.g., parent, subsidiary,
and affiliate companies, officers, stockholders, etc.)? ____
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b. A description of the transactions, including transactions to which 
no amounts or nominal amounts were ascribed, for each of the 
periods for which an income statement is presented, and such 
other information deemed necessary to an understanding of the
effects of the transactions on the financial statements? ____
c. The dollar amounts of transactions for each of the periods for 
which an income statement is presented and the effects of any 
change in the method of establishing the terms from that used in
the preceding period? ____
d. Amounts due from or to related parties as of the date of each 
balance sheet presented and, if not otherwise apparent, the terms
and manner of settlement? ____
[SFAS 57, par. 2 (AC R36.102)]
2. Is the nature of a controlled relationship disclosed, even though there 
are no transactions between the enterprises, if the reporting company 
and one or more other enterprises are under common ownership or 
management control, and the existence of the control could result in 
operating results or financial position of the reporting company being 
significantly different from those that would have resulted if the
company were autonomous? ____
[SFAS 57, par. 4 (AC R36.104)]
I. Employee Stock Ownership Plans
1. If an employer sponsors an employee stock ownership plan (ESOP), 
do the employer's disclosures include:
a. A description of the plan, the basis for determining contributions,
including the employee groups covered, and the nature and effect 
of significant matters affecting comparability of information for all 
periods presented? ____
(1) For leveraged ESOPs and pension reversion ESOPs, does the 
description include the basis for releasing shares and how 
dividends on allocated and unallocated shares are used? ____
b. A description of the accounting policies followed for ESOP trans­
actions, including the method of measuring compensation, the 
classification of dividends on ESOP shares, and the treatment of
ESOP shares for EPS computations? ____
(1) If the entity has both old ESOP shares for which it does not 
adopt the guidance in SOP 93-6 and new ESOP shares for 
which the guidance in SOP 93-6 is required, are the account­
ing policies for both blocks of shares disclosed? ____
c. The amount of compensation cost recognized during the period? ____
d. The number of allocated shares, committed-to-be-released 
shares, and suspense shares held by the ESOP at the balance-
sheet date? ____
(1) If the entity has both old ESOP shares for which it does not 
adopt the guidance in SOP 93-6 and new ESOP shares for 
which the guidance in SOP 93-6 is required, is the above 
disclosure made separately for both blocks of shares? ____
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e. The fair value of unearned ESOP shares at the balance-sheet date 
for shares accounted for under SOP 93-6?6
f. The existence and nature of any repurchase obligation, including 
disclosure of the fair value of the shares allocated as of the balance- 
sheet date, which are subject to a repurchase obligation?7
6 This disclosure need not be made for old ESOP shares for which the entity does not apply the guidance in SOP 93-6.
7 Employers may wish to disclose additional information about the obligation, particularly information about the timing of 
payments. [SOP 93-6, par. 95]
8 A nonpublic entity is any entity other than one (a) whose debt or equity securities trade in a public market either on a stock 
exchange (domestic or foreign) or in the over-the-counter market including securities quoted only locally or regionally, (ft) that makes 
a filing with a regulatory agency in preparation for the sale of any class of debt or equity securities in a public market or (c) that is 
controlled by an entity covered by (a) or (b).
[SOP 93-6, par. 53]
2. Are all the items listed in Step 8 above disclosed even if the employer 
with an ESOP does not adopt SOP 93-6 for shares held by the ESOP 
on December 31, 1992?
[SOP 93-6, par. 55]
3. For leveraged ESOPs and for nonleveraged ESOPs where the assets 
from the pension plan are used by the ESOP to purchase shares, 
when the employer reports the issuance of shares or the sale of 
treasury shares to the ESOP, is the charge to unearned ESOP shares 
presented as a separate item in the balance sheet as a contra-asset 
account?
[SOP 93-6, pars. 13 and 46]
4. If the employer sponsors an ESOP with an indirect loan, is the outside 
loan reported as a liability and the receivable from the ESOP not 
reported on the employer's balance sheet?
[SOP 93-6, par. 26]
5. If the employer sponsors an ESOP with an employer loan, is the 
ESOP's note payable and the employer's note receivable from the 
ESOP not reported in the employer's balance sheet?
[SOP 93-6, par. 27]
J. Employers' Disclosures about Pensions and Other Postretirement Benefits
Reduced Disclosure Requirements for Nonpublic Entities
1. For a nonpublic entity8 has the election been made to disclose the 
following for its pension and other postretirement benefit plans in lieu 
of the disclosures required by paragraph 5 of SFAS 132:
a. The benefit obligation, fair value of plan assets, and funded status 
of the plan?
[SFAS 132, par. 8a (AC P16.150A, P40.169A)]
b. Employer contributions, participant contributions, and benefits 
paid?
[SFAS 132, par. 8b (AC P16.150A, P40.169A)]
c. The amounts recognized in the statement of financial position, 
including the net pension and other postretirement benefit prepaid
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assets or accrued liabilities and any intangible asset and the 
amount of accumulated other comprehensive income recognized 
pursuant to paragraph 37 of SFAS 87, as amended?
[SFAS 132, par. 8c (AC P16.150A, P40.169A)]
d. The amount of net periodic benefit cost recognized and the 
amount included within other comprehensive income arising 
from a change in the minimum pension liability recognized pur­
suant to paragraph 37 of SFAS 87, as amended?
[SFAS 132, par. 8d (AC P16.150A, P40.169A)]
e. On a weighted-average basis, the following assumptions used in 
the accounting for the plans: assumed discount rate, rate of com­
pensation increase (for pay-related plans), and expected long-term 
rate of return on plan assets?
[SFAS 132, par. 8e (AC P16.150A, P40.169A)]
f. The assumed health care cost trend rate(s) for the next year used 
to measure the expected cost of benefits covered by the plan (gross 
eligible charges) and a general description of the direction and 
pattern of change in the assumed trend rates thereafter, together 
with the ultimate trend rate(s) and when that rate is expected to 
be achieved?
[SFAS 132, par. 8f (AC P16.150A, P40.169A)]
g. If applicable, the amounts and types of securities of the employer 
and related parties included in plan assets, the approximate 
amount of future annual benefits of plan participants covered by 
insurance contracts issued by the employer or related parties, and 
any significant transactions between the employer or related par­
ties and the plan during the period?
[SFAS 132, par. 8g (AC P16.150A, P40.169A)]
h. The nature and effect of significant nonroutine events, such as 
amendments, combinations, divestitures, curtailments, and settle­
ments?
[SFAS 132, par. 8h (AC Pl6.150A, P40.169A)]
Pensions and Other Postretirement Benefits
1. If an employer sponsors one or more defined benefit pension plans or 
one or more defined benefit postretirement plans has the following 
information been provided:
a. A reconciliation of beginning and ending balances of the benefit 
obligation9 showing separately, if applicable, the effects during 
the period attributable to each of the following: service cost, inter­
est cost, contributions by plan participants, actuarial gains and 
losses, foreign currency exchange rate changes10 benefits paid, 
plan amendments, business combinations, divestitures, curtail­
ments, settlements, and special termination benefits?
9 For defined benefit pension plans, the benefit obligation is the projected benefit obligation—the actuarial present value as of a date 
of all benefits attributed by the pension benefit formula to employee service rendered prior to that date. For defined benefit 
postretirement plans, the benefit obligation is the accumulated postretirement benefit obligation—the actuarial present value of 
benefits attributed to employee service rendered to a particular date.
10 The effects of foreign currency exchange rate changes that are to be disclosed are those applicable to plans of a foreign operation 
whose functional currency is not the reporting currency pursuant to SFAS 52, Foreign Currency Translations.
[SFAS 132, par. 5a (AC P16.150, P40.169)]
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b. A reconciliation of beginning and ending balances of the fair value 
of plan assets showing separately, if applicable, the effects during 
the period attributable to each of the following: actual return on 
plan assets, foreign currency exchange rate changes11 contribu­
tions by the employer, contributions by plan participants, benefits 
paid, business combinations, divestitures, and settlements?
[SFAS 132, par. 5b (AC P16.150, P40.169)]
c. The funded status of the plans, the amounts not recognized in the 
statement of financial position, and the amounts recognized in the 
statement of financial position, including:
(1) The amount of any unamortized prior service cost?
(2) The amount of any unrecognized net gain or loss (including 
asset gains and losses not yet reflected in market-related 
value)?
(3) The amount of any remaining unamortized, unrecognized 
net obligation or net asset existing at the initial date of appli­
cation of SFAS 87 or SFAS 106?
(4) The net pension or other postretirement benefit, prepaid 
assets, or accrued liabilities?
(5) Any intangible asset and the amount of accumulated other 
comprehensive income recognized pursuant to paragraph 37 
of SFAS 87, as amended?
[SFAS 132, par. 5c (AC P16.150, P40.169)]
d. The amount of net periodic benefit cost recognized, showing 
separately the service cost component, the interest cost compo­
nent, the expected return on plan assets for the period, the amor­
tization of the unrecognized transition obligation or transition 
asset, the amount of recognized gains and losses, the amount of 
prior service cost recognized, and the amount of gain or loss 
recognized due to a settlement or curtailment?
[SFAS 132, par. 5d (AC P16.150, P40.169)]
e. The amount included within other comprehensive income for the 
period arising from a change in the additional minimum pension 
liability recognized pursuant to paragraph 37 of SFAS 87, as 
amended?
[SFAS 132, par. 5e (AC P16.150, P40.169)]
f. On a weighted-average basis, the following assumptions used in 
the accounting for the plans: assumed discount rate, rate of com­
pensation increase (for pay-related plans), and expected long-term 
rate of return on plan assets?
[SFAS 132, par. 5f (AC P16.150, P40.169)]
g. The assumed health care cost trend rate(s) for the next year used 
to measure the expected cost of benefits covered by the plan (gross 
eligible charges) and a general description of the direction and 
pattern of change in the assumed trend rates thereafter, together 
with the ultimate trend rate(s) and when that rate is expected to 
be achieved?
[SFAS 132, par. 5g (AC P40.169)]
11 Refer to footnote 9.
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h. The effect of a one-percentage-point increase and the effect of a 
one-percentage-point decrease in the assumed health care cost 
trend rates on (1) the aggregate of the service and interest cost 
components of net periodic postretirement health care benefit 
cost and (2) the accumulated postretirement benefit obligation 
for health care benefits? (For purposes of this disclosure, all 
other assumptions shall be held constant, and the effects shall 
be measured based on the substantive plan that is the basis for 
the accounting.)
[SFAS 132, par. 5h (AC P40.169)]
i. If applicable, the amounts and types of securities of the employer 
and related parties included in plan assets, the approximate 
amount of future annual benefits of plan participants covered by 
insurance contracts issued by the employer or related parties, and 
any significant transactions between the employer or related par­
ties and the plan during the period?
[SFAS 132, par. 5i (AC Pl 6.150, P40.169)]
j. If applicable, any alternative amortization method used to amor­
tize prior service amounts or unrecognized net gains and losses 
pursuant to paragraphs 26 and 33 of SFAS 87 or paragraphs 53 and 
60 of SFAS 106?
[SFAS 132, par. 5j (AC P16.150, P40.169)]
k. If applicable, any substantive commitment such as past practice 
or a history of regular benefit increases, used as the basis for 
accounting for the benefit obligation?
[SFAS 132, par. 5k (AC P16.150, P40.169)]
l. If applicable, the cost of providing special or contractual termina­
tion benefits recognized during the period and a description of the 
nature of the event?
[SFAS 132, par. 51 (AC P16.150, P40.169)]
m. An explanation of any significant change in the benefit obligation 
or plan assets not otherwise apparent in the other disclosures 
required by SFAS 132?
[SFAS 132. par. 5m (AC P16.150, P40.169)]
2. Are amounts related to the employer's results of operations disclosed 
for each period for which an income statement is presented?
[SFAS 132, par. 5 (AC Pl 6.150, P40.169)]
3. Are amounts related to the employer's statement of financial position 
disclosed for each balance sheet presented?
[SFAS 132, par. 5 (AC P16.150, P40.169)]
Employers with Two or More Plans
1. The disclosures required by SFAS 132 may be aggregated for all of an 
employer's defined benefit pension plans and may be aggregated for 
all of an employer's defined benefit postretirement plans or may be 
disaggregated in groups if that is considered to provide the most 
useful information or is otherwise required by paragraph 7 of SFAS 
132. Has the entity elected to aggregate these disclosures?
2. Disclosures about pension plans with assets in excess of the accumu­
lated benefit obligation generally may be aggregated with disclosures
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about pension plans with accumulated benefit obligation in excess of 
assets. The same aggregation is permitted for postretirement plans. 
Has the entity elected to aggregate these disclosures?
3. If those disclosures are combined, has the employer disclosed the 
aggregate benefit obligation and aggregate fair value of plan assets 
for plans with benefit obligations in excess of plan assets?
4. Has the aggregate pension accumulated benefit obligation and 
aggregate fair value of plan assets for pension plans with accumu­
lated benefit obligations in excess of plan assets also been dis­
closed?
5. Do disclosure of amounts recognized in the statement of financial 
position present prepaid benefit costs and accrued benefit liabilities 
separately?
[SFAS 132, par. 6 (AC Pl 6.153, P40.172)]
6. An employer may combine disclosures about pension or postretire­
ment benefit plans outside the United States with those for U.S. plans 
unless the benefit obligations of the plans outside the United States 
are significant relative to the total benefit obligation and those plans 
use significantly different assumptions. Has the entity elected to 
combine these disclosures?
[SFAS 132, par. 7 (AC P16.153A, P40.173)]
Defined Contribution Plans
1. Has the employer disclosed the amount of cost recognized for defined 
contribution pension or other postretirement benefit plans during the 
period separately from the amount of cost recognized for defined 
benefit plans?
2. Do the disclosures include a description of the nature and effect of any 
significant changes during the period affecting comparability, such as 
a change in the rate of employer contributions, a business combina­
tion, or a divestiture?
[SFAS 132, par. 9 (AC P16.162, P40.198)]
Multiemployer Plans
1. Has the employer disclosed the amount of contributions to multiem­
ployer plans during the period?
2. Has the employer chosen to disclose total contributions to multiem­
ployer plans without disaggregating the amounts attributable to pen­
sions and other postretirement benefits? If so, do the disclosures 
include a description of the nature and effect of any changes affecting 
comparability, such as a change in the rate of employer contributions, 
a business combination, or a divestiture?
[SFAS 132, par. 10 (AC P16.166, P40.178)]
3. In some situations, withdrawal from a multiemployer plan may result 
in an employer's having an obligation to the plan for a portion of its 
unfunded benefit obligations. If withdrawal under circumstances that 
would give rise to an obligation is either probable or reasonably 
possible, have the provisions of SFAS 5, Accounting for Contingencies, 
been applied?
[SFAS 132, par. 11 (AC P16.166)]
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4. In some situations, withdrawal from a multiemployer plan may result 
in employer's having an obligation to the plan for a portion of the 
plan's unfunded accumulated postretirement benefit obligation. If it 
is either probable or reasonably possible that (a) an employer would 
withdraw from the plan under circumstances that would give rise to 
an obligation or (b) an employer's contribution to the fund would be 
increased during the remainder of the contract period to make up a 
shortfall in the funds necessary to maintain the negotiated level of 
benefit coverage (a "maintenance of benefits" clause), has the em­
ployer applied the provisions of SFAS 5, Accounting for Contingencies? ____
[SFAS 132, par. 11 (AC P40.179)]
K. Consolidations
1. Are the accounts of all majority-owned subsidiaries (except those for 
which control is likely to be temporary or does not rest with the
majority owner) consolidated? ____
[SFAS 94, par. 13 (AC C51.103)]
2. If the financial reporting periods of any subsidiaries are different from
that of the parent, are intervening events that materially affect finan­
cial position or results of operations disclosed? ____
[ARB 51, par. 4 (AC C51.107)]
L. Financial Instruments
Derivative Instruments and Hedging Activities
1. If an entity holds or issues derivative instruments (or nonderivative 
instruments that are designated and qualify as hedging instruments 
pursuant to paragraphs 37 and 42 of SFAS 133, as amended by SFAS 
138) has disclosure been made of its objectives for holding or issuing 
those instruments, the context needed to understand those objectives,
and its strategies for achieving those objectives? ____
2. Does the description distinguish between derivative instruments (and
nonderivative instruments) designated as fair value hedging instru­
ments, derivative instruments designated as cash flow hedging in­
struments, derivative instruments (and nonderivative instruments) 
designated as hedging instruments for hedges of the foreign currency 
exposure of a net investment in a foreign operation, and all other 
derivatives? ____
3. Does the description also indicate the entity's risk management policy 
for each of those types of hedges, including a description of the items
or transactions for which risks are hedged? ____
4. For derivative instruments not designated as hedging instruments,
does the description indicate the purpose of the derivative activity? ____
5. Qualitative disclosures about an entity's objectives and strategies for 
using derivative instruments may be more meaningful if such objec­
tives and strategies are described in the context of an entity's overall 
risk management profile. If appropriate, an entity is encouraged, but 
not required, to provide such additional qualitative disclosures. Have
such disclosures been made? ____
[SFAS 133, par. 44 (AC D50)]
6. Do the entity's disclosures for every reporting period for which a 
complete set of financial statements is presented also include the 
following:
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Fair value hedges
a. For derivative instruments, as well as nonderivative instruments 
that may give rise to foreign currency transaction gains or losses 
under SFAS 52, that have been designated and have qualified as 
fair value hedging instruments and for the related hedged items:
(1) The net gain or loss recognized in earnings during the report­
ing period representing (a) the amount of the hedges' ineffec­
tiveness and (b) the component of the derivative instruments' 
gain or loss, if any, excluded from the assessment of hedge 
effectiveness, and a description of where the net gain or loss 
is reported in the statement of income or other statement of
financial performance? _____ ___
(2) The amount of net gain or loss recognized in earnings when 
a hedged firm commitment no longer qualifies as a fair value
hedge? _____ ___
[SFAS 133, par. 45a (AC D50)]
Cash flow hedges
b. For derivative instruments that have been designated and have 
qualified as cash flow hedging instruments and for the related 
hedged transactions:
(1) The net gain or loss recognized in earnings during the report­
ing period representing (a) the amount of the hedges' ineffec­
tiveness and (b) the component of the derivative instruments' 
gain or loss, if any, excluded from the assessment of hedge 
effectiveness, and a description of where the net gain or loss 
is reported in the statement of income or other statement of
financial performance? _____ ___
(2) A description of the transactions or other events that will 
result in the reclassification into earnings of gains and losses 
that are reported in accumulated other comprehensive in­
come, and the estimated net amount of the existing gains or 
losses at the reporting date that is expected to be reclassified
into earnings within the next 12 months? _____ ___
(3) The maximum length of time over which the entity is hedging
its exposure to the variability in future cash flows for fore­
casted transactions excluding those forecasted transactions 
related to the payment of variable interest on existing finan­
cial instruments? _____ ___
(4) The amount of gains and losses reclassified into earnings as 
a result of the discontinuance of cash flow hedges because it 
is probable that the original forecasted transactions will not 
occur by the end of the originally specified time period (as 
documented at the inception of the hedging relationship) or
within an additional two-month period of time thereafter? _____ ___
[SFAS 133, par. 45b, as amended by SFAS 138, par. 4r (AC
D50)]
Hedges of the net investment in a foreign operation
c. For derivative instruments, as well as nonderivative instruments 
that may give rise to foreign currency transaction gains or losses
N/A
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under SFAS 52, that have been designated and have qualified as 
hedging instruments for hedges of the foreign currency exposure 
of a net investment in a foreign operation, the net amount of gains 
or losses included in the cumulative translation adjustment during
the reporting period? ____  ____  ____
[SFAS 133, par. 45c (AC D50)]
7. The quantitative disclosures about derivative instruments may be 
more useful, and less likely to be perceived to be out of context or 
otherwise misunderstood, if similar information is disclosed about 
other financial instruments or nonfinancial assets and liabilities to 
which the derivative instruments are related by activity. Accordingly, 
in such situations, has the entity presented a more complete picture 
of its activities by disclosing that information (encouraged, but not
required)? ____  ____  ____
[SFAS 133, par. 45 (AC D50)]
Disclosures about Fair Value of Financial Instruments
8. Has the entity disclosed, either in the body of the financial statements 
or in the accompanying notes12 the fair value of financial instruments 
(except for those excluded in paragraphs 8 and 13 of SFAS 107) for
12 If disclosed in more than a single note, one of the notes shall include a summary table. The summary table shall contain the fair 
value and related carrying amounts and cross-references to the location(s) of the remaining disclosures required by this Statement as 
amended.
which it is practicable to estimate fair value? ____  ____  ____
[SFAS 107, par. 10 (AC F25)]
9. Has the fair value disclosed in the notes been presented together with 
the related carrying amount in a form that makes it clear whether the 
fair value and carrying amount represent assets or liabilities and how 
the carrying amounts relate to what is reported in the statement of
financial position? ____  ____  ____
[SFAS 107, par. 10 (AC F25)]
10. In disclosing the fair value of a financial instrument, has the entity 
taken care not to net that fair value with the fair value of other financial 
instruments—even if those financial instruments are of the same class 
or are otherwise considered to be related, for example, by a risk 
management strategy—except to the extent that the offsetting of 
carrying amounts in the statement of financial position is permitted 
under the general principle in paragraphs 5 and 6 of FASB Interpre­
tation No. 39, Offsetting of Amounts Related to Certain Contracts, or the 
exceptions for master netting arrangements in paragraph 10 of Inter­
pretation 39 and for amounts related to certain repurchase and reverse 
repurchase agreements in paragraphs 3 and 4 of FASB Interpretation 
No. 41, Offsetting of Amounts Related to Certain Repurchase and Reverse
Repurchase Agreements? ____  ____  ____
[SFAS 107, par. 14 (AC F25)]
11. If it is not practicable to estimate the fair value of a financial instru­
ment or a class of financial instruments, are the following disclosed:
a. Information pertinent to estimating the fair value of that financial 
instrument or class of financial instruments, such as the carrying
amount, effective interest rate, and maturity? ____  ____  ____
b. The reasons why it is not practicable to estimate fair value? ____  ____  ____
[SFAS 107, par. 14 (AC F25)]
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Note: SFAS 126, Exemption from Certain Required Disclosures about Financial 
Instruments for Certain Nonpublic Entities, makes the disclosures about fair 
values of financial instruments prescribed in SFAS 107 optional for report­
ing entities that:
a. Are nonpublic entities.
b. Have total assets of less than $100 million on the date of the financial 
statements.
c. Have no instrument that, in whole or in part, is accounted for as a 
derivative instrument under SFAS 133, Accounting for Derivative 
Instruments and Hedging Activities, during the reporting period.
Disclosure about Concentrations of Credit Risk of All Financial Instruments
12. Except as indicated in paragraph 15b13 of SFAS 107, has the entity 
disclosed all significant concentrations of credit risk arising from all 
financial instruments, whether from an individual counterparty or 
groups of counterparties? (Group concentrations of credit risk exist if a 
number of counterparties are engaged in similar economic charac­
teristics that would cause their ability to meet contractual obligations
13 SFAS 107 paragraph 15b provides that these disclosure requirements do not apply to the following financial instruments, whether 
written or held:
a. Financial instruments of a pension plan, including plan assets, when subject to the accounting and reporting requirements of 
SFAS 87 (Financial instruments of a pension plan, other than the obligations for pension benefits, when subject to the accounting 
and reporting requirements of SFAS 35, Accounting and Reporting by Defined Benefit Pension Plans, are subject to the reporting of 
paragraph 15a).
b. The financial instruments described in paragraphs 8a, 8c, 8e, and 8f of SFAS 107, as amended by SFAS 112, Employers' Accounting 
for Postemployment Benefits, SFAS 123, Accounting for Stock-Based Compensation, and SFAS 140, except for reinsurance receivables 
and prepaid reinsurance premiums.
to be similarly affected by changes in economic or other conditions.) ____
[SFAS 107, par. 15a (AC F25)]
13. Has the entity made the following disclosures about each significant 
concentration:
a. Information about the (shared) activity, region, or economic char­
acteristic that identifies the concentration? ____
b. The maximum amount of loss due to credit risk that, based on the 
gross fair value of the financial instrument, the entity would incur 
if parties to the financial instruments that make up the concentra­
tion failed completely to perform according to the terms of the 
contracts and the collateral or other security, if any, for the amount
due proved to be of no value to the entity? ____
c. The entity's policy of requiring collateral or other security to
support financial instruments subject to credit risk, information 
about the entity's access to that collateral or other security, and the 
nature and a brief description of the collateral or other security 
supporting those financial instruments? ____
d. The entity's policy of entering into master netting arrangements 
to mitigate the credit risk of financial instruments, information 
about the arrangements for which the entity is a party, and a brief 
description of the terms of those arrangements, including the 
extent to which they would reduce the entity's maximum amount
of loss due to credit risk? ____
[SFAS 107, par. 15a (AC F25)]
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14. Has the entity disclosed quantitative information14 about the market
14 Appropriate ways of reporting the quantitative information encouraged will differ for different entities and will likely evolve over 
time as management approaches and measurement techniques evolve. Possibilities include disclosing (a) more details about current 
positions and perhaps activity during the period, (b) the hypothetical effects on comprehensive income (or net assets), or annual 
income, of several possible changes in market prices, (c) a gap analysis of interest rate repricing or maturity dates, (d) the duration of 
the financial instruments, or (c) the entity's value at risk from derivatives and from other positions at the end of the reporting period 
and the average value at risk during the year. This list is not exhaustive, and an entity is encouraged to develop other ways of reporting 
quantitative information.
risks of financial instruments that is consistent with the way it man­
ages or adjusts those risks (encouraged, but not required)? ____  ____  ____
[SFAS 107, par. 15c (AC F25)]
15. Are the classification and presentation consensuses reached in EITF 
Issue 00-19, regarding derivative financial instruments indexed to,
and potentially settled in, a company's own stock complied with? ____  ____  ____
[EITF 00-19]
M. Foreign Currency □
1. Is the aggregate transaction gain or loss included in net income for the
period disclosed? (Note: for this disclosure, gains and losses on de­
rivative instruments shall comply with paragraph 45 of SFAS 133.) ____  ____ ____
[SFAS 52, par. 30 as amended by SFAS 133 (AC F60.140)]
2. Is an analysis of changes during the period in the accumulated 
amount of translation adjustments reported in equity, included, and 
does it disclose:
a. Beginning and ending amounts of cumulative translation adjust­
ments? ____  ____  ____
b. The aggregate adjustment for the period resulting from translation
adjustments and gains and losses from certain hedges and inter­
company balances? ____  ____  ____
c. The amount of income taxes for the period allocated to translation
adjustments? ____  ____ ____
d. The amounts transferred from cumulative translation adjustments
and included in the determination of net income for the period as 
a result of the sale or complete or substantially complete liquida­
tion of an investment in a foreign entity? _____ ____  ____
[SFAS 52, par. 31 (AC F60.141)]
3. Are rate changes occurring after the date of the financial statements 
and the effects on unsettled balances related to foreign currency
translations disclosed, if significant? ____  ____ ____
[SFAS 52, par. 32 (AC F60.142)]
4. Are any foreign earnings reported in addition to amounts received in
the U.S. disclosed, if significant? ____  ____  ____
[ARB 43, Ch. 12, par. 5 (AC F65.102)]
N. Impairment of Long-Lived Assets
Note: If the provisions of SFAS 144, Accounting for the Impairment or 
Disposal of Long-Lived Assets, are effective, these questions do not apply. 
See section N1 below. The provisions of SFAS 144 are effective for financial 
statements issued for fiscal years beginning after December 15, 2001, and 
interim periods within those fiscal years. Early application is encouraged.
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1. If an impairment loss is recognized for assets to be held or used, are 
the following disclosures made in financial statements that include 
the period of impairment write-down:
a. A description of the impaired assets and the facts and circum­
stances leading to the impairment?
b. The amount of the impairment and how fair value was deter­
mined?
c. The caption in the income statement in which the impairment loss 
is aggregated if that loss has not been presented as a separate 
caption or reported parenthetically on the face of the statement?
d. The business segment(s) affected, if applicable?
[SFAS 121, par. 14]
2. If assets to be disposed of are accounted for in accordance with 
paragraphs 15-17 of SFAS 121, are all of the following disclosed in 
financial statements that include a period which those assets are held:
a. A description of assets to be disposed of, the facts and circum­
stances leading to the expected disposal, the expected disposal 
date, and the carrying amount of those assets?
b. The business segment(s) in which assets to be disposed of are held, 
if applicable?
c. The loss resulting from the application of paragraph 15 of SFAS 
121?
d. The gain or loss, resulting from changes in the carrying amounts 
of assets to be disposed of that arises from application of para­
graph 17 of SFAS 121?
e. The caption in the income statement in which the gains or losses 
in steps c. and d. are aggregated if those gains have not been 
presented as a separate caption or reported parenthetically on the 
face of the statement?
f. The results of operations for assets to be disposed of to the extent 
that those results are included in the entity's results of operations 
for the period and can be identified?
[SFAS 121, par. 19]
3. If an impairment loss is recognized, is it reported as a component of 
income from continuing operations?
[SFAS 121, pars. 13 and 18]
N1. Impairment of Long-Lived Assets to Be Held and Used
Note: These questions apply only if the provisions of SFAS 144 are 
effective. The provisions of SFAS 144 are effective for financial statements 
issued for fiscal years beginning after December 15, 2001, and interim 
periods within those fiscal years. Early application is encouraged.
1. Is an impairment loss recognized for a long-lived asset (asset group) 
to be held and used included in income from continuing operations
before income taxes in the income statement of a business enterprise? ____
[SFAS 144, par. 25]
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2. Is the following information disclosed in the notes to the financial 
statements that include the period in which an impairment loss is 
recognized:
a. A description of the impaired long-lived asset (asset group) and 
the facts and circumstances leading to the impairment?
b. If not separately presented on the face of the statement, the amount 
of the impairment loss and the caption in the income statement 
that includes the loss?
c. The method or methods for determining fair value (whether based 
on a quoted market price, prices for similar assets, or another 
valuation technique)?
d. If applicable, the segment in which the impaired long-lived asset 
(asset group) is reported under FASB Statement No. 131, Disclo­
sures about Segments of an Enterprise and Related Information?
[SFAS 144, par. 261
O. Long-Lived Assets and Disposal Groups to Be Disposed of
Note: These questions only apply if the provisions of SFAS 144, Account­
ing for the Impairment or Disposal of Long-Lived Assets, are effective.
Reporting Discontinued Operations
1. Are the results of operations of a component of an entity (as that phrase 
is defined in SFAS 144) that either has been disposed of or is classified 
as held for sale reported in discontinued operations in accordance 
with paragraph 43 of SFAS 144 (questions 2, 3, 4, and 5 below) if both 
of the following conditions are met:
a. The operations and cash flows of the component have been (or will 
be) eliminated from the ongoing operations of the entity as a result 
of the disposal transaction, and—
b. The entity will not have any significant continuing involvement in 
the operations of the component after the disposal transaction? 
[SFAS 144, par. 42]
2. In a period in which a component of an entity either has been disposed 
of or is classified as held for sale, does the income statement for current 
and prior periods report the results of operations of the component, 
including any gain or loss recognized in accordance with paragraph 
37 of SFAS 144, in discontinued operations?
[SFAS 144, par. 43]
3. Are the results of operations of a component classified as held for sale 
reported in discontinued operations in the period(s) in which they 
occur?
[SFAS 144, par. 43]
4. Are the results of discontinued operations, less applicable income 
taxes (benefit), reported as a separate component of income before 
extraordinary items and the cumulative effect of accounting changes 
(if applicable)?
[SFAS 144, par. 43]
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5. Is the gain or loss recognized on the disposal disclosed either on the
face of the income statement or in the notes to the financial statements? ____ ___
[SFAS 144, par. 43]
6. Are adjustments to amounts previously reported in discontinued 
operations that are directly related to the disposal of a component of 
an entity in a prior period classified separately in the current period
in discontinued operations? ____  ___
[SFAS 144, par. 44]
7. Are the nature and amount of such adjustments (as discussed in
question 6 above) disclosed? ____  ___
[SFAS 144, par. 44]
Note: The following two questions are derived from EITF Issues. These 
Issues concern the disposal of components of an entity and discontinued 
operations. SFAS 144 amends only pronouncements of the FASB, the APB, 
and the Committee on Accounting Procedure. Conforming changes to 
other literature, including consensuses of the FASB's Emerging Issues 
Task Force, may be made subsequently. As of the date of this Checklist, 
these EITF issues have not been updated to reflect any changes warranted 
by SFAS 144. These questions are included herein and practitioners should 
use their judgment when applying the provisions of these EITF issues in 
light of SFAS 144.
8. If an institution decides to dispose of a segment of a business ac­
counted for in accordance with APB 30 and the measurement date 
occurs after the balance sheet date but before the financial statements 
for the prior period have been issued and a loss is expected, are the 
segment's operating results presented as discontinued operations in 
the income statement of the not yet released financial statements 
(assuming that the loss does not result from a discrete and identifiable 
event that occurs unexpectedly after the balance sheet date)?
[EITF 95-18]
9. If an institution has accounted for the discontinuance of a segment in 
accordance with APB 30 and subsequently decides to retain the seg­
ment, is any impairment of the individual assets classified in continu­
ing operations?
[EITF 90-16]
Reporting Disposal Gains or Losses in Continuing Operations
10. Is a gain or loss, that is recognized for a long-lived asset (disposal 
group) classified as held for sale that is not a component of an entity, 
included in income from continuing operations before income taxes 
in the income statement?
[SFAS 144, par. 45]
11. If a subtotal such as "income from operations" is presented, does it 
include the amounts of those gains or losses considered in question 8 
above?
[SFAS 144, par. 45]
Reporting a Long-Lived Asset or Disposal Group Sold or Classified as 
Held for Sale
12. If the criteria of paragraph 30 of SFAS 144 are met (and thus a 
long-lived asset is classified as held for sale) after the balance sheet
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date but before issuance of the financial statements, does the long- 
lived asset continue to be classified as held and used in those financial 
statements when issued and is the information required by paragraph 
47(a) of SFAS 144 (question 16(a) below) disclosed in the notes to the
financial statements? ____
[SFAS 144, par. 33]
13. Is a long-lived asset that is classified as held for sale presented
separately in the statement of financial position? ____
[SFAS 144, par. 46]
14. Are the assets and liabilities of a disposal group that is classified as 
held for sale presented separately in the asset and liability sections,
respectively, of the statement of financial position? ____
[SFAS 144, par. 46]
15. Are those assets and liabilities considered in question 12 above, not
offset and presented as a single amount? ____
[SFAS 144, par. 46]
16. Are the major classes of assets and liabilities that are classified as held 
for sale separately disclosed either on the face of the statement of
financial position or in the notes to financial statements? ____
[SFAS 144, par. 46]
17. Is the following information disclosed in the notes to the financial 
statements that cover the period in which a long-lived asset (disposal 
group) either has been sold or is classified as held for sale:
a. A description of the facts and circumstances leading to the ex­
pected disposal, the expected manner and timing of that disposal, 
and, if not separately presented on the face of the statement, the 
carrying amount(s) of the major classes of assets and liabilities 
included as part of a disposal group? ____
b. The gain or loss recognized in accordance with SFAS 144 par. 37 
and if not separately presented on the face of the income statement,
the caption in the income statement that include that gain or loss? ____
c. If applicable, amounts of revenue and pretax profit or loss re­
ported in discontinued operations? ____
d. If applicable, the segment in which the long-lived asset (disposal
group) is reported under SFAS 131? ____
[SFAS 144, par. 47]
18. If either paragraph 38 or 40 of SFAS 144 applies, is a description of the 
facts and circumstances leading to the decision to change the plan to 
sell the long-lived asset (disposal group) and its effect on the results 
of operations for the period and any prior periods presented disclosed 
in the notes to the financial statements that include the period of that
decision? ____
[SFAS 144, par. 48]
19. If a long-lived asset is to be disposed of other than by sale, does it
continue to be classified as held and used until it is disposed of? ____
[SFAS 144, par. 27]
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P. Transfers and Servicing of Financial Assets and Securitizations
1. Is the policy for requiring collateral or other security disclosed if the 
entity has entered into repurchase agreements or securities lending 
transactions?
[SFAS 140, par. 17(a)]
2. If it is not practicable to estimate the fair value of certain assets 
obtained or liabilities incurred in transfers of financial assets during 
the period, are those items and the reasons why it is not practicable to 
estimate fair value described in the notes to the financial statements? 
[SFAS 140, par. 17(d)]
3. For all servicing assets and servicing liabilities are the following 
disclosures made:
a. The amounts of servicing assets or liabilities recognized and am­
ortized during the period?
b. The fair value of recognized servicing assets and liabilities for 
which it is practicable to estimate that value and the method and 
significant assumptions used to estimate the fair value?
c. The risk characteristics of the underlying financial assets used to 
stratify recognized servicing assets for purposes of measuring 
impairment in accordance with paragraph 63 of SFAS 140?
d. The activity in any valuation allowance for impairment of recog­
nized servicing assets—including beginning and ending balances, 
aggregate additions charged and reductions credited to opera­
tions, and aggregate direct write-downs charged against the al­
lowances—for each period for which results of operations are 
presented?
[SFAS 140, par. 17(e)]
4. If the entity has securitized financial assets during any period pre­
sented and accounts for that transfer as a sale, are the following items 
disclosed for each major asset type:
a. Its accounting policies for initially measuring the retained inter­
ests, if any, including the methodology (whether quoted market 
price, prices based on sales of similar assets and liabilities, or prices 
based on valuation techniques) used in determining their fair 
value?
b. The characteristics of securitizations (a description of the trans­
feror's continuing involvement with the transferred assets, includ­
ing, but not limited to, servicing, recourse, and restrictions on 
retained interests) and the gain or loss from sale of financial assets 
in securitizations?
c. The key assumptions* used in measuring the fair value of retained 
interests at the time of securitization (including, at a minimum, 
quantitative information about discount rates, expected prepay­
ments including the expected weighted-average life of prepayable 
financial assets, and anticipated credit losses, if applicable)?
If an entity has made multiple securitizations of the same major asset type during a period, it may disclose the range of 
assumptions.
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d. Cash flows between the securitization SPE and the transferor, 
unless reported separately elsewhere in the financial statements 
or notes (including proceeds from new securitizations, proceeds 
from collections reinvested in revolving-period securitizations, 
purchases of delinquent or foreclosed loans, servicing fees, and
cash flows received on interests retained)? ____ ___
[SFAS 140, par. 17(f)]
5. If the entity has retained interests in securitized financial assets at the 
date of the latest statement of financial position presented, are the 
following items disclosed for each major asset type:
a. Its accounting policies for subsequently measuring those retained 
interests, including the methodology (whether quoted market 
price, prices based on sales of similar assets and liabilities, or prices
based on valuation techniques) used in determining their fair value? ____ ___
b. The key assumptions used in subsequently measuring the fair 
value of those interests (including, at a minimum, quantitative 
information about discount rates, expected prepayments includ­
ing the expected weighted-average life of prepayable financial 
assets, and anticipated credit losses, including expected static pool
losses, if applicable)? ____ ___
c. A sensitivity analysis or stress test showing the hypothetical effect
on the fair value of those interests of two or more unfavorable 
variations from the expected levels for each key assumption that 
is reported under b. above independently from any change in 
another key assumption, and a description of the objectives, meth­
odology, and limitations of the sensitivity analysis or stress test? ____ ___
d. For the securitized assets and any other financial assets that it 
manages together with them:**
(1) The total principal amount outstanding, the portion that has 
been derecognized, and the portion that continues to be 
recognized in each category reported in the statement of
financial position, at the end of the period? ____ ___
(2) Delinquencies at the end of the period? ____ ___
(3) Credit losses, net of recoveries, during the period? ____ ___
Disclosure of average balances during the period is encouraged, 
but not required.
[SFAS 140, par. 17(g)]
Collateral
6. If the entity has pledged any of its assets as collateral that are not 
reclassified and separately reported in the statement of financial 
position pursuant to paragraph 15(a) of SFAS 140, is the carrying 
amount and classification of those assets as of the date of the latest
statement of financial position presented? ____ ___
[SFAS 140, par. 17(a)(2)]
7. If the entity has accepted collateral that it is permitted by contract or 
custom to sell or repledge, is the fair value, as of the date of each 
statement of financial position presented, of that collateral and of the
portion of that collateral that it has sold or repledged disclosed? ____ ___
[SFAS 140, par. 17(a)(3)]
Excluding securitized assets that an entity continues to service but with which it has no other continuing involvement.
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8. Is information about the sources and uses of that collateral, as of the
date of each statement of financial position presented, disclosed? ____  ____ ____
[SFAS 140, par. 17(a)(3)]
Q. Nonmonetary Transactions □
1. Do disclosures for nonmonetary transactions during the period include:
a. Nature of the transactions? ____  ____ ____
b. Basis of accounting for the assets transferred? ____  ____ ____
c. Gains or losses recognized on the transfers? ____  ____ ____
[APB 29, par. 28, fn. 7 (AC 01.102 and N35.120); FASBI 30 (AC
N35.114-.119)]
2. Is the amount of gross operating revenue recognized as a result of 
nonmonetary transactions addressed by EITF Issue 00-8, Accounting 
by a Grantee for an Equity Instrument to be Received in Conjunction with
Providing Goods or Services, disclosed in each period's financial statements? ____  ____ ____
[EITF Issue 00-8]
R. Subsequent Events □
1. Are the financial statements adjusted for any changes in estimates 
resulting from subsequent events that provide additional evidence
about conditions that existed at the balance-sheet date? ____  ____ ____
[SFAS 5, par. 8 (AC C59.105); SAS 1, secs. 560.03, .04, .07, and 561.01- 
.10 (AU 560.03, .04, .07 and 561.01-.10)]
2. Are subsequent events that provide evidence about conditions that 
did not exist at the balance-sheet date, but arose subsequent to that 
date, adequately disclosed to keep the financial statements from being
misleading? ____  ____ ____
[SFAS 5, par. 11 (AC C59.112); SAS 1, secs. 560.05-.07, .09, and 561.01- 
.09 (AU 560.05-.07, .09, and 561.01-.09)]
Note: Consider the appropriateness of dual-dating the auditor's report if 
a subsequent event is disclosed in the financial statements (AU 530.05).
S. Costs to Exit an Activity □
1. If a material liability is recognized for certain employee termination 
benefits in accordance with Section A of EITF Issue 94-3, Liability 
Recognition for Certain Employee Termination Benefits and Other Costs to 
Exit an Activity (including Certain Costs Incurred in a Restructuring), are 
the following disclosures made in all periods until the plan of termi­
nation is completed:
a. The amount of termination benefits accrued and charged to ex­
pense and the classification of those costs in the income statement? ____  ____ ___
b. The number of employees to be terminated? ____  ____  ___
c. A description of the employee group(s) to be terminated? ____  ____  ___
d. The amount of actual termination benefits paid and charged
against the liability and the number of employees actually termi­
nated as a result of the plan to terminate employees? ____  ____ ___
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e. The amount of any adjustment(s) to the liability?
[EITF 94-3, Section A]
2. If management commits to an exit plan that meets the criteria in
Section B of EITF Issue 94-3, are the following reporting requirements 
followed:
a. Reporting the statement of income effect of recognizing a liability 
at the commitment date in income from continuing operations and 
not on the face of the statement of income net of taxes?
b. No disclosure made on the face of the statement of income for 
earnings per share effect?
c. Revenue and related costs and expenses of activities that will not 
be continued should not be combined and reported as a separate 
component of income?
[EITF 94-3, Section B]
3. If the activities that will not be continued are significant to the com­
pany's revenue or operating results, or if the exit costs recognized at 
the commitment date are material, are the following disclosures made 
in all periods until the exit plan is completed:
a. A description of the major actions comprising the exit plan, activi­
ties that will not be continued, including the method of disposi­
tion, and the anticipated date of completion?
b. A description of the type and amount of exit costs recognized as 
liabilities and the classification of those costs in the income statement?
c. A description of the type and amount of exit costs paid and 
charged against the liability?
d. The amount of any adjustment(s) to the liability?
e. For all periods presented, the revenue and net operating income 
or losses from activities that will not be continued if those activities 
have separately identifiable operations?
[EITF 94-3, Section B]
T. Business Combinations
Note: This section does not apply if the provisions of SFAS 141 are being 
applied to the financial statements. The provisions of SFAS 141 apply to 
all business combinations initiated after June 30, 2001. SFAS 141 also 
applies to all business combinations accounted for using the purchase 
method for which the date of acquisition is July 1, 2001, or later. If the 
provisions of SFAS 141 are being applied, refer to section T1 below. 
Pooling of Interests Method
1. If a business combination occurred during the period and met the specified 
conditions for a pooling-of-interests, are the following disclosed:
a. The fact that a combination accounted for by the pooling-of-inter­
ests method has occurred during the period disclosed?
[APB 16, pars. 63 and 64b (AC B50.122 and .123b)]
b. The name and a brief description of the enterprises combined? 
[APB 16, par. 64a (AC B50.123a)]
c. A description and the number of shares of stock issued in the 
combination?
[APB 16, par. 64c (AC B50.123c)]
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d. Details (including revenue, extraordinary items, net income, other 
changes in shareholders' equity, and amount of and manner of 
accounting for intercompany transactions) of the results of opera­
tions of the previously separate enterprises for the period before 
the combination is consummated that are included in the current
combined net income? ____
[APB 16, par. 64d (AC B50.123d)]
e. Descriptions of the nature of adjustments of net assets of the 
combining enterprises to adopt the same accounting practices and 
the effects of the changes on net income previously reported
separately and now presented in comparative financial statements? ____
[APB 16, par. 64e (AC B50.123e)]
f. Details (including at least revenue, expenses, extraordinary items, 
net income, and other changes in shareholders' equity for the 
period excluded from the reported results of operations) of in­
creases or decreases in retained earnings from changing the fiscal
year of a combining enterprise? ____
[APB 16, par. 64f (AC B50.123f)]
g. Reconciliations of amounts of revenue and earnings previously 
reporting by the enterprise that issued the stock to effect the 
combination with the combined amounts currently presented in 
financial statements and summaries? (Or if a new enterprise was 
formed to effect the combination, the earnings of the separate 
enterprises that comprise combined earnings for prior periods
may be disclosed.) ____
[APB 16, par. 64g (AC B50.123g)]
2. If a business combination that was either incomplete as of the date of 
the financial statements or initiated after that date is consummated 
before the financial statements are issued, are details (including reve­
nue, net income, earnings per share, and the effects of anticipated 
changes in accounting methods as if the combination had been con­
summated at the date of the financial statements) of the effects of the
combination disclosed? ____
[APB 16, par. 65 (AC B50.124)]
Practice Tip
Information relating to several relatively minor acquisitions may be combined for disclosure.
Purchase Method
3. If a business combination occurred during the period and is to be 
accounted for under the purchase method, are the following disclosed:
a. The name and a brief description of the acquired enterprise? ____
[APB 16, par. 95a (AC B50.164a)]
b. The method of accounting for the combination—that is, the pur­
chase method? ____
[APB 16, par. 95b (AC B50.164b)]
c. The period for which results of operations of the acquired enterprise
are included in the income statement of the acquiring enterprise? ____
[APB 16, par. 95c (AC B50.164c)]
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d. The cost of the acquired enterprise and, if applicable, the number 
of shares of stock issued or issuable and the amount assigned to 
the shares?
[APB 16, par. 95d (AC B50.164d)]
e. A description of the plan for amortization of acquired goodwill, 
the amortization method, and period?
[APB 16, par. 95e (AC B50.164e)]
f. Contingent payments, options, or commitments specified in the 
acquisition agreement and their proposed accounting treatment 
(including consideration that is issued or issuable at the end of a 
contingency period or that is held in escrow)?
[APB 16, pars. 78 and 95f (AC B50.136 and .164f)]
g. For public companies only, the following as supplemental infor­
mation (including at least revenue, income before extraordinary 
items, net income, and earnings per share) on a pro forma basis:
(1) Results of operations for the current period as though the 
enterprises had combined at the beginning of the period, 
unless the acquisition was at or near the beginning of the 
period?
[APB 16, par. 96a (AC B50.165a); SFAS 79, par. 6 (AC B50.165)]
(2) Results of operations for the immediately preceding period 
as though the enterprises had combined at the beginning of 
that period if comparative statements are presented?
[APB 16, par. 96b (AC B50.165b); SFAS 79, par. 6 (AC 
B50.165)]
4. If the reporting entity elects not to include a preacquisition contin­
gency (other than the effects of tax loss carryforwards) in the purchase 
price allocation or, for those that arise after the end of the allocation 
period, are not included in net income of the period in which the 
adjustment is determined as described in SFAS 38, is there disclosure 
of the amount and nature of adjustments, including the effect of the 
adjustments on current or expected future cash flows?
[SFAS 38, par. 10 (AC B50.166)]
5. If, as part of a business combination accounted for as a purchase, a 
material liability is recognized by the combined company for costs 
incurred to (a) exit an activity, (b) involuntarily terminate employees 
of an acquired company, or (c) relocate employees of an acquired 
company:
a. Are the following disclosures made for the period in which a 
purchase business combination occurs:
(1) If the plans to exit an activity or involuntarily terminate 
(relocate) employees of the acquired company are not final as 
of the balance sheet date, a description of any unresolved 
issues, the types of additional liabilities that may result in an 
adjustment to the purchase price allocation, and how any 
adjustment will be reported?
(2) A description of the type and amount of liabilities assumed 
in the purchase price allocation for costs to exit an activity or 
involuntary terminate (relocate) employees?
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(3) A description of the major actions comprising the plan to exit 
an activity or involuntarily terminate (relocate) employees of 
an acquired company?
(4) A description of activities of the acquired company that will 
not be continued, including the method of disposition, and 
the anticipated date of completion and description of em­
ployee group(s) to be terminated (relocated)?
b. Are the following disclosures made for all periods presented 
subsequent to the acquisition date in which a purchase business 
combination occurred, until a plan to exit an activity or involun­
tarily terminate or relocate employees of an acquired company is 
fully executed:
(1) A description of the type and amount of exit costs, involun­
tary employee termination costs, and relocation costs paid 
and charged against the liability?
(2) The amount of any adjustment to the liability account and 
whether the corresponding entry was an adjustment of the 
costs of the acquired company or included in the determina­
tion of net income for the period?
[EITF 95-3]
6. Where the entity has purchased an enterprise and the purchase price 
is to be allocated to assets (operating unit) to be sold, are the reporting 
requirements and disclosures contained in EITF 87-11 and EITF 90-6 
complied with?
[EITF 87-11, EITF 90-6]
7. Is any portion of the valuation allowance for deferred tax assets for 
which subsequently recognized tax benefits will be allocated to re­
duce goodwill and other noncurrent intangible assets of an acquired 
entity or directly to contributed capital (paragraphs 30 and 36 of SFAS 
109, AC section I27.129 and .135) disclosed?
[SFAS 109, par. 48 (AC I27.147)]
T1. Business Combinations
Note: This section applies if the provisions of SFAS 141 are being applied 
to the financial statements. The provisions of SFAS 141 apply to all 
business combinations initiated after June 30, 2001. SFAS 141 also applies 
to all business combinations accounted for using the purchase method for 
which the date of acquisition is July 1, 2001, or later. If the provisions of 
SFAS 141 are not being applied, refer to section T above.
1. Do the notes to the financial statements of a combined entity disclose 
the following information in the period in which a material business 
combination is completed:
a. The name and a brief description of the acquired entity and the 
percentage of voting equity interests acquired?
b. The primary reasons for the acquisition, including a description of 
the factors that contributed to a purchase price that results in 
recognition of goodwill?
c. The period for which the results of operations of the acquired entity 
are included in the income statement of the combined entity?
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d. The cost of the acquired entity and, if applicable, the number of
shares of equity interests (such as common shares, preferred 
shares, or partnership interests) issued or issuable, the value as­
signed to those interests, and the basis for determining that value? ____
e. A condensed balance sheet disclosing the amount assigned to each
major asset and liability caption of the acquired entity at the 
acquisition date? ____
f. Contingent payments, options, or commitments specified in the
acquisition agreement and the accounting treatment that will be 
followed should any such contingency occur? ____
g. The amount of purchased research and development assets ac­
quired and written off in the period (refer to paragraph 42 of SFAS 
141) and the line item in the income statement in which the 
amounts written off are aggregated? ____
h. For any purchase price allocation that has not been finalized, that
fact and the reasons therefore? ____
i. In subsequent periods, the nature and amount of any material
adjustment made to the initial allocation of the purchase price? ____
[SFAS 141, par. 51]
2. Is the following information disclosed in the notes to the financial 
statements in the period in which a material business combination is 
completed if the amounts assigned to goodwill or to other intangible 
assets acquired are significant in relation to the total cost of the 
acquired entity:
a. For intangible assets subject to amortization:
(1) The total amount assigned and the amount assigned to a
major intangible asset class? ____
(2) The amount of any significant residual value, in total and by
major intangible asset class? ____
(3) The weighted-average amortization period, in total and by
major intangible asset class? ____
b. For intangible assets not subject to amortization the total amount 
assigned and the amount assigned to any major intangible asset
class? ____
c. For goodwill:
(1) The total amount of goodwill and the amount that is expected
to be deductible for tax purposes? ____
(2) The amount of goodwill by reportable segment (if the com­
bined entity is required to disclose segment information in
accordance with SFAS 131), unless not practicable. ____
[SFAS 141, par. 52]
3. If a series of individually immaterial business combinations com­
pleted during the period are material in the aggregate, is the following 
disclosed:
a. The number of entities acquired and a brief description of those
entities? ____
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b. The aggregate cost of the acquired entities, the number of equity 
interests, (such as common shares, preferred shares, or partner­
ship interests) issued or issuable, and the value assigned to those
interests? ____ ___
c. The aggregate amount of any contingent payments, options, or 
commitments and the accounting treatment that will be followed 
should any contingency occur (if potentially significant in relation
to the aggregate cost of the acquired entities)? ____ ___
d. The information described in question number 2 above, if the 
aggregate amount assigned to goodwill or to other intangible 
assets acquired is significant in relation to the aggregate cost of the
acquired entities? ____ ___
[SFAS 141, par. 53]
4. If the combined entity is a public business enterprises, is the following 
supplemental information on a pro forma basis for the period in 
which a material business combinations occurs (or for the period in 
which a series of individually immaterial business combinations oc­
cur that are material in the aggregate) disclosed:
a. Results of operations for the current period as though the business
combination or combinations had been completed at the begin­
ning of the period unless the acquisition was at or near the begin­
ning of the period? ____ ___
b. Results of operations for the comparable period as though the 
business combination or combinations had been completed at the 
beginning of that period if comparative financial statements are
presented? ____ ___
[SFAS 141, par. 54]
5. Does the supplemental pro forma information display revenue, in­
come before extraordinary items and the cumulative effect of account­
ing changes, net income, and earnings per share at a minimum? ____ ___
[SFAS 141, par. 55]
Note: In determining the pro forma amounts, income taxes, interest 
expense, preferred share dividends, and depreciation and amortization of 
assets shall be adjusted to the accounting base recognized for each in 
recording the combination. Pro forma information related to results of 
operations of periods prior to the combination shall be limited to the 
results of operations for the immediately preceding period.
[SFAS 141, par. 55]
6. Does the supplemental pro forma information disclose the nature and 
amount of material, nonrecurring items included in the reported pro
forma results of operations, if any? ____
[SFAS 141, par. 55]
7. In the period in which an extraordinary gain is recognized related to 
a business combination, do the notes to the financial statements
disclose the information required by paragraph 11 of Opinion 30? ____
[SFAS 141, par. 56]
8. If a material business combination is completed after the balance sheet 
date but before the financial statements are issued, is the information
required by question numbers 1 and 2 above disclosed if practicable? ____
[SFAS 141, par. 57]
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Interim Financial Information
9. For summarized interim financial information of a public business 
enterprise is the following information disclosed if a material business 
combination is completed during the current year up to the date of 
the most recent interim statement of financial position presented:
a. The name and a brief description of the acquired entity and the
percentage of voting equity interests acquired? ____
b. The primary reasons for the acquisition, including a brief descrip­
tion of the factors that contributed to a purchase price that results
in recognition of goodwill? ____
c. The period for which the results of operations of the acquired 
entity are included in the income statement of the combined
entity? ____
d. The cost of the acquired entity and, if applicable, the number of
shares of equity interests (such as common shares, preferred 
shares, or partnership interests) issued or issuable, the value as­
signed to those interests, and the basis for determining that value? ____
e. Supplemental pro forma information that discloses the results of 
operations for the current interim period and the current year up 
to the date of the most recent interim statement of financial posi­
tion presented (and for the corresponding periods in the preceding 
year) as though the business combination had been completed as
of the beginning of the period reported on? ____
f. The nature and amount of any material, nonrecurring items in­
cluded in the reported pro forma results of operations? ____
g. Do the pro forma information disclosures in step e above display 
at a minimum, revenue, income before extraordinary items and 
the cumulative effect of accounting changes (including those on
an interim basis), net income and earnings per share? ____
[SFAS 141, par. 58]
Other Disclosures and Presentation Items
10. Is any portion of the valuation allowance for deferred tax assets for 
which subsequently recognized tax benefits will be allocated to re­
duce goodwill and other noncurrent intangible assets of an acquired 
entity or directly to contributed capital (paragraphs 30 and 36 of SFAS
109, AC section I27.129 and.135) disclosed? ____
[SFAS 109, par. 48 (AC I27.147)]
11. Where the entity has purchased an enterprise and the purchase price 
is to be allocated to assets (operating unit) to be sold, are the reporting 
requirements and disclosures contained in EITF 87-11 and EITF 90-6
complied with? ____
[EITF 87-11, EITF 90-6]
12. If a material liability is recognized by the combined institution for 
costs incurred to (1) exit and activity, (2) involuntarily terminate 
employees of an acquired institution, or (3) relocate employees of an 
acquired entity, are disclosures made in accordance with EITF 95-3,
Recognition of Liabilities in Connection with a Purchase Business Combination? ____
[EITF 95-3]
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U. Segment Information
Note: Public business enterprises are required to provide the disclosures 
described in SFAS 131 and nonpublic business enterprises are encouraged 
to do so.
1. Are the factors used to identify the reporting entity's reportable 
segments, including the basis of organization (for example, whether 
management has chosen to organize the reporting entity around 
differences in products and services, geographic areas, regulatory 
environments, or a combination of factors and whether operating 
segments have been aggregated) disclosed?
[SFAS 131, par. 26 (AC F30.125)]
2. Are the types of products and services from which each reportable 
segment derives its revenues disclosed?
[SFAS 131, par. 26 (AC F30.125)]
3. Has a measure of profit or loss and total assets been reported for each 
reportable segment?
[SFAS 131, par. 27 (AC F30.126)]
4. If the following specified amounts (a) are included in the measure of 
segment profit or loss reviewed by the chief operating decision maker 
or (b) are otherwise regularly provided to the chief operating decision 
maker, even if not included in that measure of segment profit or loss, 
are they disclosed for each reportable segment:
a. Revenues from external customers?
b. Revenues from transactions with other operating segments of the 
reporting entity?
c. Interest revenue?
d. Interest expense?
e. Depreciation, depletion, and amortization expense?
f. Unusual items as described in paragraph 26 of APB 30?
g. Equity in the net income of investees accounted for by the equity 
method?
h. Income tax expense or benefit?
i. Extraordinary items?
j. Significant noncash items other than depreciation, depletion, and 
amortization expense?
[SFAS 131, par. 27 (AC F30.126)]
5. If the following specified amounts are (a) included in the determina­
tion of segment assets reviewed by the chief operating decision maker 
or (b) are otherwise regularly provided to the chief operating decision 
maker, even if not included in that measure of segment assets, are they 
disclosed for each reportable segment:
a. The amount of investment in equity method investees?
b. Total expenditures for additions to long-lived assets other than 
financial instruments and deferred tax assets?
[SFAS 131, par. 28 (AC F30.127)]
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6. Is an explanation of the measurements of segment profit or loss and 
segment assets that discloses the following for each reportable seg­
ment provided:
a. The basis of accounting for any transactions between reportable 
segments?
b. The nature of any differences between the reporting entity's con­
solidated income before taxes, extraordinary items, discontinued 
operations, and the cumulative effect of changes in accounting 
principle?
c. The nature of any differences between the measurements of the 
reportable segments' assets and the reporting entity's consoli­
dated assets?
d. The nature of any changes from prior periods in the measurement 
methods used to determine reported segment profit or loss and 
the effect, if any, of those changes on the measure of segment profit 
or loss?
e. The nature and effect of any asymmetrical allocations to seg­
ments?
[SFAS 131, par. 31 (AC F30.130)]
7. Are reconciliations of the totals of the reportable segments' revenues, 
measures of profit or loss, assets, and every other significant item of 
information disclosed to corresponding consolidated amounts pre­
sented with all significant reconciling items separately identified and 
described?
[SFAS 131, par. 32 (AC F30.131)]
8. If the reporting entity changes the structure of its internal organization 
in a manner that changes the composition of its reportable segments, 
is the corresponding information for prior periods restated and is the 
fact that the corresponding items of segment information for earlier 
periods have been restated disclosed?
[SFAS 131, par. 34 (AC F30.133)]
9. If the reporting entity changes the structure of its internal organization 
in a manner that changes the composition of its reportable segments 
and the corresponding information for prior periods is not restated, 
does disclosure in the year in which the change occurs include seg­
ment information for the current period under both the old basis and 
the new basis?
[SFAS 131, par. 35 (AC F30.134)]
10. For all reporting entities subject to SFAS 131, including those that have 
a single reportable segment, are the following enterprise-wide items 
disclosed:
a. Revenues from external customers for each product and service or 
each group of similar products and services unless it is impracti­
cable to do so?
[SFAS 131, par. 37 (AC F30.136)]
b. The following geographic information unless it is impracticable to 
do so:
(1) Revenues from external customers (a) attributed to the re­
porting entity's country of domicile and (b) attributed to all 
foreign countries in total from which the reporting entity 
derives revenue?
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(2) Revenues from external customers attributed to an individ­
ual foreign country, if material? ____ ___
(3) The basis for attributing revenues from external customers to
individual countries? ____ ___
(4) Long-lived assets other than financial instruments and de­
ferred tax assets (a) located in the reporting entity's country 
of domicile and (b) located in all foreign countries in total in
which the reporting entity holds assets? ____ ___
(5) Long-lived assets as described above in an individual foreign
country, if material? ____ ___
[SFAS 131, par. 38 (AC F30.137)]
c. Information about the extent of the reporting entity's reliance on 
its major customers, including the following:
(1) If revenues from transactions with any single customer 
amount to 10 percent or more of the reporting entity's reve­
nues, that fact, the total amount of revenues from each such 
customer, and the identity of the segment or segments report­
ing the revenue? ____ ___
[SFAS 131, par. 39 (AC F30.138)]
11. If the information described in Step 10.a. and b. above has not been
disclosed because it is impracticable, is that fact disclosed? ____ ___
[SFAS 131, pars. 37 and 38 (AC F30.136 and .137)]
V. Postemployment Benefits
1. If an obligation for postemployment benefits (for example, salary 
continuation, supplemental unemployment benefits, severance bene­
fits, disability related benefits, job training and counseling, and con­
tinuation of health and insurance coverage) has not been accrued 
because the amount cannot be reasonably estimated, is that fact
disclosed in the financial statements? ____ ___
[SFAS 112, par. 7 (AC P32.105)]
W. Stock Compensation Plans
1. If the reporting entity continues to apply APB 25 in accounting for its 
stock-based compensation arrangements, is the pro forma net income 
and, if earnings per share are presented, pro forma earnings per share 
determined as if the fair-value based method (described in SFAS 123) 
had been applied in measuring compensation cost, disclosed for each
year for which an income statement is presented? ____ ___
[SFAS 123, par. 45 (AC C36.144)]
2. Is a description of the plan(s), including the general terms of awards
under the plan(s) disclosed? ____ ___
[SFAS 123, par. 46 (AC C36.145)]
3. Are the following disclosed for each year for which an income state­
ment is presented:
a. The number and weighted-average exercise prices of options for 
each of the following groups of options:
(1) Those outstanding at the beginning of the year? ____ ___
(2) Those outstanding at the end of the year? ____ ___
N/A
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(3) Those exercisable at the end of the year?
(4) Those granted during the year?
(5) Those exercised during the year?
(6) Those forfeited during the year?
(7) Those expired during the year?
b. The weighted-average grant-date fair value of options granted 
during the year?
(Note: That if the exercise prices of some options differ from the 
market price of the stock on the grant date, weighted-average fair 
values of options shall be disclosed separately for options whose 
exercise price (1) equals, (2) exceeds, or (3) is less than the market 
price of the stock on the grant date.)
c. The number and weighted-average grant date-fair value of equity 
instruments other than options granted during the year?
A. A description of the method and significant assumptions used 
during the year to estimate the fair values of options, including the 
following weighted-average information: (1) risk-free interest 
rate, (2) expected life, (3) expected volatility, and (4) expected 
dividends?
e. Total compensation cost recognized in income for stock-based 
employee compensation awards?
f. The terms of significant modifications of outstanding awards? 
[SFAS 123, par. 47a-f (AC C36.146)]
4. If the reporting entity grants options under multiple stock-based 
employee compensation plans, are the items in Step 3 above disclosed 
separately for different types of awards to the extent that the differ­
ences in the characteristics of the awards make separate disclosure 
important to an understanding of the reporting entity's use of stock- 
based compensation?
[SFAS 123, par. 47 (AC C36.146)]
5. For options outstanding at the date of the latest balance sheet pre­
sented, are the following disclosed:
a. The range of exercise prices?
b. The weighted-average exercise price?
c. The weighted-average remaining contractual life?
[SFAS 123, par. 48 (AC C36.147)]
6. If the range of exercise prices is wide (the highest exercise price 
exceeds approximately 150 percent of the lowest exercise price), are 
the exercise prices segregated into ranges that are meaningful for 
assessing the number and timing of additional shares that may be 
issued and the cash that may be received as a result of option exercises 
and are the following disclosed for each range:
a. The number, weighted-average exercise price, and weighted- 
average remaining contractual life of options outstanding?
b. The number and weighted-average exercise price of options cur­
rently exercisable?
[SFAS 123, par. 48 (AC C36.147)]
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7. For bonus arrangements issued in connection with the grant of stock 
compensation awards, is any amount recognized as a bonus liability 
during the service period that exceeds the ultimate bonus paid to the
employee reclassified to equity? ____  ___
[EITF 00-23]
X. Asset Retirement Obligations
Note: The following questions are based on SFAS 143, Accounting for Asset 
Retirement Obligations. SFAS 143 is effective for financial statements issued for 
fiscal years beginning after June 15, 2002. Earlier application is encouraged.
1. Does the company disclose the following information about its asset 
retirement obligations:
a. A general description of the asset retirement obligations and the 
associated long-lived assets?
b. The fair value of assets that are legally restricted for purposes of 
settling asset retirement obligations?
c. A reconciliation of the beginning and ending aggregate carrying 
amount of asset retirement obligations showing separately the 
changes attributable to (1) liabilities incurred in the current period, 
(2) liabilities settled in the current period, (3) accretion expense, 
and (4) revisions in estimated cash flows, whenever there is a 
significant change in one or more of those four components during 
the reporting period?
[SFAS 143, par. 22]
2. If the fair value of an asset retirement obligation cannot be reasonably 
estimated is that fact and the reasons therefore disclosed?
[SFAS 143, par. 22]
3. In addition to the disclosures required by paragraphs 19 (c), 19 (d), 
and 21 of APB Opinion 20, is the liability for the asset retirement 
obligation computed on a pro forma basis disclosed in the footnotes 
for the beginning of the earliest year presented and at the end of all 
years presented as if SFAS 143 had been applied during all periods 
affected?
[SFAS 143, par. 27]
Y. Demutualizations and Formations of Mutual Insurance Holding
Companies
1. Are the nature and terms of a demutualization or formation of and 
MIHC and the basis of presentation and terms of operation of the 
closed block disclosed?
[SOP 00-3, par. 24]
2. Is a general description of the method of emergence of earnings from 
the closed block, presentation of assets and liabilities of the closed 
block, and policyholder dividend obligation provided?
[SOP 00-3, par. 24]
3. If a closed block has formed, is the following disclosed: [Note: Refer 
to SOP 00-3 Appendix A, "Illustrative Guidance—Footnote Disclo­
sure for the Closed Block," for an illustrative example]
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a. A general description of the closed block, including the purpose 
of the closed block, the types of insurance policies included, and 
the nature of the cash flows that increase and decrease the amount 
of closed block liabilities? [SOP 00-3, par. 25a]
b. An indication the continuing responsibility of the insurance enter­
prise to support the payment of contractual benefits and the nature 
of expenses charged to the closed block operations? [SOP 00-3, par. 
25a]
4. Is summarized financial data of the closed block as of, or for periods 
ending on the date of, the financial statements presented, including 
at a minimum:
a. The carrying amounts for the major types of invested assets of the 
closed block?
b. Future policy benefits and policyholders' account balances?
c. Policyholder dividend obligation?
d. Premiums?
e. Net investment income?
f. Realized investment gains and losses?
g. Policyholder benefits?
h. Policyholder dividends?
i. The amount of maximum future earnings remaining to inure to 
the benefit of stockholders from the assets and liabilities of the 
closed block as well as an analysis of the changes in the policy­
holder dividend obligation?
[SOP 00-3, par. 25b]
Note: GAAP disclosures that typically would be required for the various 
specific elements included in the closed block need not be made separately 
for the closed block if the nature of the information for the closed block 
would not differ significantly from that already included for the reporting 
entity as a whole. For example, it is not necessary to show a separate 
schedule of contractual maturities of closed block fixed maturity securities 
if the relative composition of contractual maturities is similar to those of 
the reporting entity taken as a whole. However, if the relative maturities 
of the closed block fixed maturities securities differ from those of the 
reporting entity taken as a whole, separate disclosures should be made. 
[SOP 00-3, par. 25c]
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.01 This checklist has been developed by the staff of the Accounting and Auditing Publications Team of 
the AICPA as a nonauthoritative practice aid.
.02 Explanation of References:
SAS = AICPA Statement on Auditing Standards
SOP = AICPA Statement of Position
AU = Reference to section number in AICPA Professional Standards (vol. 1)
SSARS = AICPA Statement on Standards for Accounting and Review Services
AR = Reference to section number in AICPA Professional Standards (vol. 2)
.03 Checklist Questionnaire:
Yes No N/A
1. Is every financial statement audited specifically identified in the 
introductory paragraph of the auditor's report?
[SAS 58, par. 6 (AU 508.06)]
2. Do the titles of the financial statements referred to in the introductory 
paragraph of the auditor's report match the titles of the financial 
statements presented?
[Generally Accepted]
3. Do the dates of the financial statements referred to in the introductory 
paragraph of the auditor's report match the dates of the financial 
statements presented?
[Generally Accepted]
4. Is the report appropriately addressed?
[SAS 58, par. 9 (AU 508.09)]
5. Does the auditor's report include appropriate:
a. A title that includes the word "independent"?
[SAS 58, par. 8a (AU 508.08a)]
b. A statement that the financial statements identified in the report 
were audited?
[SAS 58, par. 8b (AU 508.08b)]
c. A statement that the financial statements are the responsibility of 
management and that the auditor's responsibility is to express an 
opinion on the financial statements based on his or her audit? 
[SAS 58, par. 8c (AU 508.08c)]
d. A statement that the audit was conducted in accordance with 
generally accepted auditing standards and an identification of the 
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country of origin of those standards (for example, auditing stand­
ards generally accepted in the United States of America or U.S. 
generally accepted auditing standards)?
[SAS 58, par. 8d, as amended by SAS 93, (AU sec. 508.08d)]
e. A statement that these standards require that the auditor plan and 
perform the audit to obtain reasonable assurance about whether 
the financial statements are free of material misstatement?
[SAS 58, par. 8e (AU 508.08c)]
f. A statement that an audit includes examining, on a test basis, 
evidence supporting the amounts and disclosures in the financial 
statements; assessing the accounting principles used and signifi­
cant estimates made by management; and evaluating the overall 
financial statement presentation?
[SAS 58, par. 8f (AU 508.08f)]
g. A statement that the auditor believes that his audit provides a 
reasonable basis for his opinion?
[SAS 58, par. 8g (AU 508.08g)]
h. An opinion as to whether the financial statements present fairly, 
in all material aspects, the financial position of the reporting entity 
as of the balance sheet date and the results of operations and its 
cash flows for the period then ended in conformity with generally 
accepted accounting principles and an identification of the coun­
try of origin of those accounting principles (for example, account­
ing principles generally accepted in the United States of America 
or U.S. generally accepted accounting principles?
[SAS 58, par. 8h, as amended by SAS 93, (AU sec. 508.08h)]
i. The manual or printed signature of the auditor's firm?
[SAS 58, par. 8i (AU 508.08i)]
j. The date of the audit report?
[SAS 58, par. 8j (AU 508.08j)]
Practice Tip
Paragraph 8 of SAS 58 illustrates the form of the auditor's standard report on financial statements covering 
a single year and on comparative financial statements.
6. If a subsequent event disclosed in the financial statements occurs after 
completion of field work but before the issuance of the auditor's 
report, has the need for dual-dating of the report been considered? 
[SAS 1, sec. 530, pars. 3-5 (AU 530.03-.05)]
7. If the accountant is not independent, is a compilation report indicating 
the lack of independence issued (non-public companies only)?
[SAS 26, par. 10 (AU 504.10); SSARS 1, pars. 22 and 38 (AR 100.22 and 
.38)]
8. If the opinion is based in part on the report of another auditor:
a. Does the introductory paragraph of the standard report disclose 
the fact that the opinion is based, in part, on the report of other 
auditors?
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b. Does the opinion paragraph include a reference to the report of 
the other auditor?
[SAS 58, pars. 11a, 12, and 13 (AU 508.11a, .12, and .13)]
9. If, to prevent the financial statements from being misleading because 
of unusual circumstances, the financial statements contain a depar­
ture from an accounting principle promulgated by a body designated 
by the AICPA Council to establish such principles, does the report 
include, in a separate paragraph or paragraphs, the information re­
quired by the rule?
[SAS 58, pars. 11b and 15 (AU 508.11b and .15)]
10. If there is substantial doubt about the entity's ability to continue as a 
going concern:
a. Does the report include an explanatory paragraph, following the 
opinion paragraph, to reflect that conclusion?
b. Is that conclusion expressed through the use of the phrase "sub­
stantial doubt about its (the entity's) ability to continue as a going 
concern" or similar wording that includes the terms substantial 
doubt and going concern?
[SAS 58, par. 11c (AU 508.11c); SAS 59, as amended by SAS 64, par. 
12 (AU 341.12)]
Practice Tip
In a going concern paragraph, the auditor should not use conditional language in expressing a conclusion 
concerning the existence of substantial doubt about the entity's ability to continue as a going concern. See 
SAS 77 for an example.
11. If there has been a material change between periods in accounting 
principles or in the method of their application that has a material effect 
on the comparability of the reporting entity's financial statements:
a. Does the report include an explanatory paragraph, following the 
opinion paragraph, that refers to the change?
b. Does the explanatory paragraph identify the nature of the change 
and refer the reader to the note to the financial statements that 
discusses the change in detail?
[SAS 58, as amended by SAS 79, pars. 11d and 16 (AU 508.11d and .16)]
c. If the change in the accounting principle is a change in reporting 
entity that did not result from a transaction or an event, is an 
explanatory paragraph included in the auditor's report? (Note: A 
change in the reporting entity resulting from a transaction or 
event, such as a pooling of interest, or the creation, cessation or 
complete or partial purchase or disposition of a subsidiary or other 
business unit does not require that an explanatory paragraph 
about consistency be included in the auditor's report.)
[SAS 88, par. 8, AU 420.08]
12. In an updated report, the opinion is different from the opinion pre­
viously expressed on the financial statements of a prior period:
a. Does the report include an explanatory paragraph, preceding the 
opinion paragraph, that discloses all of the substantive reasons for 
the different opinion?
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b. Does the explanatory paragraph disclose:
(1) The date of the auditor's previous report?
(2) The type of opinion previously expressed?
(3) The circumstances or events that caused the auditor to ex­
press a different opinion?
(4) That the auditor's updated opinion on the financial state­
ments of the prior period is different from his or her previous 
opinion on those statements?
[SAS 58, as amended by SAS 79, pars. 11e and 69 (AU 508.11e 
and .69)]
13. If financial statements of a prior period (presented for comparative 
purposes) have been audited by a predecessor auditor whose report 
is not presented:
a. Does the introductory paragraph of the report indicate:
(1) That the financial statements of the prior period were audited 
by another auditor?
(2) The date of the predecessor auditor's report?
(3) The type of report issued by the predecessor auditor?
(4) If the report was other than a standard report, the substantive 
reasons therefor including a description of the nature of and 
reasons for the explanatory paragraph added to the predeces­
sor's report or his or her opinion qualification?
b. If the financial statements have been restated, does the introduc­
tory paragraph indicate that the predecessor auditor reported on 
the financial statements of the prior period before restatement? 
[SAS 58, as amended by SAS 79, pars. 11e and 74 (AU 508.11e and .74)]
14. If selected quarterly financial data required by SEC Regulation S-K 
has been omitted or has not been reviewed, does the report include 
an additional paragraph stating that fact?
[SAS 58, par. 11f (AU 508.11f); SAS 71, par. 41 (AU 722.43)
15. If supplementary information required by the FASB has been omitted, 
the presentation of such information departs materially from FASB 
guidelines, the auditor is unable to complete prescribed procedures 
with respect to such information, or the auditor is unable to remove 
substantial doubt about whether the supplementary information con­
forms to FASB guidelines, does the report include an additional 
paragraph stating that fact?
[SAS 58, par. 11g (AU 508.11g); SAS 52, par. 8 (AU 558.08)]
16. If other information in a document containing audited financial state­
ments is materially inconsistent with information appearing in the 
financial statements, has it been determined whether the financial 
statements, the auditor's report, or both require revision?
[SAS 58, par. 11h (AU 508.11h); SAS 8, par. 4 (AU 550.04)]
17. If the auditor decides to emphasize a matter regarding the financial 
statements in the report, is the explanatory information presented in 
a separate paragraph that avoids use of phrases such as "with the 
foregoing (following) explanation"?
[SAS 58, pars. 11 and 19, as amended by SAS 79 (AU 508.11 and .19); 
Interpretation 3 of SAS 1, sec. 410 (AU 9410.18); Interpretation 1 of 
SAS 57 (AU 9342.03)]
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18. If it has not been possible to conduct the audit in accordance with
GAAS or to apply all of the procedures considered necessary in the 
circumstances, has consideration been given to the need to issue a
qualified opinion or to disclaim an opinion? ____ ____  _____
[SAS 58, as amended by SAS 79, par. 22 (AU 508.22)1
19. If a qualified opinion is to be expressed because of a scope limitation:
a. Are all of the substantive reasons for the qualification disclosed in one
or more explanatory paragraphs preceding the opinion paragraph? ____ ____  _____
b. Does the qualified opinion include the word except or exception in
a phrase such as except for or with the exception of? ____ ____  _____
c. Is the situation described and referred to in both the scope and
opinion paragraphs? ____  ____  _____
d. Does the wording in the opinion paragraph indicate that the
qualification pertains to the possible effects on the financial state­
ments and not the scope limitation itself? ____ ____  _____
[SAS 58, as amended by SAS 79, pars. 22-27 (AU 508.22-.27)]
Practice Tip
Scope limitations include situations in which the auditor is unable to obtain sufficient evidential matter to 
support management's assertions about the nature of a matter involving an uncertainty and its presentation 
or disclosure in the financial statements. [SAS 58, as amended by SAS 79, par. 31]
Note: Consult the Topical Index to the AICPA Professional Standards 
under "Scope of Audit—Limitations" for additional references to specific 
types of scope limitations that could result in either a qualified or dis­
claimer of opinion.
20. If an opinion is disclaimed because of a scope limitation:
a. Are all of the substantive reasons for the disclaimer stated in a
separate paragraph or paragraphs? ____
b. Does the report state that the scope of the audit was not sufficient
to warrant the expression of an opinion? ____
c. Does the report avoid identifying procedures that were performed? ____
d. Is the scope paragraph omitted? ____
e. If there are reservations about fair presentation of the financial 
statements in conformity with GAAP, are they described in the
report? ____
[SAS 58, as amended by SAS 79, par. 63 (AU 508.63)]
21. If the financial statements are materially affected by a departure from
GAAP (including inadequate disclosure, inappropriate accounting 
principles, and unreasonable accounting estimates), has considera­
tion been given to the need to issue a qualified opinion or an adverse
opinion? ____
[SAS 58, as amended by SAS 79, par. 35 (AU 508.35)]
22. If a qualified opinion is to be expressed because of a GAAP departure:
a. Are all of the substantive reasons that have led to the conclusion 
that there is a departure from GAAP disclosed in one or more 
separate explanatory paragraphs preceding the opinion paragraph? ____
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b. Does the qualified opinion include the word except or exception in 
a phrase such as except for or with the exception of and a reference to 
the explanatory paragraph?
c. Does the explanatory paragraph disclose the principle effects of 
the departure on financial position, results of operations, and cash 
flows, if practicable, or state that the effects are not reasonably 
determinable, if not practicable to do so?
[SAS 58, as amended by SAS 79, pars. 37 and 38 (AU 508.37 and .38)]
23. If an adverse opinion is to be expressed because of a GAAP departure:
a. Are all of the substantive reasons for the adverse opinion disclosed 
in one or more separate explanatory paragraphs preceding the opin­
ion paragraph?
b. Does the explanatory paragraph disclose the principle effects of 
the departure on financial position, results of operations, and cash 
flows, if practicable, or state that the effects are not reasonably 
determinable, if not practicable to do so?
c. State that the financial statements do not present fairly the financial 
position, or results of operations or cash flows in conformity with 
GAAP?
[SAS 58, as amended by SAS 79, pars. 58 and 59 (AU 508.58 and .59)]
Note: Consult the Topical Index to the AICPA Professional Standards 
under “Departures From Established Principles," "Adverse Opinions," 
and "Qualified Opinions" for additional references to specific types of 
GAAP departures that could result in either a qualified or adverse opinion.
24. If information accompanies the basic financial statements and auditor's 
report in an auditor-submitted document, is it accompanied by a report 
that:
a. States that the audit was performed for the purpose of forming an
opinion on the basic financial statements taken as a whole? ____
b. Specifically identifies the accompanying information? ____
c. States that the accompanying information is presented for pur­
poses of additional analysis and is not a required part of the basic 
financial statements? ____
d. Includes either an opinion on whether the accompanying informa­
tion is fairly stated in all material respects in relation to the basic 
financial statements taken as a whole or a disclaimer of opinion 
(depending on whether the information was subjected to the auditing
procedures applied in the audit of the basic financial statements)? ____
[SAS 29, par. 6 (AU 551.06)]
Statutory Basis Financial Statements
25. Does the report on statutory financial statements as to fair presenta­
tion in conformity with the statutory basis of accounting not include
a disclaimer of opinion as to fair pesentation in conformity with GAAP? ____
[SOP 95-5, par. 10]
26. Is an adverse opinion expressed with respect to conformity with
GAAP, unless the auditor determines the differences between GAAP
and the statutory basis of accounting are not material and pervasive? ____
[SOP 95-5, par. 12]
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Yes No N/A
27. Do the notes to the statutory financial statements discuss the statutory
basis of accounting and describe how that basis differs from GAAP? ____
[SOP 95-5, par. 13]
Practice Tip
SAS 87, Restricting the Use of an Auditor's Report, provides guidance to auditors in determining whether an 
engagement requires a restricted-use report and, if so, what elements to include in that report.
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FSP Section 20,500
Supplemental Information for Life
Insurance Companies That Are
Securities and Exchange
Commission Registrants
.01 Footnote 3 to SAS 69 states, in part, that for Securities and Exchange Commission (SEC) registrants, 
rules and releases of the SEC have an authority similar to other officially established accounting principles.
Regulation S-X is the primary source of requirements for financial statements and related footnotes required 
to be included in documents filed with the SEC. In addition to Regulation S-X, preparers and auditors of 
financial statements should be familiar with the SEC's Financial Reporting Releases (FRR) and Staff Account­
ing Bulletins (SAB). FRRs communicate the SEC's position on accounting and auditing principles and 
practices. SABs represent interpretations and practices followed by the Division of Corporation Finance and 
the Office of the Chief Accountant of the SEC. Insurance companies are subject to the requirements of Articles 
1-4, 7, 10, and 12 of Regulation S-X.
When determining compliance with SEC requirements, preparers and auditors should refer to the appropri­
ate SEC pronouncements to ensure compliance with SEC disclosure rules. In particular, the following 
documents should be consulted:
• Regulation S-X, Article 1, Application of Regulation S-X
• Regulation S-X, Article 2, Qualifications and Reports of Accountants
• Regulation S-X, Article 3, General Instructions as to Financial Statements
• Regulation S-X, Article 4, Rules of General Application
• Regulation S-X, Article 7, Insurance Companies
• Regulation S-X, Article 10, Interim Financial Statements
• Regulation S-X, Article 12, Form and Content of Schedules
• Staff Accounting Bulletins—SABs reflect the SEC staff's views regarding accounting-related disclo­
sure practices. They represent interpretations and policies followed by the Division of Corporation 
Finance and the Office of the Chief Accountant in administering the disclosure requirements of the 
federal securities laws.
• Financial Reporting Releases (FRR)—FRRs adopt, change, or interpret requirements relating to 
accounting, auditing, and disclosure issues.
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FSP Section 20,600
Illustrative Financial Statements
.01 This section contains illustrative financial statements prepared in conformity with generally accepted 
accounting principles (GAAP). The financial statements are for illustrative purposes only, are not intended 
to be comprehensive and are not intended to establish preference among alternative principles acceptable 
under GAAP. Decisions about the application of the GAAP discussed in the accounting and financial 
reporting sections of the AICPA Audit and Accounting Guide Life and Health Insurance Entities, should not 
be made by reference to the illustrative financial statements but by a careful reading to the specified 
authoritative literature. The illustrative financial statements reflect many of the minimum disclosure require­
ments for a life and health insurance entity but do not include all of the amounts or transactions discussed 
in other chapters of the Guide or that might be found in practice. For example, the illustrative notes indicate 
the subject matter generally required to be disclosed, but they should be expanded, reduced, or otherwise 
modified to suit individual circumstances based on a careful reading of the specified authoritative 
literature.
.02 The illustrative financial statements do not include other transactions not unique to life and health 
insurance entities, such as disclosures about segments, employee benefit plans, certain risks and uncertain­
ties, or postemployment benefits other than pensions. Preparers and auditors should consult authoritative 
pronouncements for guidance on presenting such other information.
.03 The illustrative financial statements do not reflect rules and releases of the Securities and Exchange 
Commission (SEC) that, for SEC registrants, have an authority similar to other officially established account­
ing principles. SEC Regulation S-X, Article 7, Insurance Companies, should be referred to.
.04 These illustrative financial statements and notes deliberately do not reflect the provisions of SFAS 
133, Accounting for Derivative Instruments and Hedging Activities, and SFAS 144, Accounting for the Impairment 
or Disposal of Long-Lived Assets. See SFAS 133 and SFAS 144 for effective date information. As companies 
adopt SFAS 133 and SFAS 144, and as reporting practices related to these FASB Statements become generally 
accepted, these illustrative financial statements and notes will be updated accordingly.
.05 Also, preparers and auditors of SEC-registrant financial statements are reminded that as dis­
cussed in SAB Topic 11M (SAB No. 74), and AU section 9410, Item 3, The Impact on an Auditor's Report of 
an FASB Statement Prior to the Statement's Effective Date, filings with the SEC that include financial 
statements for a period ending after the issuance of an accounting standard but before the required date 
of adoption of that accounting standard should include disclosure of the impact that the recently issued 
accounting standard will have on the financial position and results of operations of the registrant when 
such standard is adopted in a future period. The following disclosures should be considered by 
registrants:
• A brief description of the new standard, the date that adoption is required and the date that the 
registrant plans to adopt, if earlier;
• A discussion of the methods of adoption allowed by the standard and the method expected to be 
utilized by the registrant, if determined;
• A discussion of the impact that adoption of the standard is expected to have on the financial 
statements of the registrant, unless unknown or not reasonably estimable. In that case, a statement 
to that effect may be made;
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• Disclosure of the potential impact of other significant matters that the registrant believes might result 
from the adoption of the new standard (such as technical violations of debt covenant agreements, 
planned or intended changes in business practices, etc.).
.06 Life and health insurance entities generally present unclassified balance sheets.
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ABC LIFE INSURANCE COMPANY 
Balance Sheet
December 31, 20X2 and 20X1
(Amounts in Thousands)
See accompanying notes to financial statements.
20X2 20X1
Assets
Investments:
Debt and equity securities:
Fixed maturities, held to maturity, at amortized cost
(estimated fair value: $47,830 in 20X2 and $45,255 in 20X1) $ 44,864 $ 46,310
Fixed maturities, available for sale, at estimated fair value
(amortized cost: $247,525 in 20X2 and $219,565 in 20X1) 255,893 214,563
Trading account securities, at estimated fair value
(cost: $4,220 in 20X2 and $4,419 in 20X1) 3,950 4,190
Mortgage loans 79,258 106,692
Real estate 6,410 6,147
Policy loans 43,549 51,013
Short-term investments 7,515 6,321
Total investments 441,439 435,236
Cash and cash equivalents 5,285 3,343
Accrued investment income 6,660 8,026
Premiums due and other receivables, net of allowance
of $4,500 and $2,100 for doubtful accounts 1,647 1,092
Reinsurance receivable on paid and unpaid losses 596 407
Reinsurance receivable related to contract holder liabilities 5,714 3,048
Deferred policy acquisition costs 38,936 36,429
Property and equipment, net of accumulated depreciation 501 420
Other assets 152 158
Separate account assets 732 525
Total assets $501,662 $488,684
Liabilities
Future policy benefits $345,887 $341,207
Guaranteed interest contracts 21,342 23,555
Policyholders funds on deposit 49,408 46,202
Unpaid claims 5,418 4,737
Policyholders dividends 2,335 3,450
Amounts held in escrow and accrued expenses 4,977 4,562
Deferred federal income taxes 1,412 1,027
Other liabilities 253 4,465
Separate account liabilities 732 525
Total liabilities 431,764 429,730
Commitments and contingencies (Note 12)
Shareholders' Equity
Capital stock: authorized—5,000,000 shares of $2 par value;
3,341,624 shares issued and outstanding 6,683 6,683
Retained earnings 57,776 55,522
Accumulated other comprehensive income 5,439 (3,251)
Total shareholders' equity 69,898 58,954
Total liabilities and shareholders' equity $501,662 $488,684
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.08
ABC LIFE INSURANCE COMPANY 
Statements of Income
Years Ended December 31, 20X2 and 20X1 
(Amounts in Thousands)
20X2 20X1
Premiums and Other Revenues
Premiums:
Life and annuity premiums $24,833 $24,783
Accident and health premiums 10,141 9,153
Other premiums 20 43
Contract holder fees 1,961 1,844
Net investment income 32,998 35,141
Net realized gains (losses) on investments 4,222 (2,670)
Total premiums and other revenues 74,175 68,294
Benefits and Other Expenses
Policyholder benefits 39,158 30,815
Interest credited to policyholder accounts 4,363 4,156
General expenses 4,288 4,984
Amortization of deferred policy acquisition costs 1,276 1,305
Underwriting, acquisition, and insurance expenses 18,029 17,266
Policyholders' dividends 4,665 6,898
Total benefits and expenses 71,779 65,424
Income before income taxes 2,396 2,870
Income taxes:
Current 1,547 601
Deferred (1,405) 540
Total income taxes 142 1,141
Net income 2,254 1,729
Net income per common share .67 .52
Dividends per common share — .98
See accompanying notes to financial statements.
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.09
ABC LIFE INSURANCE COMPANY 
Statements of Comprehensive Income (Loss)
Years Ended December 31, 20X2 and 20X1 
(Amounts in Thousands)
20X2 20X1
Net Income $ 2,254 $ 1,729
Other comprehensive income (loss) 8,690 (1,730)
Total comprehensive income (loss) $10,944 $ (1)
See Note 5 to the financial statements for information about other comprehensive income (loss).
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.10
ABC LIFE INSURANCE COMPANY 
Statement of Changes in Shareholders' Equity
Years Ended December 31, 20X2 and 20X1 
(Amounts in Thousands)
Accumulated
Capital
Stock
Retained
Earnings
Other
Comprehensive 
Income (Loss)
Total
Shareholders'
Equity
Balance at January 1, 20X1 $6,683 $57,068 $(1,521) $62,230
Net income for 20X1 — 1,729 — 1,729
Shareholders' dividends — (3,275) — (3,275)
Other comprehensive income (loss) — — (1,730) (1,730)
Balance at December 31, 20X1 6,683 55,522 (3,251) 58,954
Net income for 20X2 — 2,254 — 2,254
Other comprehensive income — — 8,690 8,690
Balance at December 31, 20X2 $6,683 $57,776 $ 5,439 $69,898
See accompanying notes to financial statements.
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.11
ABC LIFE INSURANCE COMPANY 
Statements of Cash Flows
Years Ended December 31, 20X2 and 20X1 
(Amounts in Thousands)
See accompanying notes to financial statements.
20X2 20X1
Cash flows from operating activities:
Net income $ 2,254 $ 1,729
Adjustments to reconcile net income to net 
cash provided by operating activities:
Interest credited to universal life policies 7,927 10,445
Accrual of discount on investments, net (976) (1,328)
Net realized (gains) losses on investments (4,222) 2,670
Depreciation and amortization 3,041 3,534
Amortization of deferred policy acquisition costs 1,276 1,305
Deferred federal income taxes (2,538) 540
Change in operating assets and liabilities:
Accrued investment income 1,366 880
Capitalization of deferred policy acquisition costs (3,783) (6,645)
Policy liabilities (3,440) (16,234)
Other items, net (644) 3,269
Net cash provided by operating activities 261 165
Cash flows from investing activities:
Cost of investments purchased:
Fixed maturities and equity securities (228,053) (122,495)
Mortgage loans and real estate (921) —
Proceeds from investments sold, redeemed, or matured:
Fixed maturities and equity securities 206,051 95,177
Mortgage loans and real estate 27,970 18,621
Policy loans, net 2,320 6,468
Short-term investments, net 409 15,446
Net cash provided by investing activities 7,776 13,217
Cash flows from financing activities:
Dividends to shareholders — (3,275)
Receipts from universal life policies credited to
contract holder account balances 7,918 8,365
Return of contract holder account balances on
universal life policies (4,165) (3,718)
Withdrawals from interest-sensitive contracts (9,848) (13,046)
Cash used in financing activities (6,095) (11,674)
Net increase in cash and cash equivalents 1,942 1,708
Cash and cash equivalents, beginning of year 3,343 1,635
Cash and cash equivalents, end of year $ 5,285 $ 3,343
Supplemental cash flow information:
Income taxes paid $ 1,205 $ 785
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.12
ABC LIFE INSURANCE COMPANY 
Notes to Financial Statements
Years Ended December 31, 20X2 and 20X1
Note 1: Organization and Significant Accounting Policies
Organization. ABC Life Insurance Company (ABC or the Company) is a stock life insurance 
company incorporated in the state of ABC that offers individual life, disability income, long-term 
care, annuity, and investment products. ABC does business in the continental United States, with 
a concentration in New York, New Jersey, and Connecticut.
Basis of presentation. The significant accounting policies followed by ABC that materially affect 
financial reporting are summarized below. The accompanying financial statements have been 
prepared in accordance with generally accepted accounting principles (GAAP) that differ from 
statutory accounting practices (SAP) used for regulatory authorities. The preparation of the 
financial statements in conformity with GAAP requires management to make estimates and 
assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent 
assets and liabilities at the date of the financial statements and the reported amounts of revenues 
and expenses during the reporting period. Actual results could differ from those estimates.
Investments. Fixed maturity securities available for sale consist of bonds, notes, and redeemable 
and nonredeemable preferred stock not classified as either trading or held to maturity, and are 
reported at estimated fair value. Unrealized holding gains and losses, net of tax, on available-for- 
sale securities are reported as a net amount in other comprehensive income. Deferred policy 
acquisition cost offsets for universal life type contracts and amounts attributable to certain 
participating contracts are recorded as a separate component of accumulated other comprehen­
sive income. Fixed maturity securities held to maturity consist of bonds, notes, redeemable and 
nonredeemable preferred stock which the insurance company has the intent and ability to hold 
to maturity, and are reported at amortized cost and adjusted for amortization of premium or 
discount. Declines in fair value of individual held-to-maturity and available-for-sale securities 
below their cost that are other then temporary have resulted in write-downs of the individual 
securities to their fair value. The related write-downs have been included in earnings as realized 
losses. Trading account securities consist of bonds, notes, and redeemable and nonredeemable 
preferred stock, and common stock held principally for resale in the near term, and are recorded 
at their estimated fair values. Realized and unrealized gains and losses on trading account 
securities are included in other income.
Mortgage loans on real estate are carried at unpaid balances and are adjusted for amortization of 
premium or discount, less allowance for losses. Real estate held for sale is carried at the lower of 
depreciated cost or fair value less estimated selling costs and losses which are considered other 
than temporary. Real estate, including real estate acquired in satisfaction of debt, is carried at 
depreciated cost. Impaired real estate is written down to fair value with the impairment loss being 
included in net realized gains (losses) on investments. Upon foreclosure (including in-substance 
foreclosure), the carrying value of the property is recorded at the lower of cost or fair value (less 
selling costs if to be sold), which becomes its new cost basis. The estimated fair value for real estate 
is determined based upon independent appraisals and other available information about the 
property, which may take into consideration a number of factors, including: (i) discounted cash 
flows (ii) sales of comparable properties (iii) geographic location of property and related market 
conditions (iv) disposition costs.
Foreclosed properties are actively managed by the company in order to maximize their value. 
Subsequent to foreclosure, the carrying value of the property is periodically evaluated and a 
valuation allowance is established, if necessary, to reflect any additional amounts considered 
unrecoverable upon sale. At the time of the sale, the difference between the sales price and the 
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carrying value is recorded as a realized gain or loss. Policy loans are carried at unpaid balances. 
Short-term investments are stated at amortized cost, that approximates fair value.
Provisions for impairments of securities classified as held to maturity are included in net realized 
gains and losses. Realized gains and losses are determined by specific identification.
Cash and cash equivalents. Cash equivalents are carried at cost, which approximates fair value. Cash 
equivalents are highly liquid financial instruments with an original maturity of three months or less.
Deferred policy acquisition costs. Commissions and other costs of acquiring traditional life insur­
ance, universal life insurance and investment products, and accident and health insurance, that 
vary with and are primarily related to the production of new and renewal business, have been 
deferred. Traditional life insurance and accident and health insurance acquisition costs are being 
amortized over the premium-paying period of the related policies using assumptions consistent 
with those used in computing future policy benefit liabilities. For universal life-type contracts and 
investment contracts that include significant surrender charges or that yield significant revenues 
from sources other than the investment of contract holders' funds, the deferred contract acquisi­
tion cost amortization is matched to the recognition of gross profit.
Otherwise, deferred contract acquisition costs on investment contracts are amortized using an 
accounting method that recognizes acquisition costs as expenses at a constant rate applied to net 
policy liabilities. The effect on the deferred acquisition costs (DAC) asset that would result from 
realization of unrealized gains (losses) is recognized with an offset to accumulated other compre­
hensive income in consolidated shareholders' equity as of the balance sheet date.
Property and equipment. Property and equipment are reported at cost, net of accumulated depre­
ciation of $1,915,000 and $1,721,000 in 20X2 and 20X1, respectively. Property and equipment are 
depreciated using the straight-line method over their estimated useful lives.
Future policy benefits and expenses. The liabilities for traditional life insurance and accident and health 
insurance contract benefits and expenses are computed using a net level premium method including 
assumptions as to investment yields, mortality, withdrawals, and other assumptions based on ABC's 
experience modified as necessary to reflect anticipated trends and to include provisions for possible 
unfavorable deviations. Liability interest assumptions are graded and range from 3 percent to 10 
percent. Benefit liabilities for traditional life insurance contracts include certain deferred profits on 
limited-payment policies that are being recognized in income over the contract term. Contract benefit 
claims are charged to expense in the period that the claims are incurred.
Included in contract holders' account balances is a provision for contract holder dividends. Benefit 
liabilities for contract holders' account balances are computed under a retrospective deposit 
method and represent contract account balances before applicable surrender charges. Contract 
benefits and claims that are charged to expense include benefit claims incurred in the period in 
excess of related contract account balances. Interest crediting rates for universal life and invest­
ment products range from 5.50 percent to 9.25 percent. Benefits and expenses are charged against 
the account balance to recognize costs as incurred over the estimated lives of the contracts. 
Expenses include interest credited to contract account balances and benefits paid in excess of 
contract account balances.
Accounting policy for health liabilities. Unpaid claims on accident and health policies represent the 
estimated liability for benefit expenses both reported but not paid and incurred but not reported to 
ABC through December 31. ABC does not discount its liabilities for unpaid claims. Liabilities for 
unpaid claims are estimated using individual case-basis valuations and statistical analyses. Those 
estimates are subject to the effects of trends in claim severity and frequency. Although considerable 
variability is inherent in such estimates, management believes that the liabilities for unpaid claims are 
adequate. The estimates are continually reviewed and adjusted as necessary as experience develops 
or new information becomes known; such adjustments are included in current operations.
Income taxes. Federal income taxes are charged or credited to operations based upon amounts 
estimated to be payable or recoverable as a result of taxable operations for the current year. Deferred 
FSP §20,600.12
102 Life and Health Insurance Entities
income taxes have been provided for temporary differences between the tax basis of assets and 
liabilities and their reported amounts in the financial statements using enacted income tax rates 
and laws.
Reinsurance. In the normal course of business, the Company seeks to limit its exposure to loss on 
any single insured and to recover a portion of benefits paid by ceding reinsurance to other 
insurance entities or reinsurers under excess coverage and coinsurance contracts. The Company 
retains a maximum of $400,000 of coverage per individual life. Amounts paid or deemed to have 
been paid for reinsurance contracts are recorded as reinsurance receivable.
Insurance premium revenues. Traditional life premiums, which include those products with fixed 
and guaranteed premiums and benefits and consist principally of whole life insurance contracts, 
limited-payment life insurance contracts, and certain annuities with life contingencies, are gener­
ally recognized as revenue when due. Revenues on universal life and investment-type contracts 
consist of contract charges against contract holders' funds for the cost of insurance, administra­
tion, surrender charges, actuarial margin, and other fees. Accident and health insurance premi­
ums are recognized as revenue pro rata over the terms of the contracts.
Separate accounts. Separate account assets and liabilities generally represent funds maintained in 
accounts to meet specific investment objectives of contract holders who bear the investment risk. 
Investment income and investment gains and losses accrue directly to such contract holders. The 
assets of each account are legally segregated and are not subject to claims that arise out of any 
other business of the company. The assets and liabilities are carried at market value. Deposits, net 
investment income, and realized and unrealized capital gains and losses on separate account 
assets are not reflected in the Statements of Income of ABC and are reflected directly in separate 
account liabilities.
Business risks and uncertainties. The development of liabilities for future policy benefits for the 
Company's products requires management to make estimates and assumptions regarding mor­
tality, morbidity, lapse, expense, and investment experience. Such estimates are primarily based 
on historical experience and future expectations of mortality, morbidity, expense, persistency, 
and investment assumptions. Actual results could differ materially from those estimates. Man­
agement monitors actual experience and, if circumstances warrant, revises its assumptions and 
the related future policy benefit estimates.
The Company's investments are primarily comprised of fixed maturity securities, equity securi­
ties, real estate, and mortgage loans. Significant changes in prevailing interest rates and geo­
graphic conditions may adversely affect the timing and amount of cash flows on such investments 
and their related values. In addition, the value of these investments is often derived from an 
appraisal, an estimate or opinion of value. A significant decline in the fair value of these 
investments could have an adverse effect on the Company's balance sheet.
The Company regularly invests in mortgaged backed securities (MBS) and other securities subject 
to prepayment and call risk. Significant changes in prevailing interest rates may adversely affect 
the timing and amount of cash flows on such securities. In addition, the amortization of market 
premium and accretion of market discount for MBS is based on historical experience and estimates 
of future payment speeds on the underlying mortgage loans. Actual prepayment speeds will 
differ from original estimates and may result in material adjustments to amortization or accretion 
recorded in future periods.
Codification. In 1999, the National Association of Insurance Commissioners (NAIC) completed a 
process to codify statutory accounting practices for certain insurance enterprises (Codification). 
The insurance laws and regulations of most states require insurance companies domiciled in those 
states to comply with the guidance provided in the NAIC Accounting Practices and Procedures 
Manual except as prescribed or permitted by state law.
Guaranty Funds. Guaranty fund (and other) assessments are accrued at the time the events occur 
on which assessments are expected to be based.
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Note 2: Earnings Per Common Share
Basic and diluted earnings per common share (EPS) are as follows.
(Thousands, except per Income Shares Per Common
common share data) (Numerator) (Denominator) Share Amount
20X2
Net income
Income applicable to common ownership
20X1
Net income
Income applicable to common ownership
2,254
2,254 3,342 .67
1,729
1,729 3,342 .52
Note 3: Investments
In reporting disclosures about investments in securities, entities should comply primarily with 
the requirements of paragraphs 6, 17, 19, 20, 21, and 22 of FASB Statement No. 115 (as amended); 
paragraphs 47 and 48 of FASB Statement No. 60 (as amended); paragraphs 22, 23, and 28 of FASB 
Statement No. 91 (as amended); and Appendix C of this Audit and Accounting Guide. Other 
disclosure requirements may also be applicable.
Note 4: Fair Value of Financial Instruments
The following methods and assumptions were used to estimate the fair value of each class of 
financial instruments for which it is practicable to estimate that value.
Short-term investments. For those short-term instruments amortized cost is a reasonable estimate 
of fair value.
Investment securities and trading account assets. For securities held for trading purposes and 
marketable equity securities held for investment purposes, fair values are based on quoted market 
prices or dealer quotes. For other securities held as investments, fair value equals quoted market 
price, if available. If a quoted market price is not available, fair value is estimated using quoted 
market prices for similar securities.
Mortgage loans on real estate and policy loans. The fair value of mortgage loans on real estate is 
estimated using discounted cash flows. The fair value of policy loans is estimated by discounting 
the future cash flows using reasonable assumptions for mortality and repayments and using the 
current rates at which similar loans would be made to contract holders with similar credit ratings 
and the same remaining maturities.
The estimated fair values of ABC's mortgage loans on real estate and policy loans are as follows.
20X2 20X1
Mortgage loans on real estate 
Policy loans
Carrying
Amount
$79,258
43,549
(Amounts in thousands)
Fair Carrying Fair
Value Amount Value
$83,506 $106,692 $112,027
60,000 51,013 59,000
Note 5: Accumulated Other Comprehensive Income
Accumulated other comprehensive income (loss) represents cumulative gains and losses on items 
that are not reflected in earnings. The balances and activity for the years 20X2 and 20X1 are as 
follows.
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20X2 20X1
(Amounts in thousands)
Changes in net unrealized gains (losses) on investment securities:
Net unrealized gains (losses) arising during the period 
Reclassification adjustment for gains (losses) included
$13,324 $(1,873)
in net earnings 46 (300)
Changes in net unrealized gains (losses) on investment securities 13,370 (2,173)
Adjustments for:
Policyholder liabilities, deferred acquisition costs and deferred
federal income taxes (4,680) 443
Changes in net unrealized gains (losses) net of adjustments 8,690 (1,730)
Total other comprehensive income (loss) $ 8,690 $(1,730)
Note 6: Income Taxes
Significant components for income tax expense attributable to continuing operations are as
follows.
20X2 20X1
(Amounts in thousands)
Current income tax expense $ 1,547 $ 601
Deferred income tax (benefit) expense (1,405) 540
Total income tax expense $ 142 $1,141
Deferred income taxes reflect the net tax effects of temporary differences between the carrying 
amounts of assets and liabilities for financial reporting purposes and the amounts used for income 
tax purposes. Significant components of the company's deferred tax liabilities and assets are as
follows.
December 31, December 31,
20X2 20X1
(Amounts in thousands)
Deferred tax liabilities:
Deferred policy acquisition costs $13,131 $12,297
Future policy benefits — 512
Accrual of discount on bonds 924 1,982
Other 3,641 1,024
Total deferred tax liabilities 17,696 15,815
Deferred tax assets:
Policyholder dividends 8,067 8,224
Future policy benefits 851 —
Deferred policy acquisition costs 2,078 1,561
Investment valuation allowance 1,087 1,651
Retirement plan accruals 1,917 497
Tax credits and loss carryforwards 1,820 1,945
Investment income differences 574 556
Other 406 354
Total deferred tax assets 16,800 14,788
Valuation allowance for deferred tax assets (516) —
Net deferred tax assets 16,284 14,788
Net deferred tax liabilities $ 1,412 $ 1,027
A Valuation allowance has been established due to the uncertainty of realized certain tax credits 
and loss carryforwards, and a portion of other deferred tax assets.
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A reconciliation of federal income tax expense as presented in the financial statements and income 
taxes calculated using the statutory corporate tax rate follows.
20X2 20X1
(Amounts in thousands)
Income from operations $2,396 $2,870
Application of income tax rate 838 1,005
Small company deduction for life insurance companies (556) (496)
Policyholders' share of income (loss) in excess of (less than)
dividends paid (264) 752
Dividend received deduction (3) (50)
Other 127 (70)
Total tax expense $ 142 $1,141
Note 7: Concentration of Credit Risk
At December 31, 20X2, ABC held unrated or less-than-investment grade corporate debt securities 
of $8,000,000, net of allowance for losses, with an aggregate market value of $7,500,000. Those 
holdings amounted to 4 percent of ABC's corporate debt securities investments and less than 2 
percent of total assets. The holdings of less-than-investment grade securities are widely diversi­
fied and of satisfactory quality based on ABC's investment policies and credit standards. ABC 
also invests in mortgage loans principally involving commercial real estate. At December 31, 20X2, 
3 percent of such mortgages ($2,000,000) involved properties located in California and Arizona. 
Such investments consist of first mortgage liens on completed income-producing properties, and 
mortgages on individual properties do not exceed $300,000.
Note 8: Liability for Unpaid Claims
The liability for unpaid claims and claim adjustment expenses is based on the estimated amount 
payable on claims reported prior to the balance sheet date that have not yet been settled, claims 
reported subsequent to the balance sheet date that have been incurred during the period then 
ended, and an estimate (based on prior experience) of incurred but unreported claims relating to 
such period.
Activity in the liability for unpaid claims and claim adjustment expenses for the Company's health 
and disability coverages is summarized as follows.
20X2
(Amounts in
20X1
thousands)
Balance, beginning of year $ 4,737 $ 7,669
Less: reinsurance recoverables 296 1,018
Net balance, beginning of year 4,441 6,651
Amount incurred, related to
Prior years $ (297) $ 313
Current year 26,197 25,671
Total 25,900 25,984
Amount paid, related to
Prior years 6,923 8,937
Current year 18,303 19,257
Total 25,226 28,194
Net balance, end of year 5,115 4,441
Plus: reinsurance recoverables 303 296
Balance, end of year $ 5,418 $ 4,737
As a result of changes in estimates of insured events in prior years, the provision of claims and 
claim adjustment expenses (net of reinsurance recoveries of $(7,000) and $722,000 in 20X2 and 
20X1, respectively) decreased by $297,000 in 20X2 reflecting lower-than-anticipated losses on
_________________ , and increased by $313,000 in 20X1 reflecting higher-than-anticipated losses
and related expenses for claims for_________________ .
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Note 9: Reinsurance
The Company utilizes indemnity reinsurance agreements to reduce its exposure to large losses 
in all aspects of its insurance business. Such reinsurance permits recovery of a portion of losses 
from reinsurers, although it does not discharge the primary liability of the Company as direct 
insurer of the risks reinsured. The Company evaluates the financial strength of potential reinsur­
ers and continually monitors the financial condition of reinsurers. The following tables include 
premium amounts ceded/assumed to/from other companies.
Direct
Amount
Ceded to
Other Companies
Assumed from 
Other Companies
Net
Amount
(Amounts in thousands)
20X2
Premiums:
Life insurance $2,090 $ 560 $3,330 $4,860
Accident and health 1,440 1,290 — 150
Annuities 3,130 — 70 3,200
Total earned premiums $6,660 $1,850 $3,400 $8,210
20X1
Premiums:
Life insurance $2,080 $ 520 $3,680 $5,240
Accident and health 1,510 1,370 — 140
Annuities 1,840 — 30 1,870
Total earned premiums $5,430 $1,890 $3,710 $7,250
Note 10: Guaranty Fund Assessments
At December 31, 20X2 and 20X1, ABC has recorded $45,000 and $67,000, respectively, in liabilities 
related to guaranty fund (and other) assessments which are included in other liabilities in the 
balance sheet. At December 31, 20X2 and 20X1, the carried liability was reduced by recoverables 
for related premium tax offsets and policy surcharges in the amount of $25,000 and $35,000, 
respectively. The period over which the assessments are expected to be paid and the recorded 
premium tax offsets and policy surcharges are expected to be realized is up to five and four years, 
respectively.
Note 11: Statutory Financial Information
Under the law of ABC State, the state of incorporation, the maximum dividend that may be paid 
(without prior approval of the (State) Insurance Department), in any twelve-month period is the 
greater of (a) net investment income for the preceding calendar year or (b) 10 percent of contract 
holders' surplus at the end of the preceding calendar year. In general, net investment income for 
dividend purposes is interpreted by the Insurance Department to be the statutory pretax net 
investment income including net realized capital losses but excluding net realized capital gains. 
The maximum permissible amount of dividends for 20X3, based on statutory net investment 
income for 20X2, is $20,000.
The Company, which is domiciled in ABC State, prepares its statutory financial statements in 
accordance with accounting principles and practices prescribed or permitted by the ABC state 
insurance department, which (state of domicile) recognizes for determining solvency under the 
(state of domicile) Insurance Law. The commissioner of the state of domicile Insurance Depart­
ment has the right to permit other practices that may deviate from prescribed practices. Prescribed 
SAP include state laws, regulations, and general administrative rules, as well as a variety of 
publications of the National Association of Insurance Commissioners (NAIC). Permitted SAP 
encompass all accounting practices that are not prescribed; such practices differ from state to state, 
may differ from company to company within a state, and may change in the future.
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Note: Although the following reconciliation to statutory financial information is not required to 
be disclosed in financial statements prepared in conformity with GAAP, insurance entities 
sometimes include such disclosures to facilitate use of those financial statements for purposes of 
filing with state regulatory authorities. The second disclosure on variances from NAIC SAP (as 
defined below) and permitted accounting practices is expected to be required under a proposed 
SOP, Amendments to Specific AICPA Pronouncements for Changes Related to the NAIC Codification, for 
specific amendments to SOP 94-5. Readers should be alert to any final SOP issued in the future 
inasmuch as the second disclosure is only required if and when the proposed SOP is issued as a 
final SOP.
The following reconciles ABC's statutory net income and statutory surplus and capital stock 
determined in accordance with accounting practices prescribed or permitted by the Insurance 
Department of Connecticut with net earnings (loss) and equity on a GAAP basis.
20X2
(Amounts in
20X1
thousands)
Statutory net income $ 3,572 $ 2,719
Adjustments:
Future policy benefits and policyholders' account balances 572 894
Deferred policy acquisition costs 60 40
Deferred federal income tax (expense) benefit (1,405) 540
Valuation of investments 115 270
Postretirement benefits 272 354
Other, net (932) (3,088)
GAAP net income $ 2,254 $ 1,729
Statutory surplus and capital stock $65,388 $54,505
Asset valuation reserves (1,054) (1,972)
Statutory surplus, capital stock and asset valuation reserves (875) (967)
Adjustments:
Fixed income securities (29,472) (27,905)
Future policy benefits and policyholders' account balances 115 270
Deferred federal income taxes (1,412) (1,027)
Valuation of investments 772 891
Deferred policy acquisition costs 38,936 36,429
Postretirement benefits (2,272) (2,354)
Other, net (1,228) (1,084)
GAAP equity $69,898 $58,954
The Company's statutory financial statements are presented on the basis of accounting practices 
prescribed or permitted by the [state of domicile] Insurance Department. [State of domicile] has 
adopted the National Association of Insurance Commissioners' statutory accounting practices 
(NAIC SAP) as the basis of its statutory accounting practices, except that it has retained the 
prescribed practice of writing off goodwill immediately to statutory surplus in the year of 
acquisition.
In addition, the commissioner of [state of domicile] Insurance Department has the right to permit 
other specific practices that may deviate from prescribed practices. The commissioner has 
permitted the Company to record its home office property at estimated fair value instead of at 
depreciated cost, as required by NAIC SAP. This accounting practice increased statutory capital 
and surplus by $X million and $X million at December 31, 20X2 and 20X1, respectively, over what 
it would have been had the permitted practice not been allowed. The Company's statutory capital 
and surplus, including the effects of the permitted practice, was $X million and $X million at 
December 31, 20X2 and 20X1, respectively.
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Had the Company amortized its goodwill over ten years and recorded its home office property 
at depreciated cost, in accordance with NAIC SAP, the Company's capital and surplus would 
have been $X million and $X million at December 31, 20X2 and 20X1, respectively.
Note 12: Commitments and Contingencies
Future minimum rental payments, principally for administrative offices, under noncancellable 
operating leases at December 31, 20X2, are: 20X3, $1,113,000; 20X4, $1,064,000; 20X5, $1,011,000; 
20X6, $976,000; 20X7, $976,000; and $3,906,000 thereafter. Rental expense was $1,164,000 in 20X2 
and $1,184,000 in 20X1.
ABC is named as defendant in a number of legal actions arising primarily from claims made under 
insurance contracts or in connection with previous reinsurance agreements. These actions have 
been considered in establishing its contract benefit liability. Management and its legal counsel are 
of the opinion that the settlement of these actions will not have a material effect on ABC's financial 
position or results of operations.
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Additional Core Publications to Add to Your 
Financial Reporting Library
Checklists and Illustrative Financial Statements
These industry-specific checklists are valuable tools to assist accountants in preparing financial 
statements and to assist auditors in their evaluation of the adequacy of disclosures in the financial 
statements they audit.
Dual AICPA/State CPA Society Member: $30.00
AICPA Member: $31.88
State CPA Society Member: $33.75
Nonmember: $37.50
Banks and Savings Institutions........................................................................ No. 008779XZ
Common Interest Realty Associations............................................................. No. 008766XZ
Corporations......................................................................................................No. 008781XZ
Defined Benefit Pension Plans........................................................................ No. 008776XZ
Defined Contribution Pension Plans................................................................ No. 008777XZ
Employee Health and Welfare Benefit Plan..................................................... No. 008778XZ
Health Care Organizations...............................................................................No. 008775XZ
Life Insurance....................................................................................................No. 008783XZ
Not-for-Profit Organizations.............................................................................No. 008773XZ
Property & Liability Insurance Companies....................................................... No. 008784XZ
State and Local Governmental Unit................................................................. No. 008774XZ
Supplements to Corporations Checklist
Dual AICPA/State CPA Society Member: $15.60 
AICPA Member: $16.58 
State CPA Society Member: $17.55 
Nonmember: $19.50
Construction Contractors................................................................No. 008780XZ
Investment Companies...................................................................No. 008782XZ
Real Estate Ventures......................................................................No. 008785XZ
Post Binder....................................................................................No. 007921XZ
Dual AICPA/State CPA Society Member: $21.00 
AICPA Member: $22.31 
State CPA Society Member: $23.63 
Nonmember: $26.25
To Order: Call 1-888-777-7077 or log on to www.cpa2biz.com
CPA2Biz is a strategic partner of the AICPA and State CPA Societies
Audit and Accounting Guides
Dual AICPA/State CPA Society Member: $42.40
AICPA Member: $45.05
State CPA Society Member: $47.70
Nonmember: $53.00
2001 Industry Guides
With conforming changes as of May 1, 2001.
Audits of Agricultural Producers and Agricultural Cooperatives.... No. 012356XZ
Audits of Airlines...............................................................................................No. 013185XZ
Brokers and Dealers in Securities..................................................No. 012183XZ
Audits of Casinos..............................................................................................No. 013155XZ
Common Interest Realty Associations...........................................No. 012491XZ
Construction Contractors..................................................................................No. 012098XZ
Audits of Employee Benefit Plans.................................................. No. 012341XZ
Audits of Entities With Oil and Gas Producing Activities................................. No. 012108XZ
Federal Government Contractors.................................................................... No. 012443XZ
Health Care Organizations................................................................................No. 012442XZ
Audits of Investment Companies..................................................................... No. 012365XZ
Life & Health Insurance Entities......................................................No. 012501XZ
Not-for-Profit Organizations..............................................................................No. 013394XZ
Audits of Property and Liability Insurance Cos.............................. No. 011924XZ
Audits of State and Local Governmental Units................................................No. 012062XZ
General Guides
Analytical Procedures (2001)................................................. No. 012541XZ
Audit Sampling (2001).......................................................................................No. 012530XZ
Auditing Derivative Instruments, Hedging Activities,
and Investments in Securities (2001).....................................No. 012520XZ
Auditing Revenue in Certain Industries (2001).............................No. 012510XZ
Consideration of Internal Control in a
Financial Statement Audit (1996)...........................................No. 012451XZ
Personal Financial Statements (2001)..........................................No. 011138XZ
Prospective Financial Information (2000).....................................No. 011179XZ
Use of Real Estate Appraisal Information (1997).........................No. 013159XZ
To Order: Call 1-888-777-7077 or log on to www.cpa2biz.com
CPA2Biz is a strategic partner of the AICPA and State CPA Societies
Comment Letter
We welcome any comments and suggestions you have regarding this Checklist. Please send this 
completed form to: AICPA Accounting and Auditing Publications Team, Harborside Financial Center, 
201 Plaza Three, Jersey City, NJ, 07311-3881. Thank you.
Checklist Title:________________________________________________________________________________
Comments and Suggestions:
TECHNICAL HOTLINE
The AICPA Technical Hotline answers 
inquiries about specific audit or accounting problems. 
Call Toll Free
(888)777-7077
This service is free to AICPA members.
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